Investigation of neurobiological-genetic correlates and source-informants of attention deficit hyperactivity disorder (ADHD) in adolescents and adults by Du Rietz, Ebba Eva Charlotte
This electronic thesis or dissertation has been 
downloaded from the King’s Research Portal at 
https://kclpure.kcl.ac.uk/portal/  
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT 
Unless another licence is stated on the immediately following page this work is licensed 
under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International 
licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to copy, distribute and transmit the work
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any
way that suggests that they endorse you or your use of the work).
 Non Commercial: You may not use this work for commercial purposes.
 No Derivative Works - You may not alter, transform, or build upon this work.
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 
other rights are in no way affected by the above. 
The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
Investigation of neurobiological-genetic correlates and source-informants of attention
deficit hyperactivity disorder (ADHD) in adolescents and adults
Du Rietz, Ebba Eva Charlotte
Awarding institution:
King's College London
Download date: 01. Mar. 2021
 
 
Investigation of neurobiological-genetic correlates and 
source-informants of attention deficit hyperactivity disorder 
(ADHD) in adolescents and adults 
 
Ebba Du Rietz 
 
Social, Genetic and Developmental Psychiatry Centre, Institute of 
Psychiatry, Psychology and Neuroscience, King’s College London 
 














Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental 
disorder associated with wide-spread impairments in behavioural, neurocognitive and 
biological functions. This thesis aimed to investigate neurobiological and genetic 
correlates, as well as informant source validity, of ADHD in adolescents and adults 
using a multi-disciplinary approach. In the first part of the thesis, the aim was to 
evaluate the validity of informant sources for ADHD by examining associations with 
cognitive-neurophysiological correlates and future adverse life outcomes using both 
clinical and epidemiological samples. The findings suggest that both parent- and self-
report of ADHD in adolescence and young adulthood may provide some valuable 
insight into symptoms and impairments, but parent-reports may have higher construct 
and predictive validity in this age range. In the second part of the thesis, the aims were 
to further our understanding of different neurobiological and genetic risk factors 
associated with ADHD, using cognitive-neurophysiological, electrodermal and genetic 
methods, in both clinical and population samples. Firstly, genetic analyses showed that 
ADHD risk alleles considered ‘en masse’, using polygenic risk scores, predicted several 
frequently co-occurring traits and disorders. These findings suggest that common 
genetic variation underlying risk for ADHD also contributes to higher body mass index, 
neuroticism, anxiety and depressive disorders, substance use, risk-taking and lower 
general cognitive ability in the general population. Secondly, analyses using 
electrodermal data suggest that abnormal autonomic arousal in ADHD varies as a 
function of recording context rather than reflecting stable impairments in the disorder. 
Finally, results from a randomised cross-over trial show that electroencephalogram 
(EEG) brain measures of executive and sustained attention improved after a single 
session of high-intensity exercise, suggesting that high-intensity exercise interventions 
may be appropriate for improving inattentiveness. Overall, this thesis provides insights 
into the validity of source-informants of ADHD in adolescents and young adults, and 
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CHAPTER 1 – Introduction 
1.1 Abstract 
In this introductory chapter, I will give an overview of attention-deficit/hyperactivity 
disorder (ADHD). I will first summarise diagnostic criteria, categorical and dimensional 
approaches, epidemiology and informant source validity in ADHD. I will then review 
the research on the genetic and environmental aetiology of ADHD and discuss 
neurobiological impairments in affected individuals. Treatments and interventions for 
ADHD will then be discussed. Finally, I will provide the specific aims of this thesis and 
discuss how the chapters will address these objectives.   
1.2 Introduction to ADHD 
ADHD is a neurodevelopmental disorder characterised by developmentally 
inappropriate levels of inattention, hyperactivity and impulsivity. The concept of 
ADHD-like problems was first introduced in the medical literature in the late 18th 
century by the German physician Melchior Adam Weikard in 1775 and the Scottish 
physician Alexander Crichton in 1798 (Barkley & Peters, 2012). The American 
Psychiatric Association (APA) first included ADHD, which was referred to as 
“hyperactive child syndrome”, in the Diagnostic and Statistical Manual (DSM) of 
Mental Disorders in its second edition in 1968 (DSM-II; APA, 1968). This was later 
updated in the third edition of DSM (DSM-III; APA, 1980), where equal emphasis was 
placed on the two symptom dimensions, and it was acknowledged that there could be 
heterogeneity in symptom presentations. This later led to the first distinction between 
ADHD subtypes (inattentive, hyperactive-impulsive and combined) in DSM-IV and the 
revised version DSM-IV-TR (APA, 1994; APA, 2000). In the latest DSM version (DSM-5), 
ADHD is further described into adulthood and the age of onset has been raised from 
seven years to twelve years, highlighting the possibility of ADHD symptoms emerging 
in early adolescents. Further, the DSM-5 has lowered the number of symptoms 
required to meet diagnosis in adults, from six to five symptoms, of either inattention 
or hyperactivity-impulsivity, and the ADHD subtypes are now termed “presentations”, 
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acknowledging that research shows that subtypes may not be stable across 
development (Willcutt, 2012).  
 
DSM diagnostic criteria are similar to those included in the International Classification 
of Disease (ICD-10), which is another diagnostic system by the World Health 
Organization (WHO) (World Health Organization, 1992). The latest version, ICD-10, 
refers to ADHD as “hyperkinetic disorder”, defined by the presence of symptoms from 
all three dimensions of inattention, hyperactivity and impulsivity in at least two 
settings (e.g. at home and at school). The ICD-10 is therefore considered more 
stringent as it describes a more severe form of ADHD (Sørensen, Mors, & Thomsen, 
2005).  
1.2.1 Diagnostic criteria of ADHD 
The diagnostic criteria used for the studies of clinical ADHD in this thesis have been 
based on the DSM-IV-TR, as the newer DSM-5 was not yet available during data 
collection procedures for SEFOS or the PGC. The DSM-IV-TR lists eighteen symptoms of 
ADHD (Table 1.1), which includes nine inattentive symptoms and nine hyperactive-
impulsive symptoms (six hyperactive, three impulsive). An individual is diagnosed with 
ADHD if they show a minimum of six symptoms from one of the subscales for at least 
six months and if symptoms are manifested before the age of seven years. According 
to the DSM-IV-TR, these symptoms should also be associated with functional 
impairments in at least two settings. Additionally, ADHD symptoms should not occur 
exclusively during the course of a pervasive developmental or psychotic disorder and 
should not be better explained by another psychiatric condition. Individuals can be 
diagnosed with one of three ADHD subtypes: predominantly inattentive-type (ADHD-
IA) if they display at least six inattentive symptoms, predominantly hyperactive-
impulsive type (ADHD-HI) if they display at least six hyperactive-impulsive symptoms, 
or ADHD combined-type (ADHD-C) if they display at least six symptoms in both 
subscales. Adults are diagnosed with ADHD according to the DSM-IV-TR if they first 
met diagnostic criteria in childhood and symptoms were present before the age of 
seven years, and if they meet diagnostic criteria in adulthood.  
18 
 
Table 1.1 DSM-IV-TR diagnostic items for ADHD 
Inattention  
1. Often fails to give close attention to details or makes careless mistakes in 
schoolwork, work, or other activity 
2. Often has difficulty sustaining attention in tasks or play activities 
3. Often does not seem to listen when spoken to directly 
4. Often does not follow through on instructions and fails to finish schoolwork, chores, 
or duties in the workplace (not due to oppositional behaviour or failure to 
comprehension) 
5. Often has difficulty organizing tasks and activities 
6. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained 
mental effort (such as schoolwork or homework) 
7. Often loses things necessary for tasks or activities at school or at home (e.g. toys, 
pencils, books, assignments) 
8. Is often easily distracted by extraneous stimuli 
9. Is often forgetful in daily activities 
Hyperactivity 
10. Often fidgets with hands or feet or squirms in seat 
11. Often leaves seat in classroom or in other situations in which remaining seated is 
expected 
12. Often runs about or climbs excessively in situations in which it is inappropriate (in 
adolescents or adults, may be limited to subjective feelings of restlessness) 
13. Often has difficulty playing or engaging in leisure activities quietly 
14. Often talk excessively 
15. Is often ‘on the go’ or often acts as if ‘driven by a motor’ 
Impulsivity 
16. Often has difficulty awaiting turn in games or group situations 
17. Often blurts out answers to questions before they have been completed 
18. Often interrupts or intrudes on others, e.g. butts into other children’s games 




1.2.2 Categorical and dimensional approaches 
The DSM and ICD frameworks use a categorical classification system to diagnose 
mental disorders such as ADHD. A disorder is classified as present or not present using 
binary definitions of disorders based on symptoms and impairment. This categorical 
classification is reflected by binary treatment protocols in clinical practice and has 
advantages, such as allowing clear diagnostic decisions and effective communication 
between professionals in health care and research (Coghill & Sonuga-Barke, 2012). This 
binary classification approach, however, does not reflect the mounting research that 
suggests that inattentive and hyperactive-impulsive symptoms represent the high end 
of traits that occur continuously throughout the population (Asherson, Buitelaar, 
Faraone, & Rohde, 2016). For example, sophisticated statistical modelling approaches, 
including factor mixture and taxometric procedures, have shown that ADHD represents 
a continuum of severity (Hudziak et al., 1998; Lubke, Hudziak, Derks, van Bijsterveldt, 
& Boomsma, 2009). Aetiological research has further shown that genetic influences 
underlying ADHD (Chen et al., 2008; Larsson, Anckarsater, Råstam, Chang, & 
Lichtenstein, 2012; Stergiakouli et al., 2016), and neurobiological correlates (Kuntsi et 
al., 2010, 2014), are similar across clinically diagnosed ADHD and ADHD symptoms in 
the population. This research has led to a paradigm shift initiated by the Research 
Domain Criteria (RDoC) by the National Institute of Mental Health (NIMH) to employ a 
more dimensional approach for the classification of mental illness (Insel et al., 2010). 
The RDoC may, however, have limited clinical utility for diagnostic and treatment 
practice (Brown & Barlow, 2005), as the dimensional approach has a less clear 
distinction between affected and unaffected individuals and fails to incorporate 
functional impairment experienced by individuals. Both categorical and dimensional 
frameworks may be valuable in research in different ways, and both approaches are 




1.2.3.1 Prevalence and developmental trajectories 
Meta-analyses suggest that the prevalence of ADHD is 5-7% in childhood and 
adolescence (Polanczyk, De Lima, Horta, Biederman, & Rohde, 2007; Willcutt, 2012) 
and around 2-5% in adults worldwide (Simon, Czobor, Bálint, Mészáros, & Bitter, 2009; 
Willcutt, 2012). While ADHD was initially regarded as a childhood-limited disorder (Hill 
& Schoener, 1996), research shows that the disorder can persist into adulthood. Adult 
ADHD has received increasing clinical and research awareness and recognition 
(Asherson et al., 2016; APA, 2013).  The lower prevalence of ADHD in adulthood may 
be explained by remission of symptoms in ADHD from childhood to adulthood. 
Another explanation may also be the low recognition of ADHD in adulthood, which in 
turn can lead to under-diagnosis in later ages. Until the recent DSM-5, the symptoms 
of ADHD included in the diagnostic manual were based on behavioural descriptions in 
children (APA, 2000; APA, 2013). Symptoms of hyperactivity-impulsivity in adulthood 
are often manifested as feelings of restlessness and inner tension (Kooij et al., 2010). If 
these are not captured by the DSM, the prevalence rate would be lower in adults as a 
result of under-diagnosis. Further, as clinicians may be less experienced with adult 
ADHD, it may be likely that adults with the disorder are easily misdiagnosed with 
another, perhaps more common, adult psychiatric disorder (Asherson et al. 2014).  
 
Numerous studies have found that ADHD symptoms, especially hyperactivity-
impulsivity, tend to decline with age (Faraone, Biederman, & Mick, 2006; Pingault et 
al., 2015; Willcutt, 2012). This has been reflected as remission of ADHD in adulthood, 
and follow-up studies have attempted to establish the proportion of individuals with 
childhood ADHD who will remit in adulthood. A meta-analysis of longitudinal studies 
found that, while ADHD in 15% of individuals diagnosed with the disorder in childhood 
persisted into young adulthood, 50% of individuals with childhood ADHD met criteria 
for partial remission, i.e. continued to have impairing symptoms despite failing to meet 
all DSM-IV diagnostic criteria (Faraone et al., 2006). However, there are large 
discrepancies in ADHD persistence rates that are derived from different studies.  
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Recent studies that followed up individuals with clinical childhood diagnosis of the 
severe ADHD-C type have reported persistence rates into adolescence and young 
adulthood of 79-87% (Cheung et al., 2015; van Lieshout et al., 2016). Persistence rates 
from recent birth-cohort studies, however, have been estimated around 1.5-10% 
(Agnew-Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015; Riglin et al., 2016). One 
reason for the large discrepancy between population-based and clinical studies in 
ADHD persistence rates may be that the clinically-referred children with ADHD 
identified in the clinical studies may have a more severe form of ADHD, compared to 
non-clinically referred children who did not seek treatment for the ADHD symptoms 
and impairment. The more severe form of ADHD may be less likely to remit in 
adulthood, which would lead to higher persistence rates. There have also been wide 
differences in the criteria adopted to establish ADHD ‘persistance’ across studies, such 
as only using ADHD symptoms rather than full ADHD diagnoses, which has been found 
to have a large effect on persistence rates (Caye et al., 2016; Sibley, Mitchell, & Becker, 
2016). Another possible reason for the discrepancy in persistence rates is the different 
use of source informants during follow-up, which will be discussed in further detail in 
section 1.3.  
 
Recent findings from population-based studies have now suggested that it may be 
possible for adults to present with ADHD without having met criteria for diagnosis in 
childhood (Agnew-Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015), which is 
required for an ADHD diagnosis according to the ICD and DSM manuals. These studies 
propose that ADHD can emerge in adolescence-to-adulthood and that this adult-onset 
ADHD may represent a distinct diagnostic condition from childhood ADHD. This 
proposal, which redefines how we diagnose adult ADHD, has recently been the topic of 
controversial debate. Critics have, for example, suggested that these population-based 
studies (1) overestimate the prevalence of adult-onset ADHD and (2) fail to take into 
account that childhood ADHD may have been missed, for example due to familial 
scaffolding. First of all, while childhood ADHD is diagnosed based on parent- and 
teacher-reports, adolescent and adult ADHD diagnoses have relied on self-reports in 
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the studies. The use of self-report may have led to less valid and over-estimated 
reports of ADHD symptoms, a trend which has been found in other population-based 
research (Merwood et al., 2013) as opposed to clinical studies where self-reports are 
often under-estimated compared to parents (Barkley, 2002; Sibley et al., 2012). 
Further, these studies have relied on screening instruments to assess ADHD and have 
failed to consider alternative causes of ADHD symptoms and to obtain full psychiatric 
histories of participants (Caye, Sibley, Swanson, & Rohde, 2017). A recent population-
based study found that the majority of late-onset ADHD cases were disregarded 
because of symptoms or impairment occurring exclusively in the context of heavy 
substance use or another mental disorder (Sibley et al. 2018). Second, researchers 
have suggested that children may experience sub-threshold ADHD symptoms, which 
may not reach a full ADHD diagnosis due to positive external scaffolding or protective 
factors, such as having a supporting family or high IQ (Faraone & Biederman, 2016). 
When such children face challenges later in development, possibly without the same 
external scaffolding, their symptoms may become more impairing and in turn reach 
diagnostic criteria. Adult-onset ADHD is still poorly understood and much more 
research, addressing these points of concern, is needed to clarify the nature of the 
condition.  
1.2.3.2 Gender differences 
The prevalence of ADHD, documented as rates of diagnoses or ADHD symptom count, 
has consistently been found to be higher in boys than in girls (Willcutt, 2012). 
Numerous studies report a higher prevalence in boys in childhood, with estimated 
gender ratios of 3:1 in population-based studies and 9:1 in clinic-referred studies 
(Polanczyk et al., 2007; Gaub & Carlson, 1997; Staller and Faraone, 2006). In adults, the 
prevalence rates have been found to be more similar across gender, with estimated 
gender ratios of 1:1 to 1.6:1 (Das, Cherbuin, Butterworth, Anstey, & Easteal, 2012; 
Faraone & Biederman, 2005; Kessler, Berglund, et al., 2005).   
 
There are several proposed theories attempting to explain the substantial lower 
prevalence of ADHD in girls. One possible reason may be that the diagnostic tools 
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currently used to diagnose ADHD are not suitable to diagnose girls. As current 
diagnostic criteria were developed on predominantly male samples, they may not be 
adequately generalisable to female samples (Nussbaum, 2012). Another possible 
explanation for the gender difference in prevalence rates is that girls with ADHD are 
underrepresented in childhood due to a gender-based referral bias. ADHD in girls is 
less often manifested by hyperactive-impulsive symptoms or associated disruptive 
behaviours than in boys (Biederman et al., 2002; Thorell & Rydell, 2008; Willcutt, 
2012). These externalising symptoms and behaviours are often associated with clinical 
referral, by parents and teachers, and may therefore explain why more boys receive an 
ADHD diagnosis in childhood. The more similar ADHD prevalence rates seen in 
adulthood may be explained by the fact that more adult ADHD cases are often self-
referred and thus, would not be subject to a gender-based referral bias due to 
externalising behaviour (Biederman et al., 2004). Alternatively, it may be that adult 
women with ADHD are more likely to self-refer to mental health services, which would 
in turn lead to more equal prevalence rates across genders because of an under-
diagnosis in adult men (Arcia & Conners, 1998; Biederman et al., 1994). Another 
possible reason for lower prevalence rates of ADHD in girls is that the disorder in girls 
could represent a less severe disorder than in boys. However, evidence for this theory 
has been mixed, with some studies showing that girls show less severe ADHD 
symptoms than boys (Arnett, Pennington, Willcutt, Defries, & Olson, 2015; Gaub & 
Carlsson, 1997), but other studies showing the opposite effect (Elkins, Malone, Keyes, 
Iacono, & Mcgue, 2011) or no gender difference (Novik et al., 2006).  
 
Yet another possible explanation for the gender difference in ADHD prevalence rates in 
children but not in adults, is a “protective model” in females (Jacquemont et al., 2014). 
This model suggests that for girls to meet ADHD diagnostic criteria they require more 
exposure to ADHD risk factors, such as a higher genetic or familial burden than boys as 
they would be more resilient to developing the disorder. Evidence for this model 
comes from studies showing that first-degree relatives (co-twins and siblings) of 
females with ADHD had significantly more ADHD symptoms than co-twins of males 
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(Martin et al., 2018; Smalley et al., 2000; Taylor et al., 2016), suggesting that females 
with ADHD may carry a higher familial risk burden for ADHD, indicated by their co-
twins having increased symptoms. Recent molecular genetic findings, however, 
suggest that females with ADHD do not have increased burden of common genetic 
variants and that autosomal variants show an almost complete overlap between 
females and males (Martin et al., 2018). Further, it may be that girls need more time to 
be exposed to sufficient risk factors to reach the criteria for an ADHD diagnosis and 
therefore have later-onset ADHD than boys. This is supported by the more equal 
gender ratio of ADHD prevalence in adults.  
 
The difference in prevalence rates between females and males is still, overall, poorly 
understood and there is a need for more empirical research to investigate the reasons 
for the discrepancy. The higher rate of ADHD in boys has led to a greater focus on 
ADHD in boys than in girls in many large-scale studies (e.g. Chen et al. 2008; Kuntsi et 
al. 2010; Doyle et al. 2000; Klein et al. 2012), which should be considered when 
interpreting research findings in the literature.   
1.2.3.3 Co-occurring conditions and associated life outcomes 
Individuals with ADHD are also at an increased risk of a wide range of mental and 
physical health conditions. Research has, for example, shown that over half of children 
with ADHD present with another psychiatric comorbidity (Jensen & Steinhausen, 2015; 
Kraut et al., 2013; Larson, Russ, Kahn, & Halfon, 2011), most commonly conduct 
disorder (CD) and oppositional defiant disorder (ODD) (Biederman, Newcorn, & Sprich, 
1991; Kraut et al., 2013; Larson et al., 2011). Children and adolescents with ADHD also 
often exhibit academic problems, which may in part be due to the high co-occurrence 
of specific learning difficulties such as dyslexia, dyscalculia and dysgraphia. A review 
reported that reading and numerical disorders occurred in 24-38%, and writing 
disorders in 59-65% of children diagnosed with ADHD (DuPaul, Gormley, & Laracy, 
2013). ADHD in children and adults is also associated with impairments in social 
communication and functioning, which are key component of autism spectrum 
disorder (ASD) (Polderman, Hoekstra, Posthuma, & Larsson, 2014; Rommelse, Geurts, 
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Franke, Buitelaar, & Hartman, 2011). Studies have suggested that around 20-50% of 
individuals with ADHD also display ASD symptoms (Banaschewski, Poustka, & 
Holtmann, 2011; Polderman et al., 2014; Rommelse et al., 2011).   
 
Numerous clinical and population-based studies also show that ADHD in adults is 
associated with an increased prevalence for a range of other co-occurring psychiatric 
conditions compared to the general population. These co-occurring conditions include 
anxiety (any anxiety disorder: 47% vs 20%), depression (19-33% vs 6-8%), bipolar 
disorder (BD; 5-19% vs 0.2-3%) (Faraone et al., 2006; Kessler et al., 2006; Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005; Larsson et al., 2013a), schizophrenia (0.8% vs 
0.1-0.3%) (Larsson et al., 2013b; McGrath, Saha, Chant, & Welham, 2008), and abuse 
of alcohol (6-42% vs 3-32%), drugs (2-30% vs 1-12%) and nicotine (42-55% vs 28-31%) 
(Faraone et al., 2006; Frei, Hornung, & Eich, 2010; Kessler et al., 2006; Kessler, Chiu, et 
al., 2005; Pomerleau, Downey, Stelson, & Pomerleau, 1995). Several lines of research 
have investigated the extent to which the same aetiological mechanisms may explain 
the co-occurrences of these psychiatric conditions with ADHD. Twin studies suggest 
moderately large shared genetic effects (genetic correlation (rA)=0.50-0.77) for the co-
occurrence of ADHD with depression and anxiety (Cole, Ball, Martin, Scourfield, & 
Mcguffin, 2009; Michelini, Eley, Gregory, & McAdams, 2015; Schmitz & Mrazek, 2001) 
and alcohol dependence (Capusan, Bendtsen, Marteinsdottir, Kuja-Halkola, & Larsson, 
2015), and family studies suggest that relatives of ADHD probands are more likely to 
have BD (odds ratio [OR]=1.84-2.54) and schizophrenia (OR=1.71-2.22) (Cole et al., 
2009; Faraone, Biederman, & Wozniak, 2012; Larsson et al., 2013b; McGrath et al., 
2008; Michelini et al., 2015; Schmitz & Mrazek, 2001), compared to relatives of 
controls. Emerging, yet limited, molecular genetic studies using genome-wide data 
have revealed moderate genetic correlations of ADHD with depression (rg=0.32-0.48), 
BD (rg=0.25), schizophrenia (rg=0.22) and smoking (rg=0.38-0.48) (Anttila et al., 2016; 




Research has further shown that ADHD diagnoses or elevated ADHD symptoms are 
associated with somatic health conditions, such as higher BMI in children (OR=1.20-
1.22) and in adults (OR=1.30-1.55) (Cortese et al., 2016; Nigg et al., 2016), regardless of 
medication use. Limited but growing research also suggests that the prevalence of 
asthma (5-24% vs 3-11%) (Fasmer, Halmøy, Eagan, Oedegaard, & Haavik, 2011; Secnik, 
Swensen, & Lage, 2005), sleep problems or disorders (43-80% vs 12-29%) (Brevik et al., 
2017; Fisher et al., 2014; Fuller-Thomson, Lewis, & Agbeyaka, 2016) and migraine (28% 
vs 19%) are higher in individuals with adult ADHD compared to controls (Fasmer, 
Halmøy, Oedegaard, & Haavik, 2011; Instanes, Klungsøyr, Halmøy, Fasmer, & Haavik, 
2018). Few studies have investigated the aetiological relationships between ADHD and 
co-occurring somatic conditions; however, emerging evidence points to common 
genetic mechanisms underlying the common co-occurrence of obesity with ADHD. A 
recent study found that siblings of obese men had increased risk for ADHD (OR=1.42, 
95% CI=1.24-1.63), compared to siblings of men with normal BMI (Chen et al., 2017). 
Furthermore, two recent genome-wide studies report significant genetic correlations 
(rg=0.21-0.26) between BMI and ADHD, identified through linkage disequilibrium score 
regression (LDSR) (Anttila et al., 2016; Demontis et al., 2018).  
 
Further research using neurobiological, genetic and environmental approaches is 
needed to identify the common mechanisms underlying these psychiatric and somatic 
co-occurrences with ADHD to better understand why the conditions frequently occur 
together. This may in turn be useful for preventing the emergence of other impairing 
disorders in ADHD, and improve treatment for individuals with co-occurring 
conditions. In Chapter 4, I further investigate the genetic associations between ADHD 
and co-occurring traits and disorders using powerful polygenic risk scoring methods.  
1.2.4 Summary 
ADHD is a common neurodevelopmental disorder that is often first diagnosed in 
childhood but can persist into adulthood. While childhood ADHD is more prevalent in 
boys than in girls, approximately half of the adult ADHD population consists of women. 
The change in the male-to-female ratio of ADHD prevalence from childhood to 
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adulthood is still poorly understood and more research is needed to reach conclusive 
explanations. Individuals with ADHD are more likely than the general population to 
display many co-occurring mental and physical health conditions, and emerging 
evidence suggests that these co-occurrences are largely due to common genetic 
mechanisms.  
1.3 Informant sources in diagnosing ADHD 
Different informant sources for reports of ADHD symptoms and functional 
impairments may be used to establish an ADHD diagnosis in clinical and research 
settings, depending on age and availability of informants. In childhood and young 
adolescence, parent reports, often together with teacher reports, are recommended 
and commonly used as informant sources (Taylor et al., 2004). Research suggests that 
teacher and parent reports of ADHD symptoms show low-to-moderate agreement 
across clinical and population-based samples (r=0.23-0.42) (McLoughlin, Rijsdijk, 
Asherson, & Kuntsi, 2011a; Mitsis, Mckay, Schulz, Newcorn, & Halperin, 2000; Sollie, 
Larsson, & Mørch, 2013). The low agreement reflects the fact that each informant may 
provide slightly different and unique information and points of views on the childrens’ 
behaviour in different settings.  
 
Self-report becomes increasingly important during diagnostic interviews from 
adolescence into adulthood and is recommended as the primary informant source for 
adult diagnosis (Kooij et al., 2010). It becomes more difficult in adulthood to collect 
multi-informant reports and therefore diagnoses are often solely based on self-report 
in both clinical and research settings (Asherson, 2005). Emerging empirical evidence, 
however, suggests that young adults with ADHD may underestimate or lack insight into 
their problems, which raises potential concerns regarding the accuracy of their 
accounts in research and clinical settings (Faraone & Biederman, 2016; Knouse, 
Bagwell, Barkley, & Murphy, 2005; Sibley et al., 2012).  
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1.3.1 Evaluation of informant sources in adolescence and adulthood 
Previous research suggests modest agreement between self- and parent-ratings of 
ADHD symptoms in adolescents and young adults (r=0.16-0.30) (Barkley, 2002; 
Pierrehumbert, Bader, Thévoz, Kinal, & Halfon, 2006; Wan Salwina, Baharudin, Nik 
Ruzyanei, Midin, & Rahman, 2013). Adolescents and young adults with ADHD tend to 
report their ADHD symptoms as less severe than their parents (Barkley, 2002; 
Guelzow, Loya, & Hinshaw, 2017; Pierrehumbert et al., 2006), which results in lower 
rates of ADHD persistence into adulthood when based on self-report. This suggests 
that previous clinical follow-up studies that have relied on self-report may have 
estimated persistence of ADHD to be lower than studies using parent-report. Follow-
up studies of clinical samples in young adulthood have confirmed that lower rates of 
persistence of ADHD are generally found when based on self-report compared to other 
informants such as parent-report (Barkley, 2002; Biederman et al., 2009, 2012; 
Biederman, Petty, Evans, Small, & Faraone, 2010; Klein et al., 2012; van Lieshout et al., 
2016).   
 
The exclusive reliance on adult self-report may have contributed to the low ADHD 
persistence rate of 5% reported by Moffitt et al. (2015), and similar low persistence 
rates in other recent population-based studies (Agnew-Blais et al., 2016; Caye et al., 
2016), which are substantially lower than previous follow-up studies that have relied 
on both self- and parent-report, reporting persistence rates between 15% and 35% 
(Biederman et al., 2010; Faraone et al., 2006). The discrepancy could also be explained 
by differences between population and clinical samples. One exception is a population 
study by Riglin et al. (2016) that reported a low persistence rate of 3.9% based on 
parent-report, but this may partly have been due to the short follow-up duration from 
childhood to 17 years of age and the use of a short 5-item ADHD scale to classify 
individuals. While adolescents and young adults with diagnosed ADHD tend to report 
their ADHD symptoms as less severe than their parents (Guelzow et al., 2017; 
Pierrehumbert et al., 2006), the opposite trend is often found in population-based 
samples, where self-ratings are higher than parent- or other-ratings (Merwood et al., 
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2013; Sibley et al., 2012). This may contribute to inflation in reports of adult-onset 
prevalence in population samples (Agnew-Blais et al., 2016; Moffitt et al., 2015).  
 
While it is possible that parents over-estimate the persistence of ADHD in their 
children after their children have left the family environment, the lower persistence 
rates based on self-report may also reflect under-diagnosis from under-estimated 
ADHD symptoms and impairments (Faraone & Biederman, 2016; Ginsberg, Quintero, 
Anand, Casillas, & Upadhyaya, 2014; Knouse et al., 2005). Emerging evidence supports 
the latter statement, suggesting that self-report of ADHD may be less accurate for 
capturing symptoms and impairment than parent-report in adolescence and young 
adulthood. Population-based and clinical studies have found that parent-reported 
ADHD symptoms show stronger associations with poor school achievement in 
adolescence and major life events in young adulthood, compared to self-report 
(Barkley, 2002; Pierrehumbert et al., 2006). Further, twin studies have found that the 
heritability estimate for ADHD is much lower when based on self-ratings (48%) than 
parent-ratings or clinically diagnosed ADHD (82-88%) (Larsson, Chang, D’Onofrio, & 
Lichtenstein, 2014; Merwood et al., 2013), which may partly indicate a rater-bias 
(Brikell, Kuja-Halkola, & Larsson, 2015). If individuals with ADHD tend to over- or 
under-estimate symptoms, systematic measurement error is introduced, which would 
influence the heritability estimates (Brikell et al., 2015). However, there are other 
possible explanations for the discrepancy in heritability estimates as further explained 
in section 1.4.1.1.  
 
Further research is needed to establish the validity of different informant sources for 
ADHD symptoms and impairment across the transitional stage between childhood and 
adulthood, to inform diagnostic procedures in both clinical and research settings. In 
Chapters 1 and 2 the construct and predictive validity of self- and parent-reports of 




While parent and teacher reports are used to diagnose childhood ADHD in clinical and 
research settings, self-report becomes increasingly important in adolescence and 
adulthood. Young individuals with ADHD tend to report their ADHD symptoms as less 
severe than their parents, which results in lower rates of ADHD persistence into 
adulthood based on self-report. Emerging evidence is consistent with the possibility 
that parent-reports in this age group are more reliable; however, more research is 
needed to understand the validity of informant sources and how they differ.  
1.4 Aetiology of ADHD 
1.4.1 Genetics 
ADHD is a complex disorder with a multifactorial aetiology. Quantitative genetic 
research during the last decades has established that ADHD runs in families and is 
largely influenced by genetic factors, while individual-specific environmental factors 
may also play a limited role. These findings have guided molecular genetic research 
that have explored the specific variants that underlie the genetic factors contributing 
to ADHD. There have also been efforts in identifying environmental risk factors in 
ADHD and studying how they interact with genes. These research efforts have 
highlighted the complexity of aetiological pathways to ADHD and how much is still to 
be learned.  
1.4.1.1 Quantitative genetic studies  
Family studies have consistently reported that relatives (parents and siblings) of 
children diagnosed with ADHD are more likely to have ADHD than relatives of typically 
developing children (Faraone et al., 2005). Adoption studies have further found that 
biological parents and siblings of nonadopted children with ADHD generally have 
significantly higher rates of ADHD, while adoptive parents of children with ADHD are 
not significantly different from parents of comparison children without ADHD (Willcutt, 
2006). These findings together suggest that ADHD is a heritable disorder that tends to 
run in families. Numerous twin studies have set out to estimate the heritability of 
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ADHD. Twin study designs can disentangle environmental and genetic influences 
underlying traits by comparing identical twins, who share many of the same aspects of 
their environment as well as their genetic makeup, and non-identical twins, who also 
share many of the same aspects of their environment but only 50% of their segregating 
(i.e. varying) genes. Meta-analyses of twin studies on ADHD in children and 
adolescents converge on heritability estimates of around 70-80% (Nikolas et al., 2010; 
Faraone et al., 2004). This suggests that around 70-80% of individual variance in ADHD 
symptoms is due to genetic influences. Most of the remaining variance has been 
attributed to non-shared environmental influences that are specific to each twin, 
rather than shared environmental influences that are shared between twins, such as 
family environments. These twin findings have replicated across gender and ADHD 
symptom dimensions (Greven, Rijsdijk, & Plomin, 2011; Nikolas & Burt, 2010). Twin 
study findings have further indicated that ADHD represents the quantitative extreme 
of symptoms that are continuously distributed throughout the population. This is 
supported by findings of similar genetic and environmental factors that contribute to 
ADHD in children across different levels of impairment (Larsson et al., 2012). 
 
While family studies of ADHD in adults have suggested a high degree of familial 
clustering (Faraone, 2004), most twin studies on adult ADHD have reported much 
lower heritability estimates (h2=37-44%) than in childhood and adolescent ADHD 
(Boomsma et al., 2010; Larsson et al., 2013; Polderman et al., 2013; Reiersen, 
Constantino, Grimmer, Martin, & Todd, 2008; Van Den Berg, Willemsen, De Geus, & 
Boomsma, 2006). Several lines of research suggest that the lower heritability estimates 
in older adults with ADHD might not reflect less of a genetic influence underlying 
ADHD in older ages, but may reflect the use of self-report for ADHD, rather than 
parent- and teacher-report. The use of self-reports may generate lower heritability 
estimates if self-assessed ADHD provides a less reliable measure of behaviour (Brikell 
et al., 2015; Knouse et al., 2005). Low reliability of measures increases measurement 
error (Franke et al., 2012), which would increase the non-shared environmental 
component in classical twin modelling and in turn impose a ceiling on heritability 
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estimates (Brikell et al., 2015; Merwood et al., 2013). This account would, however, 
not be enough to explain why heritability estimates of ADHD calculated from a 
different teacher or parent rater for each twin pair, rather than the same rater, have 
been similarly low as self-ratings (Kan, Van Beijsterveldt, Bartels, & Boomsma, 2014; 
Merwood et al., 2013). Thus, another plausible explanation for the lower heritability 
estimates for self-report in adult ADHD is the switch from relying on one informant 
(e.g. teacher/parent) in childhood for both twins in a pair, to relying on different 
informants for each twin in adulthood, as twins rate themselves. Agreement between 
two raters will always be lower than agreement between one rater, thus, twin studies 
relying on different raters for each twin in a pair may underestimate the twin 
correlation and heritability (Brikell et al., 2015). Conversely, when the same informant 
is used to rate both twins in a pair, this may produce inflation in twin correlations and 
heritability estimates (Freitag, Rohde, Lempp, & Romanos, 2010).  
1.4.1.2 Molecular genetic studies 
Genome-wide association analyses (GWAS), testing associations of several hundreds of 
thousands of genotyped common variants (single-nucleotide polymorphisms; SNPs) 
with an outcome, have previously struggled to identify genetic variants that show 
reliable and significant association with ADHD, and that explain more than a small 
fraction of its heritability (Neale et al., 2010; Williams et al., 2012). The difficulty in 
identifying genetic variants has likely been due to insufficient power and the polygenic 
nature of ADHD, in that risk is a consequence of a large number of genetic variants, 
each with very small effects.  
 
The most recent mega-GWAS of ADHD, however, including more than 20,000 ADHD 
cases and 35,000 controls has for the first time identified 12 independent loci in the 
genome that are significantly associated with ADHD (Demontis et al., 2018). The 
statistical power of GWAS allows the investigation of different aspects of the genetic 
aetiology of ADHD through the creation of polygenic risk scores (PRSs), which are 
composite scores, created for individuals based on the sum of their risk alleles across 
the genome, weighted by GWAS-derived effect sizes (more detail in Chapter 4). PRSs 
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derived from the new mega-GWAS could explain up to 5.5% of variance in ADHD case-
control status, when using five different sets of target and independent training 
samples (Demontis et al., 2018). These genetic association studies, together with twin 
study findings (Larsson et al., 2012), suggest that ADHD is largely explained by common 
genetic variants that are continuously distributed throughout the population.  
The SNP-based heritability based on the mega-GWAS sample (Demontis et al., 2018), 
i.e. the estimated amount of variance due to genotyped variants that commonly occur 
throughout the population, was estimated at 0.22, which is still noticeably lower than 
estimates from twin studies that incorporate both common and rare genetic variants. 
Thus, a proportion of heritability is likely to be explained by more penetrant, rare 
genetic variants (Martin, Hamshere, Stergiakouli, O’Donovan, & Thapar, 2015; Williams 
et al., 2010). A genome-wide analysis of rare copy number variants (CNV), with less 
than 1% population frequency, found enrichment of large, rare CNVs in children with 
ADHD compared to controls and identified duplications at a specific locus with a 
relatively large effects size of OR=2.22 (Williams et al., 2012). The successes in recent 
genetic studies on ADHD as a result of the growing sample sizes and technological 
advances have provided important insights into the aetiological underpinnings of 
ADHD and comorbid conditions and will allow for more advanced future genetic 
investigations. 
1.4.2 Environmental risk factors and gene-environment interplay 
Genetic studies have demonstrated that genes do not fully account for the risk of 
developing ADHD and several environmental risk factors have been suggested as being 
associated with the disorder. These putative environmental risk factors include pre-
natal smoking and alcohol-use, prematurity and low birth weight, diet and family 
adversity (Sciberras, Mulraney, Silva, & Coghill, 2017; Thapar, Cooper, Eyre, & Langley, 
2013). While several studies have reported significant associations between these 
environmental factors and ADHD, findings have not always replicated and studies have 
often failed to account for familial confounding, e.g. genetic risks that confer risk to 
both the risk factor and ADHD and other unmeasured familial factors shared between 
individuals in the same family (Sciberras et al., 2017; Thapar et al., 2013). One 
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approach that studies have taken to account for the unmeasured confounding has 
been sibling-comparison designs. In sibling-comparison studies, siblings are compared 
to estimate effects of individual-specific environmental effects while controlling for 
genetic and environmental effects that make siblings within a family similar. Research 
has shown that while controlling for unmeasured confounding using sibling-
comparison designs, or other similar genetically sensitive designs such as the in vitro 
fertilisation (IVF) design, the associations between ADHD and prenatal smoking and 
anti-depressant use, maternal BMI and family adversity were no longer significant, 
which questions the causality of these risk factors on ADHD (Chen et al., 2014; 
Laugesen, Olsen, Andersen, Frøslev, & Sørensen, 2013; Sciberras et al., 2017; Skoglund, 
Chen, D’Onofrio, Lichtenstein, & Larsson, 2014; Thapar et al., 2009). Other 
environmental risk factors, such as prematurity and low birth weight, may be causally 
associated with ADHD independent of other unmeasured confounding, however more 
research is needed controlling for other risks, such as smoking or alcohol use during 
pregnancy and familial confounding to establish the causality of these associations 
(Sciberras et al., 2017).  
 
It has been increasingly recognised that the relationship between genetic and 
environmental influences underlying ADHD is likely complex, as these factors may 
interact in different ways (Thapar, Harold, Rice, Langley, & O’Donovan, 2007). Genetic 
and environmental factors may interact (gene-environment interaction), such that 
certain environmental risk factors may contribute to ADHD only in individuals who 
have a particular genetic predisposition. An individual’s genetic predisposition may 
also increase the likelihood for them to be exposed to a certain environmental risk 
factor (gene-environment correlation), which might lead for example to inflated 
heritability estimates in twin studies. The complex interplay between genes and 
environments leads to difficulties when trying to identify genetic or environmental risk 
factors separately, and only a relatively small number of studies have studied the 
interplay between them in ADHD. Research has, for example, suggested that certain 
variations of genes involved in dopaminergic and serotonergic neurotransmission (e.g. 
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DAT1, COMT, 5-HTTLPR) moderate the adverse risk of early institutional deprivation, 
lower birth weight, perinatal substance use and stress on ADHD (Brookes et al., 2006; 
Kahn, Khoury, Nichols, & Lanphear, 2003; Stevens et al., 2009; Van Der Meer et al., 
2014). However, replications of these findings are needed to determine the role of 
gene-environment interplay in ADHD, and so far, some of these findings have proven 
difficult to replicate (Gould, Coventry, Olson, & Byrne, 2018; Nigg, Nikolas, & Burt, 
2010).  
1.4.3 Summary 
In this section I first reviewed how quantitative genetic research has established that 
ADHD is largely influenced by genetic factors, but also by individual-specific 
environmental factors. These findings have guided molecular genetic research, and 
recently a mega-GWAS successfully identified 12 loci in the genome that were 
significantly associated with ADHD. There have also been efforts in identifying 
environmental risk factors in ADHD, which has been proven difficult due to the 
complex relationship between genetic and environmental factors. More research is 
needed to establish the specific genetic and environmental risk factors underlying 
ADHD, and the complex interactions and correlations by which they operate.  
1.5 Neurobiological impairments in ADHD 
Cognitive, neurophysiological and electrodermal studies in ADHD aim to identify 
neurobiological correlates of ADHD to elucidate the mechanisms underlying impairing 
symptoms. A greater understanding of impairments related to ADHD on a 
neurobiological level may provide insights into the mechanisms involved in the 
pathways that lead to the clinical manifestation of ADHD. Such insights may prove 
beneficial for clinical diagnostic procedures, as well as inform targets for treatment of 
symptoms. In this section, I will review the literature on cognitive, neurophysiological 




1.5.1 Studies of cognitive impairments 
Executive function (EF) is an umbrella term for several higher cognitive functions 
including response inhibition, planning and working memory. EFs have consistently 
been found to be impaired in individuals with ADHD, and a meta-analysis of 83 studies 
report medium effect sizes (Cohen’s d=0.46-0.69) for EF impairments in children and 
adolescents with ADHD (Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). 
Particularly large effect sizes were found for response inhibition, vigilance, working 
memory and planning (Willcutt et al., 2005). Studies have revealed similar impairments 
in adults with ADHD (Lijffijt, Kenemans, Verbaten, & Van Engeland, 2005; Mowinckel, 
Pedersen, Eilertsen, & Biele, 2015).  
 
Individuals with ADHD also tend to show difficulties with focusing their attention over 
an extended period of time, which can be assessed using continuous performance 
tasks (CPTs). CPTs require participants to detect target stimuli among a sequence of 
distractor stimuli and respond to them by for example pressing a button (described in 
more detail in Chapters 2, 5 and 6). The CPT is designed to measure omission errors 
(OE), which are errors where participants fail to respond when they are expected to 
and reflect sustained attention. Other performance measures can also be obtained 
such as commission errors (CE), when participants respond to non-target stimuli and 
reflect poor response inhibition, and reaction time measures, including reaction time 
variability (RTV), which reflects intra-individual fluctuations in reaction times. A meta-
analysis of 47 studies found that children with ADHD consistently showed increased 
OE, CE and RTV (d=0.55-0.62) during CPTs compared to controls (Huang-Pollock, 
Karalunas, Tam, & Moore, 2012).  
 
A similar cognitive task, the Go/NoGo task, including Go and NoGo stimuli, is well-
designed to measure CEs as it has a higher target-to-non-target ratios than a CPT 
(more target stimuli and fewer distractor stimuli). A meta-analysis of 30 studies using 
Go/NoGo tasks found that children with ADHD showed increased CEs during task 
performance with moderate-to-large effects and the standard mean difference ranged 
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from 0.37 to 0.57 (Metin, Roeyers, Wiersema, Van Der Meere, & Sonuga-Barke, 2012). 
Similar results of impaired sustained attention (Antshel et al., 2010; Malloy-Diniz, 
Fuentes, Leite, Correa, & Bechara, 2007) and response inhibition (Bekker et al., 2005; 
Boonstra, Kooij, Oosterlaan, Sergeant, & Buitelaar, 2010; Boonstra, Oosterlaan, 
Sergeant, & Buitelaar, 2005) have been found in adults. The Eriksen flanker task is 
another performance task often used to study cognitive and neurophysiological 
impairments in ADHD, where target stimuli are presented with congruent or 
incongruent flanking stimuli (described in more detail in Chapter 6). The Eriksen 
flanker task is designed to measure cognitive processes of performance monitoring, 
inhibitory control and interference control, which have successfully distinguished 
between ADHD and control groups in both children and adults (Albrecht et al., 2008; 
McLoughlin et al., 2009; Michelini et al., 2016a).  
 
ADHD is also associated with slower and more variable reaction times relative to 
controls on cognitive tasks requiring a speeded response. A meta-analysis of 319 
studies reported a substantial effect size of RTV in children and adolescents with ADHD 
(Hedges’ g=0.76) and a medium effect size in adults with ADHD (g=0.46) (Kofler et al., 
2013) across a range of cognitive tasks, suggesting that high RTV is a consistent feature 
of ADHD. A meta-analysis of mean reaction times (MRT), obtained during continuous 
performance tasks, suggests a more modest effect size for increased MRT (d=0.37) 
(Huang-Pollock et al., 2012). Studies have further found that RTV decreases more 
among individuals with ADHD than controls during more stimulating task conditions 
(faster and with reward) (Andreou et al., 2007; Cheung et al., 2017; Kuntsi et al., 2013), 
suggesting that RTV is not a stable deficit but rather malleable and may be explained 
by deficits in arousal regulation or attentional allocation (James, Cheung, Rijsdijk, 
Asherson, & Kuntsi, 2016; Sergeant, 2005). The Fast task is a four-choice reaction time 
task with two conditions; the slow, unrewarded baseline condition has been found to 
consistently capture the characteristic slow and variable reaction times in individuals 
with ADHD, which improve in a fast, rewarded condition (Andreou et al., 2007; Cheung 




ADHD has also been associated with lower IQ scores. A meta-analysis of children with 
ADHD and controls reported an average difference of 7 to 11 points (Frazier et al., 
2004) and population-based studies have reported moderate negative correlations 
between IQ and ADHD symptoms (r=-0.20-0.40) (Kuntsi et al., 2004; Rommel, Rijsdijk, 
Greven, Asherson, & Kuntsi, 2015; Wood, Asherson, Van Der Meere, & Kuntsi, 2010). 
Several studies have suggested that higher IQ scores predicts better ADHD outcome 
among individuals with a diagnosis (Agnew-Blais et al., 2016; Cheung et al., 2015; Gao 
et al., 2015).  
1.5.2 Studies of neurophysiological impairments 
Complementing the literature on cognitive-performance deficits in ADHD, research has 
also outlined abnormalities in brain activity during task performance, reflecting a more 
direct measurement of covert neurophysiological processes that underlie the cognitive 
processes (Luck, 2005). A neuroimaging technique which has proven suitable in 
delineating the neurophysiological impairments in ADHD is electroencephalography 
(EEG), which allows direct investigation of underlying neural processes with 
millisecond temporal resolution. EEG measures electrical activity across the scalp, 
capturing brain voltage fluctuation generated by post-synaptic potential changes from 
groups of simultaneously active and similarly oriented cortical cells (Buzsáki & 
Draguhn, 2004).  
 
Research using other neuroimaging methods, particularly functional Magnetic 
Resonance Imaging (fMRI), have revealed that ADHD is associated with abnormalities 
across several partially separate neural systems. These include networks involved in 
executive cognitive functions, such as hypoactivation in the fronto-parietal network, as 
well as non-executive (e.g. reward) functions, such as hyperactivation in the default 
mode and the ventral-attentional networks (Castellanos & Proal, 2012; Cortese et al., 
2012). A recent cross-sectional mega-analysis of structural MRI brain scans of 
subcortical and intracranial structures in individuals with ADHD and controls, further 
reported reduced volumes of several brain regions in ADHD including the 
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hippocampus, accumbens and amygdala, with the most pronounced effects in 
childhood (Hoogman et al., 2017). The largest effect sizes were found for the 
amygdala, which is implicated in emotional regulation problems (Hoogman et al., 
2017). Functional and structural MRI techniques are useful for detecting brain regions 
and patterns of connectivity implicated in cognitive processes, behaviours and 
disorders, as they produce high-resolution images of the brain and its activity. These 
techniques do have their limitations however, as they are expensive and bulky to use 
in testing conditions. Furthermore, fMRI has poor temporal resolution and measures 
brain activity indirectly through magnetic changes associated with blood oxygen flow 
in areas of the brain. While EEG only captures brain activity at a scalp level and has 
poor spatial resolution, it is a direct measure of brain activity, has excellent temporal 
resolution, and can be portable, allowing for testing outside of laboratory settings. 
1.5.2.1 Quantitative EEG 
One way to examine EEG data is to measure spontaneous brain activity across a 
resting-state or task condition. As the EEG data consist of overlapping brain oscillations 
at different frequencies across power spectra, these can be decomposed from the 
measured data. Spectral decompositions, such as the Fast Fourier Transform (FFT), can 
delineate the activity into the different frequency bands. These bands are measured in 
hertz (Hz), i.e. cycles per seconds and are often divided into delta (0.5-3.5 Hz), theta 
(3.5-7.5 Hz), alpha (7.5-12.5 Hz), beta (12.5-30 Hz) and gamma (>30 Hz) (Loo & Makeig, 
2012), although the cut-offs for each band may vary slightly between studies (see 
Figure 1.1). These frequency bands have demonstrated high test-retest reliability 
(0.71-0.95), especially the theta and delta bands (>0.85) (Williams et al., 2005). The 
grouping of these different frequency bands has shown to have functional significance, 
as each of them has been found to be associated with different aspects of neural 
processes and behaviour. Traditionally, the frequency bands are examined during 
resting-state, where delta activity has often been associated with sleep and 
drowsiness, theta activity with arousal and conflict processes, alpha activity with 
wakeful relaxation and attentiveness, and beta activity with concentration and motor 
processes (Hughes & John, 1999; Klimesch, 2012; Uhlhaas & Singer, 2006). 
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Quantitative EEG (QEEG) is a measure of amount of power within frequency bands and 
has often been used to characterise atypical neurophysiological profiles in psychiatric 
disorders.  
 
Figure 1.1 EEG frequency bands. Adapted from Tye et al. (2011).  
 
 
QEEG studies have highlighted several aspects of atypical brain activity in children and 
adults with ADHD across resting-state and task conditions (Tye et al., 2011; 2012; 
Kitsune et al., 2015; Loo et al., 2009; 2010; Loo & Makeig, 2012). For example, 
individuals with ADHD often display increased power in slow (delta and theta) 
frequency bands and decreased power in fast (beta and alpha) bands during resting-
state conditions (Kitsune et al., 2015; Loo et al., 2009; Snyder & Hall, 2006; Tye et al., 
2012; Tye, McLoughlin, Kuntsi, & Asherson, 2011). Research has further suggested an 
imbalance in slow and fast wave brain activity in individuals with ADHD. This is 
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indicated by increased theta/beta ratio, compared to controls, with meta-analytic 
evidence suggesting an effect size of 3 and sensitivity and specificity of 94% (Snyder & 
Hall, 2006). The large effects sizes and high classification accuracy of the theta/beta 
ratio led the Federal Drug Administration in the USA to approve the ratio as an aid for 
clinicians during ADHD evaluations, along with standard diagnostic procedures 
(Snyder, Rugino, Hornig, & Stein, 2015). More recent studies, however, have failed to 
replicate the increased theta/beta ratio in ADHD populations (Arns et al., 2016; Loo et 
al., 2013; Rommel et al., 2016; Saad, Kohn, Clarke, Lagopoulos, & Hermens, 2015; 
Skirrow et al., 2015), which questions the validity of it being regarded as a putative 
biomarker for ADHD and being used to aid the diagnostic procedure (Arns et al., 2016). 
QEEG obtained during performance of tasks, such as the CPT, has also been used to 
study atypical patterns of brain activity in ADHD, but the research is more limited and 
has produced inconsistent findings. While some studies have reported elevated alpha 
and theta activity during task performance in individuals with ADHD, relative to 
controls (El-Sayed, Larsson, Persson, & Rydelius, 2002; Nazari, Wallois, Aarabi, & 
Berquin, 2011; Swartwood, Swartwood, Lubar, & Timmermann, 2003), other studies 
have reported no differences between groups (Loo et al., 2009; Rommel et al., 2016; 
Skirrow et al., 2015). These inconsistencies in findings may, in part, be attributed to 
differences between age groups of samples or tasks used in the studies. 
1.5.2.2 Event-related potentials 
Event-related potential (ERP) approaches take advantage of the excellent temporal 
precision of EEG measurement, as ERPs reflect increases in voltage that are time-
locked to an event. Typically, a participant’s ERP response to a specific stimulus in a 
task is averaged across all trials to produce an averaged ERP response, to remove any 
EEG oscillations unrelated to the stimulus, i.e. “noise”.  ERP components are used to 
describe the alternating positive and negative peaks of the ERP waveform (Luck, 2005) 
and components are quantified by obtaining their amplitude (i.e. magnitude) in 
microvolt (μV), and latency (i.e. timing in milliseconds) of the brain activity that 
contributes to each component (Figure 1.2) (Rusnáková & Rektor, 2012). Researchers 
have often used CPT and Go/NoGo paradigms to elicit ERP components that are 
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especially implicated in ADHD. A modified version of the CPT, the cue CPT with flankers 
(CPT-OX), has often been used to study cognitive processes relating to attention, 
response preparation and inhibitory control in individuals with ADHD (Banaschewski et 
al., 2003; Van Leeuwen et al., 1998) and is used in Chapters 2, 5 and 6. In the CPT-OX, 
participants are exposed to Cue stimuli that precede both Go and NoGo stimuli and are 
asked to respond only when the Go stimuli follow the Cue stimuli. ERPs that are time-
locked to the different stimuli reflect different covert processes. For example, the P3 is 
a late positive component evoked from stimulus presentation, which is thought to 
reflect (1) executive attention when evoked by the Go stimuli, (2) response inhibition 
when evoked by the NoGo stimuli and (3) attention orientation when evoked by the 














Figure 1.2 Simulated ERP waveform with typical components and naming 
conventions. Adapted from Rusnakova & Rektor (2012).  
Note: Negative voltage is plotted upwards.  
 
Studies of ADHD using the CPT and Go/NoGo paradigms have often demonstrated 
attenuated ERP components, relating to a range of cognitive processes, across ages 
(Albrecht et al., 2013; Cheung et al., 2016; Geburek, Rist, Gediga, Stroux, & Pedersen, 
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2013; Tye et al., 2011). For example, several studies have reported an attenuated 
fronto-central P3 component in response to NoGo stimuli (NoGo P3) in individuals with 
ADHD, which is thought to reflect poor response inhibition (Albrecht et al., 2013; 
Banaschewski et al., 2003; McLoughlin et al., 2010). Studies have also reported an 
attenuated parietal P3 component (Cue P3) and central contingent negative variation 
(CNV) following Cue stimuli using the CPT-OX task in individuals with ADHD, which 
reflect atypical attention orienting and response preparation, respectively (Cheung et 
al., 2016; Doehnert, Brandeis, Schneider, Drechsler, & Steinhausen, 2013; McLoughlin 
et al., 2010). Another, although less consistent, finding is an attenuated P3 to target 
stimuli in individuals with ADHD, which is thought to reflect atypical attention 
allocation during response execution (Cheung et al., 2017; Grane et al., 2016; Groom 
et al., 2010; Szuromi, Czobor, Komlosi, & Bitter, 2011). This finding has, however, not 
consistently replicated in other studies (Albrecht et al., 2013; Groom et al., 2008; 
McLoughlin et al., 2010), which may indicate that ADHD case-control differences may 
depend on the specific cognitive task or paradigm used.  
 
Studies have further found that ADHD is associated with atypical ERP components 
during performance monitoring paradigms (used in Chapter 6), such as Eriksen flanker 
tasks, which index goal-directed behaviours to monitor ongoing performance and 
adjust response selections. These studies have for example found that children and 
adults with ADHD show reduced frontal N2, which reflects conflict monitoring arising 
from two competing responses and evaluation of the correct response (McLoughlin et 
al., 2009; Michelini et al., 2016a; Wild-Wall, Oades, Schmidt-Wessels, Christiansen, & 
Falkenstein, 2009). Reduced N2 components have generally not been found in studies 
using the CPT-OX (Doehnert et al., 2013; McLoughlin et al., 2010, 2011), which may 
indicate that these impairments are only evident in higher-conflict monitoring 
paradigms (McLoughlin et al., 2009). Studies in children and adults with ADHD have 
further reported performance monitoring impairments of atypical error-related 
negativity (ERN) and error-related positivity (Pe), two ERP components that underlie 
error processing when an incorrect response has been made. A reduced fronto-central 
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ERN, reflecting impaired automatic error processing, has been found in individuals 
with ADHD during flanker tasks (Albrecht et al., 2008; Geburek et al., 2013; McLoughlin 
et al., 2009), however findings have been mixed, especially when using Go/NoGo 
paradigms (Groom et al., 2013; O’Connell et al., 2009). Similarly mixed findings have 
been found for the Pe, which is thought to reflect conscious error processing (Bjoern 
Albrecht et al., 2008; Groom et al., 2013; McLoughlin et al., 2009; Michelini et al., 
2016a; O’Connell et al., 2009). Inconsistent ERP findings in the literature on 
performance monitoring may be due to the variability across studies in how they 
measure the components, such as peak amplitude or area amplitude, as well as the 
modest sample sizes of most investigations into these ERPs.   
1.5.3 Studies of autonomic arousal  
Research further suggests that individuals with ADHD show abnormal profiles in 
autonomic arousal, which reflects changes in electrodermal activity obtained from 
electrodes on the skin surface. Electrodermal activity is a sensitive index of 
sympathetic nervous system (SNS) activity, a system that plays a key role influencing 
arousal and alertness and is part of the autonomic system (Boucsein, 2012; Dupuy, 
Clarke, Barry, Selikowitz, & McCarthy, 2014; Van Lang et al., 2007). Investigations of 
electrodermal activity rely on the assumption that the skin has electrical properties 
that can be altered in a short time frame, are influenced by the SNS and show 
associations with cognitive states (Boucsein, 2012). Increased activation of the SNS 
stimulates sweat gland activity in turn increases skin conductance (SC), an index of 
electrodermal activity (Figure 1.3). SC is commonly measured through electrodes on 
the palms or fingers of the non-dominant hand. A very small constant voltage (0.5 
Volt) is applied across the electrodes to measure the current flow and in turn 
determine how well the skin conducts electricity. SC (expressed in microSiemens) can 
be measured as SC level (SCL), which represents a tonic level of arousal averaged 
across a time-window, usually resting-state or cognitive performance, or SC responses 
(SCRs), which represent a phasic change in SC (Boucsein, 2012; Figner & Murphy, 
2010). SCRs can be obtained as averaged time-locked components to a specific event, 
e.g. stimuli in a cognitive task, or be obtained as non-specific SCRs, also called non-
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specific fluctuations (NSFs), which can be studied across a whole time-window during 
resting-state or task performance. Chapter 5 in this thesis will focus on SCL, which 
indexes increased peripheral arousal, and NSFs, which indexes more variability in 















Figure 1.3 An eccrine sweat gland. Adapted from Hassett (1978).  
The sympathetic nervous system (SNS) stimulates the production of sweat in the 
secretory portion of eccrine sweat glands in the subdermis layer of the skin. Sweat rises 
up to sweat pores in the epidermis layer of the skin, through eccrine sweat ducts in the 




Numerous studies have found that children with ADHD have lower levels of SCL, 
indicating hypo-arousal during resting-state and task conditions (Barry et al., 2012; 
Conzelmann et al., 2014; Dupuy et al., 2014; Iaboni, Douglas, & Ditto, 1997; Lazzaro et 
al., 1999; Mangeot et al., 2001; Mangina, Beuzeron-Mangina, & Grizenko, 2000; 
O’Connell, Bellgrove, Dockree, & Robertson, 2004). Research is however more limited 








Mayer, Wyckoff, & Strehl, 2016). One study found that lower SCL in ADHD was 
reported in a slow, unrewarded reaction time task, but normalised in a faster, 
incentive task, suggesting that hypo-arousal can be modifiable in ADHD (James et al., 
2016). Mixed findings, mainly from studies on children and adolescents with ADHD, 
have also emerged for NSFs in the skin conductance. Several studies have reported 
significantly fewer NSFs in individuals with ADHD compared to controls during resting-
state (Beauchaine, Katkin, Strassberg, & Snarr, 2001; Crowell et al., 2006; Satterfield & 
Dawson, 1971), while other studies report no significant difference (Beauchaine et al., 
2015) or an effect in the opposite direction (Pliszka, Hatch, Borcherding, & Rogeness, 
1993). Further research is needed using larger sample sizes and where effects are 
examined across contexts, to clarify these inconsistencies in the SC literature. In 
Chapter 5 we discuss this further in a study where SC profiles of individuals with ADHD 
are examined across a long testing assessment in a large sample of adolescents and 
young adults with ADHD and controls.  
1.5.4 Summary 
In this section, I have reviewed cognitive tasks that are commonly used to study 
cognitive-performance and neurophysiological impairments in ADHD. Overall, research 
has shown that ADHD is associated with a range of neurobiological impairments 
relating to attentional orienting and lapses, response inhibition and preparation, 
conflict monitoring and autonomic arousal, amongst others, during resting-state and 
task performance. I have reviewed studies on brain activity using the EEG approach, as 
this is the methodology used in the data-based chapters, but other neuroimaging 
methods are largely in line with the cognitive-electrophysiological abnormalities 
reported. fMRI studies, for example, indicate that ADHD is associated with 
abnormalities across several partially separate neural networks involved in executive 
as well as non-executive cognitive functions, including hypoactivation in the fronto-
parietal network and hyperactivation in the default mode and the ventral-attentional 
networks (Castellanos & Proal, 2012; Cortese et al., 2012).  
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1.6 Treatment and interventions for ADHD 
As ADHD can be a highly impairing disorder and is often associated with adverse 
outcomes, it is important that affected individuals receive continued support and 
treatment for their symptoms. In this section the literature on the effectiveness of 
pharmacological and non-pharmacological treatments for ADHD will be reviewed. I will 
also describe in more detail the beneficial effects of physical exercise on ADHD and 
related impairments.   
1.6.1 Pharmacological and non-pharmacological treatments 
The National Institute of Health and Care Excellence (NICE) guidelines recommend 
pharmacotherapy for children and young people with ADHD only if their symptoms are 
still causing impairment in at least one domain after environmental modifications have 
been implemented (NICE, 2018). Cognitive behavioural therapy (CBT) is recommended 
for young people with ADHD who have benefited from medication but whose 
symptoms are still causing impairments. Parent training along with group-based ADHD-
focused support is recommended for children and adolescents with severe 
impairments or comorbid symptoms of oppositional defiant disorder and conduct 
disorder (ODD/CD). Pharmacotherapy is also recommended for adults with ADHD 
whose symptoms are still causing significant impairment after environmental 
modifications have been implemented (NICE, 2018). Non-pharmacological treatment is 
recommended in combination with medication for adults with ADHD who have 
benefited from medication but are still experimenting significant impairments in at 
least one domain. The first-line medication for ADHD is the psychostimulant 
methylphenidate, although other common medications are dexamphetamine, and 
non-stimulant drug treatments with atomoxitine (NICE, 2018; Retz, Retz-Junginger, 
Thome, & Rösler, 2011).  
 
A large body of research, including meta-analytic evidence, suggests beneficial effects 
of drug treatments on ADHD, with moderate-to-large effect sizes across studies in both 
children and adults (Chan, Fogler, & Hammerness, 2016; Gayleard & Mychailyszyn, 
2017; Maneeton et al., 2015; Prasad et al., 2013). A recent meta-analysis of 185 
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randomised clinical trials and 243 non-randomised studies questioned the beneficial 
effects of stimulant medication and its safety for children and adolescents with ADHD 
(Storebø et al., 2015) because of low quality of clinical trials and associated adverse 
events such as sleep problems and decreased appetite; however, several major flaws 
of this study have been highlighted by other scientists in the field (Banaschewski et al., 
2016; Mulder, Hazell, Rucklidge, & Malhi, 2016). For example, Storebø and colleagues 
added their own item on the Cochrane protocol to the quality of measures that was 
used to deem studies as ‘low quality’ and the average duration of evaluation of the 
effects of medication was only 75 days, which may have been too short of a duration 
to pick up the beneficial effects of medication. 
 
It is also important to thoroughly investigate the effectiveness of non-pharmacological 
treatments, as some individuals wish to avoid taking medication and as almost one 
third of individuals with ADHD experience non-effectiveness or intolerable side effects 
from treatment (Biederman, Spencer, & Wilens, 2004). Behavioural interventions are 
recommended as non-pharmacological treatment in the NICE guidelines. Meta-
analyses of randomised control studies indicate that when outcomes are rated by 
blinded reviewers, there are significant small-to-medium beneficial effects of 
behavioural interventions on child and parent functioning, but non-significant effects 
on core ADHD symptoms (Daley et al., 2014; Sonuga-Barke et al., 2013). The lack of 
significant effects on core symptoms may be attributed to the potentially poor validity 
of probably blinded measurements of outcomes; these are often based on small 
snapshots of behaviour or are rated by teachers who may not know the child well 
(Sonuga-Barke et al., 2013), or due to variability in effectiveness of different 
behavioural interventions. Other non-pharmacological interventions that have been 
developed are psychological, such as cognitive training, mindfulness and 
neurofeedback (Cortese et al., 2015; van Doren et al., 2018), and dietary treatments, 
such as restricted elimination diets and free fatty acid supplementation (Nigg & 
Holton, 2014; Pelsser, Frankena, Toorman, & Pereira, 2017). Yet, blinded evidence for 
reductions of non-pharmacological treatments on core ADHD symptoms in controlled, 
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randomised studies are highly needed as limited small effects have only been reported 
for few-foods diets, artificial food colour exclusion and neurofeedback (Pelsser et al., 
2017; Sonuga-Barke et al., 2013; van Doren et al., 2018). 
1.6.2 Exercise as a protective factor and potential intervention 
Physical exercise has emerged as another putative non-pharmacological intervention 
for ADHD and initial evidence suggests that it may work as a potential protective 
factor, increasing adaptive functioning, in individuals with ADHD (Rommel, 
Lichtenstein, et al., 2015; Rommel, Halperin, Mill, Asherson, & Kuntsi, 2013). Emerging 
but limited studies using experimental designs have even showed that a single bout of 
acute exercise can facilitate performance and brain processes during cognitive tasks in 
individuals with a diagnosis. Studies that have employed acute (short-lived) exercise 
paradigms of moderate and high intensity and sufficient duration (20 minutes or 
longer) have reported improvements on cognitive performance measures of EF, 
attention, vigilance, response accuracy, reaction time and even scholastic achievement 
(reading and arithmetic tests), in children and young adults with ADHD (Chang, Liu, Yu, 
& Lee, 2012; Gapin, Labban, Bohall, Wooten, & Chang, 2015; Piepmeier et al., 2015; 
Pontifex, Saliba, Raine, Picchietti, & Hillman, 2013). Few studies have explored the 
effects of acute exercise on brain measures underlying cognitive processing in 
individuals with ADHD, but limited evidence suggest beneficial effects of larger P3 
amplitudes during a flanker task, indicating improved attention allocation (Pontifex et 
al., 2013) and smaller CNV amplitude following a No-Go stimulus, indicating improved 
response preparation (Chuang, Tsai, Chang, Huang, & Hung, 2015).   
 
A greater number of studies have investigated the acute effects of exercise on 
cognitive performance and brain measures in the general population. As research 
suggests that ADHD symptoms and associated neurocognitive impairments may reflect 
the extreme end of continuous traits and measures distributed throughout the 
population (Kuntsi et al., 2014; Larsson et al., 2012), studying these measures in 
healthy populations will also be informative for understanding ADHD. Positive effects, 
particularly of acute exercise sessions of 20 minutes or more in duration, have been 
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reported in experimental studies on a range of cognitive performance measures. These 
measures include inhibition and interference control (effect size; ES=0.25-0.46), 
attention (ES=0.42), mean reaction time (MRT) (ES=0.30-1.41) and short-term memory 
(ES=0.26) (Chang, Labban, Gapin, & Etnier, 2012; McMorris & Hale, 2012; McMorris, 
Sproule, Turner, & Hale, 2011; Roig, Nordbrandt, Geertsen, & Nielsen, 2013; Verburgh, 
Königs, Scherder, & Oosterlaan, 2014). Several studies suggest that effects are largest 
for executive functioning, such as response inhibition and interference control (Chang 
et al., 2012b; Kramer & Erickson, 2007; Tomporowski, Davis, Miller, & Naglieri, 2008), 
but relatively few studies have investigated effects on measures of attention and 
attentional lapses. Findings on executive functioning and processing speed have also 
been mixed, as some studies have failed to replicate the beneficial effect of acute 
exercise (Coles & Tomporowski, 2008; Wang et al., 2015). These inconsistent findings 
might be explained by differences in the experimental paradigms used, such as the 
intensity of exercise, fitness level of participants and time lapse after exercise (Chang 
et al., 2012a), as well as by differences in the tasks and aspects of cognitive functions 
being studied.  
 
Further beneficial effects of acute exercise in children and adults have been reported 
using neurophysiological methods, such as EEG, to better understand the neural 
processes enhanced by exercise. These findings, from experimental studies in children 
and adults, include increased alpha (Brümmer, Schneider, Abel, Vogt, & Strüder, 2011; 
Mierau et al., 2014; Moraes et al., 2011; Schneider, Brümmer, Abel, Askew, & Strüder, 
2009b; St-Louis-Deschenes, Moore, & Ellemberg, 2015a) and beta spectral power 
(Moraes et al., 2007, 2011; Schneider et al., 2009b), mainly in frontal and parietal 
areas, during resting-state conditions, which are thought to reflect arousal and 
activation. However, the direction of these effects on alpha and beta EEG power has 
been mixed and findings have been inconsistent (Brümmer et al., 2011; Mierau et al., 
2014; Moraes et al., 2007; Schneider et al., 2009b; St-Louis-Deschenes et al., 2015a). 
Discrepancies in study findings are likely due to heterogeneity in study methodologies 
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and exercise paradigms, but also a lack of a control group in some studies (Fumoto et 
al., 2010; Mierau et al., 2014; Schneider et al., 2009b). 
 
The most consistent ERP finding has been an exercise-induced increase in P3 
amplitude in flanker and Go/No-go tasks during target stimulus presentation (Go P3), 
reflecting attention allocation and execution (Chang, Pesce, Chiang, Kuo, & Fong, 
2015a; Drollette et al., 2014; Hillman, Snook, & Jerome, 2003; Kamijo et al., 2004; 
Kamijo, Nishihira, Higashiura, & Kuroiwa, 2007; St-Louis-Deschenes, Moore, & 
Ellemberg, 2015b). Enhancements in Go P3 amplitude after exercise have in some 
studies been paralleled with improved behavioural performance of faster reaction 
times (Kamijo et al., 2009, 2007; Ludyga et al., 2017), and increased performance 
accuracy (Drollette et al., 2014; Hillman, Kamijo, & Scudder, 2011). The literature on 
the effect of exercise on brain measures of specific cognitive processes is still limited 
and few studies have explored effects across several cognitive tasks and ERP 
components in a single testing session.     
 
In Chapter 6 we aimed to investigate the effects of a single bout of high-intensity 
aerobic exercise on a cycle ergometer on a range of performance and EEG measures 
implicated in attention, inhibition and performance-monitoring. These measures were 
obtained across three successive cognitive tasks, performed 30 to 64 minutes after 
exercise, in a population sample of young adult men. 
1.6.3 Summary 
NICE guidelines recommend behavioural interventions as first-line treatment for 
children and adolescents with mild to moderate severity of ADHD symptoms, while 
pharmacotherapy can be used in combination with behavioural interventions as first-
line treatment in cases with severe impairments or comorbid ODD/CD. 
Pharmacotherapy is used as first-line treatment for adults with ADHD. Meta-analytic 
evidence suggests that pharmacological medication is overall effective in treating core 
ADHD symptoms. Behavioural interventions have been found to be effective in 
treating parent and child functioning, but not core ADHD symptoms. Emerging 
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research has suggested beneficial effects of physical exercise on performance and 
brain-indices of cognitive processing in individuals with ADHD and in healthy 
populations, highlighting the potential role for exercise as a protective factor and 
treatment in ADHD.   
 
1.7 Aims and objectives 
This thesis aims to investigate informant source validity, genetic and neurobiological 
correlates of ADHD in adolescents and adults using a multi-disciplinary approach. In 
the first part of the thesis (Chapters 2 and 3), the aim is to evaluate the validity of 
informant sources for ADHD by examining associations with cognitive-
neurophysiological correlates and future adverse life outcomes using both clinical and 
epidemiological samples. The second part of the thesis (Chapters 4, 5 and 6) aims to 
further our understanding of different aspects of biological factors associated with 
ADHD, using a combination of both clinical and population samples. Specifically, the 
aims are to (1) examine the genetic associations between ADHD and commonly co-
occurring traits and disorders, (2) establish the stability of autonomic arousal profiles 
in ADHD, indexed by electrodermal activity, and (3) study the effects of physical 
exercise on cognitive-neurophysiological measures of attention, inhibition and 
performance-monitoring.  
1.7.1 Informant source validity of ADHD in adolescents and young adults (Chapters 2 
and 3) 
In the first two data-based chapters, the studies aim to investigate the validity of self- 
and parent-report of ADHD in the transitional stage from childhood (where parent- 
and teacher-report are gold-standard for diagnosis) into young adulthood, where self-
report becomes increasingly important for diagnosis, in both research and clinical 
settings.  
 
In Chapter 2, the main aim is to evaluate the construct validity of self-reported ADHD 
by investigating how well self-report of symptoms and impairment is reflected by 
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cognitive-neurophysiological and movement measures, which have previously been 
well reflected by parent-reported ADHD in the same sample (Cheung et al., 2016). 
These analyses are conducted on a follow-up sample of children with ADHD diagnoses 
and controls when they reached adolescence and young adulthood (Sibling EEG Follow 
Up Study; SEFOS). The objective in Chapter 3 is to evaluate the predictive validity of 
self- and parent-rated ADHD symptoms across adolescence on future adverse life 
outcomes. In a population-based sample (Twin Study of Child and Adolescent 
Development; TCHAD), I examine how well self- and parent-rated symptoms in early 
(13-14 years) and late (16-17 years) adolescence can predict adverse socioeconomic 
and health outcomes in early adulthood, both by exploring the unadjusted associations 
and associations adjusted for the other informant.  
 
The overarching aim of the research in these two chapters are to examine the validity 
of each informant using different, converging approaches, in the transitional age 
between childhood and adulthood. Understanding which informant source is the most 
valuable or insightful in a certain developmental stage can inform researchers and 
clinical practitioners about the source to prioritise during diagnosis in the age group.  
1.7.2 Neurobiology and genetics in ADHD (Chapters 4, 5 and 6) 
The second part of this thesis aims to elucidate different aspects of the biological 
underpinnings of ADHD, by employing genetic, electrodermal and cognitive-
electrophysiological methods in population-based and clinical samples.  
 
In Chapter 4, the objective is to examine whether the frequent co-occurrences of other 
traits and disorders in ADHD can be explained by common genetic factors, by using 
powerful PRSs derived from the newly available large-scale mega-GWAS. Specifically, 
associations are examined between PRSs for ADHD and several frequently co-occurring 
conditions in a large population-based sample (UK Biobank Resource). In Chapter 5, 
the main goal is to investigate if autonomic arousal, indexed by electrodermal activity, 
in individuals with ADHD changes over a long testing session and across time, to clarify 
if arousal profiles are context-dependent or reflect stable impairments. Using a clinical 
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sample (SEFOS), autonomic arousal profiles of individuals with ADHD are explored 
across a long testing assessment, consisting of four successive resting-state and task 
(CPT-OX and Fast Task) conditions. The main aim in Chapter 6 is to explore the effects 
of physical exercise, compared to rest, on cognitive-performance and EEG measures of 
attention, inhibition and conflict-monitoring. Cognitive-performance and EEG 
measures across three successive task conditions (CPT-OX, Flanker and Fast Tasks) are 
compared before and after a high-intensity exercise session and a resting control 
condition in young and healthy adult men (Effect of Physical Activity on Cognition and 
Brain Function; PHAB).   
 
Overall, the second part of this thesis uses a multidisciplinary approach to investigate 
biological correlates in ADHD, to further our understanding of the underlying 
mechanisms underlying the disorder. The knowledge gained from this research will 
hopefully add to our understanding of the aetiology of ADHD - with long-term 


















CHAPTER 2 – Self-report of ADHD shows limited agreement with 


























































































2.3.4 EEG recording and processing 
2.3.5 ERP analyses 
2.3.6 EEG frequency analyses 





















Table 2.1 Comparisons on age, sex, IQ, digit span, cognitive, event-related potential 
(ERP), electroencephalogram (EEG) and actigraph measures between ADHD groups 

























2.4.1 Do self-reports of ADHD symptoms and impairments differ in severity from 
parent-reports in individuals with a childhood diagnosis of ADHD? 
Table 2.2 Comparisons on age, sex, IQ, digit span, cognitive, event-related potential 
(ERP), electroencephalogram (EEG) and actigraph measures between ADHD groups 


























2.4.2 Which processes are impaired in the ADHD persistent group defined by self-
report? 
2.4.3 Which processes are impaired in the ADHD remittent group defined by self-
report? 
2.4.4 Which processes are markers of remission that distinguish between ADHD 
persistent and remittent groups defined by self-report? 
2.4.5 How well do the objective data discriminate between ADHD groups based on 
DSM-5 diagnostic symptom criterion? 
2.4.6 Which objective measures are associated with the continuous ratings of self-
reported ADHD symptoms and impairments at follow-up in individuals with 
childhood ADHD? 
Table 2.3 Pearson correlations (two-tailed) of IQ, digit span, cognitive, event-related 
potential (ERP), electroencephalogram (EEG) and actigraph measures with self-
reported symptoms and impairment in individuals with childhood ADHD (N = 108) 
Table 2.4 Pearson correlations of IQ, digit span, cognitive, event-related potential 
(ERP), electroencephalogram (EEG) and actigraph measures with self-reported 













2.4.7 Concordant versus discordant diagnostic groups according to self- and parent-
report 
2.5 Discussion 
Table 2.5 Comparison on objective measures and reports of impairments between 
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CHAPTER 3 – Predictive validity of parent- and self-rated ADHD 






















































































3.3.2.1 ADHD symptoms 




3.3.2.6 Unintentional injury 
















3.3.2.8 Statistical analyses 
3.4 Results 
3.4.1 Predictive value of parent- and self-rated ADHD symptoms at 13-14 and 16-17 
years on life outcomes in early adulthood 
 






















Figure 3.1 Odds of experiencing each adverse socioeconomic and health outcome if 
individuals score >90th centile compared to <90th centile on ADHD symptoms rated 


























Table 3.1 Rates of adverse socioeconomic and health outcomes in young adulthood 
 
Table 3.2 Predictive value of parent- and self-rated ADHD symptoms across 
adolescence on adverse socioeconomic and health outcomes in early adulthood 
 






















Figure 3.2 Odds of experiencing each adverse socioeconomic and health outcome if 
individuals score >90th centile compared to <90th centile on ADHD symptoms rated 





























Table 3.3 Discriminatory accuracy of parent- and self-rated ADHD symptoms on 
adverse socioeconomic and health outcomes estimated by the area under the 
receiver operating characteristic curve (AU-ROC) 
 
3.4.2 Unique predictive value of parent- and self-rated ADHD symptoms at 13-14 and 
16-17 years on life outcomes in early adulthood, over and above the other informant 
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CHAPTER 4 – Association of polygenic risk for attention-























































4.3 Methods and materials 
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4.4.3 Internalizing traits and psychiatric disorders 
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Figure 4.1 Association between polygenic risk scores for attention-















































Table 4.2 Polygenic risk score by sex interaction and main effects of sex on target 
phenotypes 
4.5 Discussion 
Table 4.3 Prediction of polygenic risk score for attention-deficit/hyperactivity 
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4.6 Acknowledgements and disclosures 










































































CHAPTER 5 – Autonomic arousal profiles in young individuals with ADHD 




A recent study (James et al., 2016) found that attention-deficit/hyperactivity disorder 
(ADHD) was associated with hypo-arousal, indexed by low electrodermal activity, 
during a low-demand reaction-time task, which normalised in a fast-incentive 
condition. We now investigate if (1) autonomic arousal in individuals with ADHD 
changes over a long testing session and (2) across time, to clarify if arousal profiles are 
context-dependent. We also examine (3) how autonomic arousal relates to each ADHD 
symptom domain, and specificity of arousal profiles to ADHD, by controlling for 
oppositional defiant/conduct disorder (ODD/CD) symptoms. Skin conductance level 
(SCL) and non-specific fluctuations (NSFs) were measured during four successive 
resting-state and cognitive conditions from 71 adolescents/young adults with ADHD 
and 140 controls. Lower arousal was observed in individuals with ADHD only during a 
slow, low-demanding task, and more fluctuating arousal was observed towards the 
end of assessment. Both inattentive and hyperactive-impulsive symptoms were 
associated with arousal levels and fluctuations, independently from ODD/CD. Overall, 
we extend previous findings showing that under-arousal, but also fluctuating arousal, 













Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental 
disorder with postulated links to hypo-arousal and arousal dysregulation. The state 
regulation and cognitive-energetic accounts suggest that a sub-optimal arousal state in 
ADHD may lead to inconsistent cognitive performance, reflected for example by 
within-subject fluctuations in reaction time (van der Meere, 2005; Sergeant, 2005). 
Recent initial findings from our research group have suggested that hypo-arousal, 
while observed during performance on a low-demand reaction time task, is not stable 
in individuals with ADHD but may be normalised during more stimulating tasks (James 
et al., 2016). More research is needed to understand the physiological underpinnings 
of ADHD by exploring whether ADHD case-control differences are context-dependent 
or stable across time, and whether these differences are specific to ADHD or can be 
explained by other related behaviours.  
 
Skin conductance (SC) provides an objective and reliable index of arousal in the 
peripheral nervous system (Boucsein, 2012). SC is a measure of electrodermal activity, 
which is stimulated by the autonomic sympathetic nervous system, a system involved 
in regulating arousal and alertness (Boucsein, 2012; Critchley, 2002). In this study, we 
use the term ‘arousal’ to describe changes in electrodermal activity. Skin conductance 
level (SCL) represents the tonic level of arousal (average level) and non-specific 
fluctuations (NSFs) represent a phasic (transient) change in arousal. Increased SCL 
indexes an increase in peripheral arousal (Boucsein, 2012), whereas increased non-
specific fluctuations indicate more variability in arousal.  
 
Several studies have reported attenuated SCL in children with ADHD, compared to 
controls, indicating hypo-arousal during resting-state (eyes open and eyes closed) and 
task conditions (Barry et al., 2012; Conzelmann et al., 2014; Dupuy, Clarke, Barry, 
Selikowitz, & McCarthy, 2014; Iaboni, Douglas, & Ditto, 1997; Lazzaro et al., 1999; 
Mangeot et al., 2001; Mangina, Buezeron-Mangina, & Grizenko, 2000; O'Connell, 
Bellgrove, Dockree, & Robertson, 2004). Research is more limited in adults, where 
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study findings across resting-state and task conditions are inconclusive in terms of 
hypo-arousal in ADHD (Hermens et al., 2004; Mayer, Wyckoff, & Strehl, 2016). Mixed 
findings, mainly from studies on younger children and adolescents with ADHD, have 
emerged also for NSFs. While several studies on children and adolescents with ADHD 
reported significantly fewer NSFs in their electrodermal activity during resting 
conditions than controls (Beauchaine, Katkin, Strassberg, & Snarr, 2001; Crowell et al., 
2006; Satterfield & Dawson, 1971), other studies in children have not replicated these 
findings (Beauchaine et al., 2015) and one study even found the opposite direction of 
effects in a resting condition while participants listened to 40-decibel white noise 
(Pliszka, Hatch, Borcherding, & Rogeness, 1993). Further research is needed using large 
samples, across testing conditions, to clarify these inconsistencies in the literature. 
 
Our understanding is also limited regarding the specific aspects of ADHD that arousal 
measures tap into. Only one study, which consisted of girls with and without ADHD, 
has explored the relationship between SCL and the two ADHD symptoms domains 
separately, reporting that lower SCL was strongly correlated with higher inattentive 
symptoms (r = -0.45) and weakly-to-moderately correlated with hyperactive-impulsive 
(r = -0.23) symptoms, in individuals with and without ADHD (Dupuy et al., 2014). No 
study to our knowledge has explored this with NSFs, and the relationship between SCL 
and NSFs remains poorly understood. Studies in children have reported that NSFs 
correlate positively with average SCL (Burch & Greiner, 1960; Silverman, Cohen, & 
Shmavonian, 1959); yet neuroimaging and electrophysiological studies suggest that 
NSFs and SCL index different underlying processes (Lazzaro et al., 1999; Nagai, 
Critchley, Featherstone, Trimble, & Dolan, 2004).  
 
In a recent investigation with a large sample of adolescents and young adults, we 
found that individuals with ADHD displayed autonomic under-arousal during a baseline 
(slower, non-rewarded) task condition of a four-choice reaction time called the Fast 
Task, but this was normalised in a more stimulating fast-incentive condition (James et 
al., 2016). These findings support an arousal dysregulation account of ADHD rather 
90 
 
than suggesting that individuals with ADHD display stable hypo-arousal. Further 
support for this view comes from a study that investigated autonomic arousal 
measures in participants during a sustained attention to response task before and 
after taking part in either self-alert training, where participants learned to modulate 
their arousal levels, or placebo training (O’Connell et al., 2008). Results showed that 
both ADHD and control participants had increased specific skin conductance 
responses, indicating increased phasic arousal, after the alertness training. Another 
study in a healthy population sample found increased SCL during a continuous 
performance task compared to baseline, a difference defined as ‘activation’, which 
further suggests context-dependent effects of autonomic arousal (Vaez Mousavi, 
Barry, & Clarke, 2009). We now investigate context effects in ADHD further by studying 
tonic (SCL) and phasic (NSF) autonomic arousal across a longer experimental 
assessment, to improve our understanding of the stability of autonomic arousal 
profiles in ADHD. 
 
In this study we firstly aim to (1) extend initial findings from James et al., (2016) and 
investigate if ADHD case-control differences in both tonic arousal, indexed by SCL, and 
phasic arousal, indexed by NSF, vary across a long testing session consisting of a 
combination of resting-state and task conditions (Resting-state time 1, CPT-OX, Fast 
Task, Resting-state time 2) commonly used in ADHD research, in a large sample of 
adolescents and young adults. We then more specifically aim to (2) examine if ADHD 
case-control differences in arousal measures vary across time from Resting-state time 
1 to time 2. These findings may provide insight on whether low levels and fluctuating 
arousal in ADHD reflect context-specific states or stable traits, which in turn would be 
relevant both for our understanding of the biological underpinnings of ADHD and 
potentially for treatment. Thirdly, to further understand which aspects of ADHD 
specifically tap into tonic and phasic arousal, we aim to investigate (3) how arousal 





In all analyses, we also aim to investigate if associations between ADHD and arousal 
are independent of oppositional defiant disorder and conduct disorder (ODD/CD) 
symptoms, which frequently co-occur with ADHD and have previously been associated 
with lower SCL and skin conductance responses (Delamater & Lahey, 1983; Fung et al., 
2005; Posthumus, Bocker, Raaijmakers, Van Engeland, & Matthys, 2009). One small 
study of males found that among individuals with ADHD, those with and without 
comorbid CD showed similar profiles of fewer NSFs during a baseline resting condition 
compared to controls (Beauchaine et al., 2001); however, more powerful studies 
including both males and females are needed to determine the specificity of arousal 
profiles in ADHD. 
5.3 Materials and methods 
5.3.1 Participants 
The original sample (before quality control and exclusions) consisted of 275 
participants, followed-up on average 5.8 years (SD = 1.1) after initial assessments. At 
follow-up, participants were on average 18.0 years of age (age range: 11.1-25.9). 108 
participants had a diagnosis of DSM-IV combined type ADHD in childhood (9 sibling 
pairs, 90 singletons) and 167 were controls (74 sibling pairs, 19 singletons). 
 
Participants with ADHD were initially recruited from ADHD clinics in south-east 
England (Kuntsi et al., 2010). Diagnosis of DSM-IV combined type ADHD was 
established using the Parental Account of Childhood symptoms (PACS), a semi-
structured interview with high inter-rater reliability (Chen et al., 2008). Controls were 
recruited from schools in the same region and were age and sex matched with the 
clinical sample. All participants were aged between 6 and 17 at initial assessment. 
Exclusion criteria were: IQ<70, autism, epilepsy, general learning difficulties, brain 
disorders and any genetic or medical disorder associated with externalizing behaviors 
that might mimic ADHD. At follow up, six controls met DSM-IV ADHD criteria based on 
parent-ratings on the Barkley Informant Rating Scale (Barkley & Murphy, 2006); these 
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participants were excluded from analyses. The investigation was carried out in 
accordance with the latest version of the Declaration of Helsinki. 
 
SC data were available for 221 participants (mean age: 17.7 years, age range: 11.9-
23.3), out of our original sample of 256, as SC data collection equipment did not arrive 
until after the initial participants had been assessed. We additionally excluded 
participants within each testing condition who experienced SC equipment failure or 
extreme drowsiness. The final sample consisted of 71 ADHD probands (‘ADHD 
persisters’) and 140 controls. The ADHD and control groups did not differ in age (t = 
.20, p = .66), gender (χ2 = .63, p < .43), but did differ on IQ scores (t = -7.47, p < .001) 
(Table 5.1). 
5.3.2 Materials and procedure 
Participants with childhood ADHD were classified as having ADHD if they met DSM-IV 
criteria for ADHD at follow-up. If they scored a ‘yes’ on ≥ 6 items in either the 
inattention or hyperactivity-impulsivity domains of the Diagnostic Interview for ADHD 
in adults (DIVA) (Kooij & Francken, 2007) and if they scored ≥ 2 on two or more areas 
of impairments from the Barkley’s functional impairment scale (BFIS) (Barkley & 
Murphy, 2006), they were classified as ADHD persisters at follow-up. Out of the 108 
participants with childhood ADHD, 23 were classified as ADHD ‘remitters’ at follow-up 
and were not included in this study.  
 
Conners’ Parent Rating Scale – Revised (L): is a questionnaire measure used to assess 
internalizing and externalizing behavior from children and adolescents based on parent 
ratings. The scale includes 18 statements that measure DSM-IV inattentive and 
hyperactive-impulsive ADHD symptoms (Conners, 1997). Each statement is rated on a 
three-point scale, by parents, and the highest possible score is 54. These subscales 





The Development and Well-Being Assessment (DAWBA) (Goodman et al., 2000): is a 
structured interview administered by lay interviewers. The K-section of the DAWBA 
questionnaire, which measures ‘behaviours which sometimes gets children into 
trouble’, was administered to participants. These items reflect current symptoms, 
closely related to DSM-IV diagnoses of ODD and CD (Heiervang et al., 2007; Goodman 
et al., 2000). Ten items were administered to participants, each rated from 0 to 2, and 
the total sum of scores were calculated for each participant.  
 
IQ:  The vocabulary and block design subtests of the Wechsler Abbreviated Scale of 
Intelligence (WASI) were administered to derive an IQ estimate (Wechsler, 1999).  
 
Resting-state with eyes open: Participants were asked to keep as still as possible while 
resting in a chair with their eyes open before and after the cognitive assessments. They 
were encouraged to find a spot on the wall in front of them where they could fixate 
their gaze. The resting-state sessions each lasted for 3 minutes.  
 
The Fast Task; baseline condition (Andreou et al., 2007): The baseline condition of the 
Fast Task consists of 72 trials, which followed a standard warned four-choice RT task. 
Four empty circles (warning signals, arranged horizontally) first appeared for 8s, after 
which one of them (the target) was colored in. Participants were asked to press the 
response key that corresponded to the target position. Following a response, the 
stimuli disappeared and a fixed inter-trial interval of 2.5s followed. Speed and accuracy 
were emphasized equally. If participants did not respond within 10s, the trial 
terminated.  
 
The cued flanker Continuous Performance Task (CPT-OX): This CPT-OX (Doehnert et al., 
2008; Valko et al., 2009) includes rare cued Go and NoGo conditions embedded in a 
vigilance task with frequent distractors to assess attentional and inhibitory processes. 
The test consists of 400 letters presented for 150ms with a stimulus onset asynchrony 
of 1.65s in a pseudo-randomized order. The cue letter O occurred with 20% probability 
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(80 Cue stimuli), signaled a Go–NoGo task, and induced response preparation. 
Participants pressed a mouse button as fast as possible every time the cue was 
followed directly by the letter X (O-X) target sequence, 10% probability, 40 Go stimuli] 
but had to withhold responses to O-not-X sequences (NoGo trials, also 10%, 40 NoGo 
stimuli).  
5.3.3 Procedure 
Participants were re-contacted by telephone and scheduled for a follow-up clinical 
interview and cognitive assessments at our research centre while electrodermal and 
electroencephalogram (EEG) measures were recorded. Before the cognitive 
assessments, participants were asked to remain still and rest with their eyes open 
while fixating at a point in front of them for 3 minutes. They then performed the CPT 
for 11 minutes, followed by the Fast Task baseline condition for 13 minutes, and were 
asked to rest again with their eyes open for 3 minutes at the end of the testing session. 
A 48-hour ADHD medication-free period was required and the participants were also 
asked to abstain from caffeine, smoking, and alcohol on the day of testing.  
5.3.4 Skin conductance  
Skin conductance response was recorded using PSYCHLAB SC5 24 bit equipment 
system, which has an absolute accuracy of +/- 0.1 microsiemens. The SC5 is connected 
to a computer that runs the PSYCHLAB software where the data can be monitored and 
recorded in real time and parameters can be set. SC was measured by attaching a pair 
of 8mm diameter silver-silver chloride electrodes on the palm of participants’ non-
dominant hand (thenar eminence and hypothenar eminence) at the beginning of the 
cognitive test battery. An electrode paste, formulated with 0.5% saline in a neutral 
lotion/cream style base (provided by PSYCHLAB), was used to establish a stable 
electrical SC signal. The SC5 is DC coupled (infinite time constant), and a constant 
imperceptible voltage (0.5V) was applied. SC5 automatically calibrates itself when 
switched on and then runs at a fixed internal sample rate of 80Hz and an additionally 




SC variables were calculated using a system that is based on a SC sigmoid-exponential 
model that allows the tonic measure of SCL to be disentangled from phasic SC 
fluctuations and allows the decomposition of overlapping SC fluctuations (Lim et al., 
1997). The statistical model was applied to each task condition. Each participant’s data 
were inspected visually by a researcher to confirm that the data were scored properly 
using the statistical model. Each NSF reflects a rise in SCL for at least 500 milliseconds 
followed by at least 300 milliseconds of non-rising SC, and the minimum amplitude of 
the NSFs was set to 0.02 microsiemens. The number of NSFs per second was used as 
the final measure to control for minor individual differences in recording lengths. 
Mean SCL and NSFs per second were calculated for each participant in each testing 
condition. We examined average measures of SCL and NSFs across task performance in 
the CPT-OX and Fast Task, and did not exclude event-locked SC variables, as event 
codes during the CPT-OX were not retrievable in these data.   
5.3.5 Data Analysis 
We ran regression models to investigate ADHD case-control group differences in SCL 
and NSF measures within each testing condition (Resting-state time 1, CPT-OX, Fast 
Task, Resting-state time 2). Relatedness between sibling pairs was controlled for by 
using the ‘robust cluster’ command in STATA (StataCorp, College Station, TX). Random-
intercept linear models were used to test the main and interaction effects of group 
(ADHD cases, controls) and time (Resting-state time 1, Resting-state time 2) on SCL and 
NSFs, to examine the change in autonomic arousal in ADHD and control groups over 
time. Random-intercept models control for clustered data, due to relatedness between 
siblings, and handle missing data using the maximum likelihood method, which in turn 
reduces the loss in power from missing data points. We re-ran all analyses controlling 
for ODD/CD symptoms to examine if any identified ADHD case-control differences 
could be explained by co-occurring ODD/CD symptoms.  
 
We ran linear regression models to investigate the associations of SC measures with 
inattentive and hyperactive-impulsive symptoms, respectively, and added an 
interaction term (SC*ADHD group) to investigate if the strength of the associations 
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were different in the ADHD and control groups. We tested these associations only in 
conditions that showed sensitivity to ADHD as indicated by a significant case-control 
difference in SC measures. We re-ran all analyses controlling for ODD/CD symptoms.  
 
We re-ran the main analyses on ADHD case-control group comparisons with IQ added 
as a covariate to examine its potential effects. We further ran sensitivity analyses 
testing age and gender as covariates in the main analyses in line with previous analyses 
in the same sample (Kitsune et al., 2015). The effects of potential longer-term use of 
medication on SC measures were examined by running SC comparison tests between 
unmedicated and medicated participants with ADHD.  
5.4 Results 
5.4.1 ADHD case-control differences in arousal across testing sessions 
Pairwise comparisons revealed no significant differences (p > .05) between the ADHD 
and control groups in NSFs or SCL during the two initial testing conditions (Resting-
state time 1 and CPT-OX task performance; Figure 5.1). During performance on the 
Fast Task and Resting-state time 2, individuals with ADHD showed significantly more 
NSFs than the control group. There was no significant group difference in SCL during 
Resting-state time 2, in contrast to the significantly lower SCL found during the Fast 
Task, as reported James et al. (2016) (Figure 5.1, Table 5.1).  
 
Individuals with ADHD had a significantly higher level of ODD/CD symptoms (M = 4.03, 
SD = 2.63) than individuals in the control group (M = 1.61, SD = 1.90; t(210) = 6.87, p < 
.001). After controlling for ODD/CD symptoms in the models, SCL findings of case-
control differences did not change but NSF findings during the Fast Task changed 
slightly, in regards of the effect size (Cohen’s d: from .33 to .27) and p-value (from .04 
to .07) (Table 5.1), although an overlap in 95% confidence intervals of coefficients 





Figure 5.1 Mean skin conductance level (A) and non-specific fluctuations (B) for 
























Note: Data on SCL from the Fast Task have already been presented (James et al., 2016), 
but for ease of comparison, results specific to this analysis have been replicated here 
with the additional results across other task conditions.  
*p-value < .05 for comparison between ADHD-control groups. CPT: continuous 





Table 5.1 Descriptives and pair-wise comparisons between Groups (ADHD, control) in 
each condition on skin conductance measures  
Note. Data on SCL from the Fast Task have already been presented (James et al., 2016), 
but for ease of comparison, results specific to this analysis have been replicated here 
with the additional results across other task conditions. 
*p-value < .05. d: Cohen’s d. Cov: Covariate included in models. CPT: Continuous 
performance task. SCL: Skin conductance level. NSF/s: Non-specific fluctuations per 
second. ADHD: Attention-deficit/hyperactivity disorder group. ODD/CD: Oppositional 












t/χ² p d d Cov: 
ODD/CD  
Male sex, n (%)  59 (83%) 107 (76%) .63 .43 .17  
IQ, M (SD)  95.38 (14.97) 110.08 (12.69) 7.47 .001 -1.03  
Age, M (SD)  17.70 (2.83) 17.75 (2.28) .20 .66 .02  
Rest time 1 SCL 2.88 (2.07) 3.29 (2.26) -1.43 .31 -.20 -.18 
NSF/s .07 (.05) .06 (.06) .33 .74 .05 .01 
CPT SCL 3.72 (2.16) 4.24 (2.68) -.96 .32 -.13 -.09 
NSF/s .23 (.13) .23 (.13) .02 .98 .01 .01 
Fast Task SCL 2.96 (2.05) 4.16 (1.91) -3.44 <.01 -.49* -.56* 
NSF/s .10 (.04) .08 (.04) 2.06 .04 .33* .27 
Rest time 2 SCL 4.28 (2.23) 4.73 (2.77) -.41 .69 -.06 -.01 
NSF/s .09 (.06) .07 (.06) 2.14 .03 .32* .30* 
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5.4.2 ADHD case-control differences in arousal across time 
The random-intercept models revealed significant main effects of time (Resting-state 
time 1 vs 2) on NSFs and SCL (Table 5.2), showing that NSFs and SCL significantly 
increased over time. We found no significant main effect of group (ADHD vs control) or 
group-by-time interaction effects on NSFs or SCL (Table 5.2). When ODD/CD symptoms 
were controlled for, the group-by-time interaction effect became significant for NSFs (z 
= 2.00, p = .045). Post-hoc analyses when controlling for ODD/CD symptoms revealed 
significant increases in NSFs from resting-state time 1 to time 2 in the ADHD group (t = 
3.32, p = .002), but not in the control group (t = 0.63, p = 0.53).  
 
As the group-by-time interaction effect on NSFs emerged as significant after 
controlling for ODD/CD symptoms, we decided to run regression analyses to explore 
the associations between ODD/CD symptoms and SC measures, within each group 
(ADHD, control) and each condition. We found no significant associations between 
ODD/CD symptoms and SC in any of the groups or conditions (Table S1).   
 
Table 5.2. Main effects of Group (ADHD vs Control), Time (Resting-state time 1 vs 2) 














 Skin conductance level Non-specific fluctuations 
 z p z p 
Group -0.94 .35 1.61 .11 
Time 8.91 .001* 2.71 .01* 
Group*Time 0.38 .71 1.53 .12* 
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5.4.3 Linear associations between arousal measures and each ADHD symptom 
domain 
Linear regression models revealed that NSF recorded during the Fast Task was 
significantly and positively associated with hyperactive-impulsive symptoms in the full 
sample, and NSF during Resting-state time 2 was significantly and positively associated 
with both inattentive and hyperactive-impulsive symptoms (Table 5.3). SCL recorded 
during the Fast Task was significantly and negatively associated with both symptom 
domains. While NSF during the Fast Task was not significantly associated with 
inattentive symptoms in the full sample, the NSF-by-group interaction was significant, 
revealing that the association between NSF and inattentive symptoms was significant 
in the ADHD group (Beta = .13, p = .01), but not in the control group (Beta = -.01, p = 
.77). No other interaction terms (SC*group) were significant (Table 5.3). When we 
controlled for ODD/CD symptoms in the regression models, the pattern of results did 
not change with regard to significance level (Table 5.3).  
 
Table 5.3 Main associations between skin conductance level and non-specific 
fluctuations with ADHD symptom domains and skin conductance-by-group (ADHD, 
control) effects on ADHD symptom domains 
 
Note: Associations between ADHD symptoms and arousal measures were only tested 
during the conditions that revealed significant case-control differences in arousal.  
* p < .05 after controlling for ODD/CD. H/I: Hyperactivity/Impulsivity symptoms. IN: 
Inattentive symptoms.  
 





















 B p B p B p B p B p B p 
H/I .20 <.01* -.06 .66 -.26 <.01* -.15 .19 .18 .02* -.01 .98 
IN .10 .19 -.12 .04* -.26 <.01* -0.10 .10 .18 .02* -.02 .77 
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5.4.4 Sensitivity analyses 
We re-ran the main pairwise comparisons of groups (ADHD vs Control) with IQ added 
as a covariate (Table S2). We found that the pattern of results remained the same for 
NSFs but for SCL the ADHD case-control difference during the Fast Task was no longer 
significant and the effect size (Cohen’s d) changed from -.49 to -.09 (Table 5.1), 
although 95% CI’s showed an overlap before and after controlling for IQ (95% CI [-0.95, 
-0.28] to [-0.58, 0.15]).  
 
Due to the changes in results after controlling for IQ in the SCL analyses (Table S2), we 
ran additional sensitivity analyses to investigate the associations between IQ and SC 
measures across conditions (Table S3). Linear regression models revealed significant (p 
< .05) and positive associations between SCL and IQ (Beta = .17-.40) in all four testing 
conditions. The interaction terms (SCL*group) were not significant in any conditions, 
revealing that associations were similar across groups. We found no significant 
associations between NSF and IQ (Table S3).   
 
We further re-ran the main pairwise comparisons of groups (ADHD vs Control) with 
age and gender added as covariates and found that the pattern of findings remained 
the same in terms of significance of findings (Table S4). We also ran SC comparison 
tests between unmedicated and medicated participants with ADHD to investigate the 
long-term effects of medication. Short-term effects of medication were controlled for, 
as participants were asked to have a 48-hour medication-free period before testing. 
There were no significant differences in SCL (t(34) = .68, p = .50) or NSF (t(35) = -.48, p 
= .64) between unmedicated and medicated participants. 
 
As we found significant ADHD case-control differences in SC during the 13-minute long 
Fast Task but not during the 11-minute long CPT, we aimed to explore whether the 
significant differences during the Fast Task emerged because of the longer testing 
session, rather than the order or nature of the task. James et al. (2016) previously 
demonstrated that the significant ADHD case-control difference in SCL during the Fast 
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Task (baseline condition) was consistent across time, as significant differences were 
found in each 4-minute long snippet of the task. Here, we extracted NSF data during 
the first 11 minutes of the Fast Task to match the CPT on task length, and re-ran the 
ADHD case-control comparisons. We found that the ADHD case-control difference in 
NSFs during the Fast Task was reduced to trend level when using the shorter 11-
minute time period (Beta = .03, p = .068).  
5.5 Discussion 
In this large study of 211 adolescents and young adults, we found that autonomic 
arousal profiles of individuals with ADHD varied across testing conditions. First of all, 
ADHD case-control differences in tonic arousal, indexed by SCL, only emerged during a 
slow and low-demanding cognitive task. Case-control differences in phasic arousal, 
indexed by NSF, emerged towards the end of the assessments, during the low-
demanding cognitive task and the final resting-state condition (time 2). Further 
analyses showed that case-control differences in phasic arousal, but not tonic arousal, 
emerged over time from resting-state time 1 to time 2, once ODD/CD symptoms were 
controlled for. Lastly, both ADHD symptom domains were significantly associated with 
lower levels of tonic arousal and more fluctuating arousal, independently of ODD/CD 
symptoms. Overall, our findings suggest that individuals with ADHD experience 
difficulties regulating their arousal rather than being constantly under-aroused. 
Inconsistent findings in the literature on autonomic arousal in ADHD might be 
explained by differences in experimental designs and tasks.  
 
Extending the initial report from James et al. (2016), we now show that tonic 
autonomic arousal, measured by SCL, did not remain significantly lower in individuals 
with ADHD compared to controls beyond the slow, baseline condition of the Fast Task; 
during resting-state conditions and CPT-OX task performance. These findings suggest 
that lower arousal levels in individuals with ADHD may be especially salient during slow 
and low-demanding tasks compared to faster-paced and more demanding tasks such 
as the CPT or the fast-incentive condition of the Fast Task (as demonstrated in James 
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et al., 2016). It is also possible that the lower arousal level in the ADHD group during 
the Fast Task, but not the CPT condition, was due to fatigue effects as the Fast Task 
followed the CPT in the order of tasks. We were unable to separate fatigue effects 
from effects of cognitive demand, as the tasks were not counterbalanced in this 
experiment. Our analyses further revealed that lower tonic arousal during the Fast 
Task, where case-control differences were identified, was associated with a higher 
level of inattentive and hyperactive-impulsive symptoms, supporting initial findings 
from a study only in girls (Dupuy et al., 2014). Our finding suggests that individuals 
with ADHD may experience difficulties in regulating their arousal levels rather than 
experience constant hypo-arousal, which implies that arousal is malleable in 
individuals with ADHD and may therefore be suitable as a potential treatment target. 
Our findings further suggest that inconsistencies in the literature (Hermens et al., 
2004; Mayer et al., 2016) may be explained by the different experimental paradigms 
used across studies.  
 
We further found that individuals with ADHD displayed significantly more fluctuating 
arousal, indexed as a higher number of NSFs per second, compared to controls, during 
the two final testing conditions (the Fast Task and Resting-state time 2) only. These 
findings suggest that arousal variability in ADHD, similarly to under-arousal, may 
become more salient during slower and low-demanding tasks, but also towards the 
end of assessment, over time. This is further supported by our sensitivity analysis 
showing that the ADHD case-control difference in NSFs during the 13-minute long Fast 
Task was no longer significant when we shortened the task to match the 11-minute 
long CPT. These findings indicate that more fluctuations in ADHD may become 
especially salient over time, possibly in combination with the low-demanding task.  
 
Our results further showed that the fluctuations in and level of arousal increased over 
time, from resting-state time 1 to time 2. When we tested the group-by-time 
interaction on fluctuations, the effect emerged as significant once ODD/CD symptoms 
were controlled for and post-hoc analyses revealed than the fluctuations in arousal 
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increased over time only in the ADHD group. These findings further suggest that 
fluctuating arousal profiles in ADHD, relative to controls, become more salient over 
time; an effect that is enhanced by controlling for other co-occurring externalizing 
behaviours.  
 
NSFs were associated with both inattentive and hyperactive-impulsive symptoms, 
across groups, in the testing conditions that showed case-control differences, with the 
only exception of the Fast Task where NSFs and inattention were only significantly 
associated in the ADHD group. Overall, we found that individuals with ADHD did not 
show stable abnormalities in fluctuating arousal, similarly to under-arousal, which may 
in turn explain highly inconsistent findings in the literature where different 
experimental designs have been used. The direction of effects is in line with findings 
from one previous study that showed a trend of more NSFs in children with ADHD 
compared to controls (Pliszka et al., 1993), but is inconsistent with other studies of 
children and adolescents which have found opposite effects of less frequent NSFs in 
individuals with ADHD (Lazzaro et al., 1999; Satterfield & Dawson, 1971). Further 
research across different experimental conditions and age groups, is therefore needed 
to clarify the discrepancy in findings.  
 
This is the first larger study, to our knowledge, to investigate the specificity of both 
phasic and tonic arousal profiles in young adults with ADHD by controlling for ODD/CD 
symptoms in analyses. ODD/CD symptoms did not account for our findings on atypical 
tonic arousal profiles in ADHD, which is in line with previous research (Beauchaine et 
al., 2001; van Lang et al., 2007). For phasic arousal, ODD/CD symptoms did not account 
for the associations with ADHD, however, the group-by-time effect emerged as 
significant after controlling for ODD/CD symptoms. This suggests that controlling for 
ODD/CD symptom enhances the relationship between phasic arousal and ADHD over 
time, but it is not clear from these results how ODD/CD symptoms relate to the other 
variables, as they (a) do not account for the linear associations between NSFs and 
ADHD symptom domains (Table 5.3) and (b) are not significantly associated with NSFs 
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(Table S1). While previous research has suggested that individuals with 
antisocial/conduct problems have smaller amplitude of specific skin conductance 
responses (Delamater & Lahey, 1983), less is known of non-specific fluctuations. 
Further studies are needed to clarify the complex relationship between ODD/CD, NSFs 
and ADHD, to determine the specificity of fluctuating arousal profiles in ADHD.  
 
We further showed that individuals, regardless of ADHD diagnosis, who had lower 
levels of tonic arousal also tended to have lower IQ scores and that the ADHD case-
control difference in tonic arousal was mainly accounted for by IQ. These intriguing 
findings suggest that it is important that IQ is taken into consideration in future studies 
that investigate arousal levels in ADHD and that any potential mediating variables are 
explored further.  
 
A limitation of this study is that we used measures of NSF averaged across each of the 
CPT-OX and Fast Task conditions, as we were unable to retrieve event codes. This 
means that we could not tease apart SC fluctuations during stimuli presentation and 
response execution from SC fluctuations during no task events. It would have been 
interesting to study both event-specific and non-specific fluctuations separately to 
explore how they each are implicated in ADHD, however, given that very few studies 
have investigated arousal variability in ADHD, we believe it is still meaningful to study 
average fluctuations in our rich dataset that spans across a long testing session.  
5.6 Conclusion 
We found that adolescents and young adults with ADHD displayed lower levels of and 
more fluctuating autonomic arousal under certain experimental conditions. ADHD 
case-control differences in tonic arousal emerged only during a slow, low-demanding 
cognitive task. A case-control difference in phasic arousal was also observed during the 
low-demanding task and also towards the end of the assessment. We further found 
that tonic and phasic arousal were associated with both inattentive and hyperactive-
impulsive symptoms, independently of ODD/CD symptoms. Our findings suggest that 
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both tonic and phasic autonomic arousal profiles in ADHD are context-specific rather 
than representing stable impairments. Our findings also highlight how inconsistent 
findings in the ADHD literature on arousal may be explained by differences in 




























CHAPTER 6 – Beneficial effects of acute high-intensity exercise on 




Background: Emerging research suggests that a single bout of aerobic exercise can 
improve cognition, brain function and psychological health. Our aim was to examine 
the effects of high-intensity exercise on cognitive-performance and brain measures of 
attention, inhibition and performance-monitoring across a test-battery of three 
cognitive tasks. Method: Using a randomised cross-over design, 29 young men 
completed three successive cognitive tasks (Cued Continuous Performance Task [CPT-
OX]; Eriksen Flanker Task; four-choice reaction-time task [Fast Task]) with 
simultaneous electroencephalogram (EEG) recording before and after a 20-minute 
high-intensity cycling exercise and resting control session. Cognitive-performance 
measures, EEG power and event-related potential measures, were obtained during the 
tasks. Random-intercept linear models were used to investigate the effects of exercise, 
compared to rest, on outcomes. Results: A single bout of exercise significantly (p<0.05) 
increased the amplitude of the event-related potential Go P3, but had no effect on the 
contingent negative variation (CNV), Cue P3 or NoGo P3, during the CPT-OX. Delta 
power, recorded during the CPT-OX, also significantly increased after exercise, whereas 
there was no effect on cognitive-performance in this task. Exercise did not influence 
any cognitive-performance or brain measures in the subsequent Flanker or Fast Tasks.  
Conclusion: Acute high-intensity exercise improves brain-indices reflecting executive 
and sustained attention during task performance (Go P3 and delta activity), in the CPT-
OX, but not anticipatory attention (Cue P3 and CNV) or response inhibition (NoGo P3) 
in young-adult men. Exercise had no effect on cognitive-performance or brain 
measures in the subsequent Flanker and Fast tasks, which may potentially be 






Emerging evidence suggests that physical exercise can enhance cognition, brain 
function and psychological health (Brummer, Schneider, Abel, Vogt, & Struder, 2011; 
Chang, Labban, Gapin, & Etnier, 2012a; Verburgh, Konigs, Scherder, & Oosterlaan, 
2014). Recent meta-analyses, including studies using varying controlled (e.g. 
randomised controlled, within-subject) and non-controlled (quasi-experimental, 
observational) methodologies, indicate that even a single bout of aerobic exercise, 
such as running or cycling, improves neurocognitive function in both children and 
adults (Chang et al., 2012a; Lambourne, Audiffren, & Tomporowski, 2010; McMorris & 
Hale, 2012; McMorris, Sproule, Turner, & Hale, 2011; Roig, Nordbrandt, Geertsen, & 
Nielsen, 2013; Verburgh et al., 2014).  
 
Positive effects, particularly of acute (short-lived) exercise sessions of 20 minutes or 
more in duration (Chang et al., 2012a), have been reported in experimental studies on 
a range of cognitive performance measures. These measures include inhibition and 
interference control (Effect size; ES=0.25-0.46) (Chang et al., 2012a, Verburgh et al., 
2014), attention (ES=0.42), mean reaction time (MRT) (ES=0.30-1.41) (McMorris et al., 
2011; 2012) and short-term memory (ES=0.26) (Roig et al., 2013). Several studies 
suggest that effects are largest for executive functioning, such as response inhibition 
and interference control (Chang et al., 2012a; Kramer & Erickson, 2007; Tomporowski, 
Davis, Miller, & Naglieri, 2008). However, relatively few studies have investigated 
effects on measures of attention and attentional lapses (Chang et al., 2012a) and 
findings on executive functioning and MRT have been mixed, as some studies fail to 
replicate the beneficial effect of acute exercise (Coles & Tomporowski, 2008; Wang et 
al., 2015). These inconsistent findings might be explained by differences in the 
experimental paradigms used, such as the intensity of exercise, fitness level of 
participants and time lapse after exercise (Chang et al., 2012a), as well as by 




A growing body of research has also incorporated neurophysiological methods, such as 
electroencephalography (EEG), which provides a direct measurement of brain activity, 
to better understand the neural processes enhanced by exercise (Chang, 2016; 
Hillman, Snook, & Jerome, 2003). Experimental studies have reported beneficial effects 
of acute exercise in children and adults on brain activity relating to attentional and 
arousal processes. These findings include increased alpha (Brummer et al., 2011; 
Mierau et al., 2014; Moraes et al., 2011; Schneider, Brummer, Abel, Askew, & Struder, 
2009b; St-Louise-Deschenes, Moore, & Ellemberg, 2015a) and beta spectral power 
(Moraes et al., 2007; 2011; Schneider et al., 2009b), mainly in frontal and parietal 
areas, during resting-state conditions, which are thought to index background 
processes such as arousal and activation. However, the direction of these effects on 
alpha and beta EEG power have been mixed and findings have been inconsistent 
(Brummer et al., 2011; Mierau et al., 2014; Moraes et al., 2007; Schneider et al., 
2009a; St-Louise-Deschenes et al., 2015a). No effect has been found for slower-wave 
delta and theta activity during resting-state (Moraes et al., 2011; Schneider et al., 
2009a). Discrepancies in study findings are likely due to heterogeneity in study 
methodologies and exercise paradigms (Schneider et al., 2009a; Stroth et al., 2009; St-
Louise-Deschenes et al., 2015a), but also a lack of a control group in some studies 
(Fumoto et al., 2010; Mierau et al., 2014; Schneider et al., 2009a). 
 
Fewer studies have investigated the effect of acute exercise on event-related 
potentials (ERPs), which are time-locked brain responses to specific events. The most 
consistent finding has been an exercise-induced increase in P3 amplitude in Flanker 
and Go/No-go tasks, during target stimulus presentation (Go P3), which reflects 
attention allocation and execution (Chang, Pesce, Chiang, Kuo, & Fong, 2015a; Hillman 
et al., 2003; Drollette et al., 2014; Kamijo et al., 2004b; 2007; St-Louise-Deschenes, 
Moore, & Ellemberg, 2015b). Enhancements in Go P3 amplitude after acute exercise 
have in some studies been paralleled with improved behavioural performance of faster 
reaction times (Kamijo et al., 2007; 2009; Ludyga et al., 2017; Wang, Shih, & Tsai, 
2016), and increased performance accuracy (Drollette et al., 2014; Hillman, Kamijo, & 
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Scudder, 2011). Although most acute exercise research has focused on the Go P3 
component, a small number of studies have also reported beneficial effects of exercise 
on the NoGo P3 (inhibition of a response) (Kamijo et al., 2004b), the contingent 
negative variation (CNV; response preparation) (Stroth et al., 2009; Tsai et al., 2014), 
and the N2 (conflict monitoring) (Drollette et al., 2014; Stroth et al., 2009). The 
literature on the effect of exercise on brain measures of specific cognitive processes is 
still limited and few studies have explored effects across several cognitive tasks and 
ERP components in a single testing session.     
 
A few studies have explored if aerobic fitness of participants, often measured as the 
peak oxygen consumption (VO2peak), moderates the beneficial effects of acute exercise 
on cognitive performance. While some research suggests that individuals with higher 
fitness levels improve more from acute exercise on a range of cognitive-performance 
measures (Chu, Chen, Hung, Wang, & Chang, 2015; Chang, Chu, Wang, Song, & Wei, 
2015b; Hogan et al., 2013), findings have been mixed and a meta-analysis did not 
confirm a moderating role of fitness (Chang et al., 2012a). More limited studies have 
investigated the moderating role of fitness on the effects of exercise on EEG/ERP 
outcome measures. While one study failed to find moderating effects of fitness on the 
relationship between acute exercise and alpha event-related desynchronization (Chang 
et al., 2015b), another study found that only ‘unfit’ individuals showed higher levels of 
coherence in the alpha band after rest compared to exercise in NoGo task trials, 
possibly indicating greater allocation of cognitive resources to the task demands 
(Hogan et al., 2013). The limited and inconclusive research warrants further 
investigation of the effect of individual fitness level on the beneficial effects of acute 
exercise.   
6.2.1 Aims 
We aimed to investigate the effects of a single bout of high-intensity aerobic cycling 
exercise on a range of performance and EEG measures implicated in attention, 
inhibition and performance-monitoring, in a population sample of young adult men. 
Using a cross-over trial design, outcome measures were obtained during three 
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successive cognitive conditions, 30 to 64 minutes after cycling exercise or rest, which 
have been used to identify impairments in several psychiatric and neurodevelopmental 
disorders, such as attention-deficit/hyperactivity disorder (ADHD) (Cheung et al., 2017; 
Michelini et al., 2016a; 2016b). The primary aim was to examine the effects of acute 
exercise across performance and brain measures that are either well- or under-studied 
in the exercise literature, to better understand the specific cognitive and brain 
processes that improve from acute exercise. Our secondary aim was to investigate if 
the degree of improvement from exercise on identified performance and brain 
measures is related to aerobic fitness and physical activity levels of the participants. 
This may shed light on characteristics of individuals who would especially benefit from 
exercise interventions. 
6.3 Materials and methods 
6.3.1 Participants 
We recruited 29 men between the ages of 18 and 26 (mean=21.5; standard deviation 
[SD]=2.52) years, of whom 22 were graduate/postgraduate students, 4 were employed 
and 3 were unemployed. We only included men to reduce sample heterogeneity and 
increase power in our study. Participants were recruited from a recruitment website 
for research (callforparticipants.com), through posters in the community near the 
research centre and through internal advertisement at King’s College London. 
Participants had an average IQ of 111.72 (SD=11.33). Exclusion criteria were having any 
cardiovascular or metabolic disease (e.g. diabetes), being obese (BMI>30), having bone 
or joint problems, epilepsy, asthma or any other lung disease. None of the participants 
were on any psychiatric medication which may have had an influence on cognitive 
performance. In Figure 6.1, we display a CONSORT flow diagram of participants 
through each stage of the trial for information on participant drop-out (N=3) and the 
random allocation of participants to the intervention groups. The study was approved 
by the Research Ethics Committee at King’s College London (Ref: HR-15/16-3032) and 










This cross-over trial comprised of three laboratory visits conducted over a range of 11 
to 21 days. The assignment of participants in each trial arm was randomised. 
Participants attended all three testing sessions at the same time of the day for all three 
assessments, either in the morning or afternoon.  
 
Visit 1: Fitness assessment 
At the first initial visit, which occurred 4 to 14 days (mean=7.4, SD=3.6) before the first 
experimental testing session, each participant underwent an aerobic fitness 
assessment and health screening procedure. During this first visit, we measured the 
participant’s stature and body weight to calculate body mass index 
(BMI=weight(kg)/height(cm)2) and asked the participant to complete a health 
questionnaire (Physical Activity Readiness Questionnaire). Each participant then 
performed a continuous step-incremental exercise test to exhaustion in order to 
determine their VO2peak and gas exchange threshold (GET). Participants were asked to 
cycle on a cycle ergometer (Monark 874E) at a constant cadence of 70 revolutions per 
minute at a starting power output of 70 Watts for 5 minutes. Power output was 
subsequently increased every minute by 28 Watts until participant exhaustion, which 
was defined as a drop in cadence below 60 revolutions per minute for five consecutive 
seconds. Test duration was on average 19.3 minutes (SD=2.1), including a 5-minute 
warm-up and 5-minute cool-down period. Measures of VO2, carbon dioxide output 
(VCO2), minute ventilation (VE) and respiratory exchange ratio (RER) were recorded 
during the exercise test using a breath-by-breath metabolic cart, facemask and turbine 
(Cortex Metalyzer 3B, Leipzig, Germany). The participant wore a wireless chest strap to 
monitor heart rate (Polar, Electro, Finland). Perceived exertion was measured every 
minute during the cycle test using a 6-20 Borg rating of perceived exertion (RPE) scale 
(Borg, 1982). Peak VO2 was taken as the highest 10 s average VO2 achieved during the 
test and was used as a measure of aerobic fitness level after normalising for body 
weight (mL*min-1*kg-1). The V-slope method was used to determine the GET, which is 
a non-invasive estimate of the blood lactate threshold (Barker, Williams, Jones, & 
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Armstrong, 2011; Beaver, Wasserman, & Whipp, 1986). The resistance equivalent to 
20% delta (∆; difference between GET and VO2peak), which is considered high-intensity 
exercise, was then calculated and verified by two researchers and used for the 
subsequent exercise trial. The delta concept was used for the exercise condition rather 
than a fraction of peak VO2, as it minimises between participant variation in the 
physiological response to exercise (Lansley, Dimenna, Bailey, & Jones, 2011). High-
intensity exercise was chosen because it has been found to have largest effects on 
cognitive measures when tested after a delay post-exercise (Chang et al., 2012a).  
 
Visits 2 and 3: Experimental sessions 
During each of the two experimental testing sessions, which were seven days apart, 
individuals first performed the three computerized cognitive tasks, while their EEG 
brain activity was recorded. The cognitive tasks were followed by one of two 
conditions: 1) a 30-minute exercise bout consisting of 20-minute of exercise at 20% 
delta with a 5-minute warm-up and 5-minute cool-down; or 2) a 30-minute resting 
control session. The order of the two testing sessions, i.e. whether a participant 
attended the exercise or control session first, was counterbalanced. During the 
exercise intervention, the participant cycled and simultaneously watched a nature 
documentary (Ocean Giants on BBC, either episodes 2 or 3). During the resting control 
session the participant was sat on the cycle ergometer without pedalling, while again 
watching the nature documentary (order of episodes counterbalanced between 
sessions), in order to standardise paradigms between the two exercise and control 
sessions. The amount of water consumed by the participant during the first 
experimental testing session was recorded and they were encouraged to consume the 
same amount of water on the second experimental testing session. RPE was recorded 
at the 5th, 10th, 15th and 20th minute of the exercise and control sessions. Heart rate 
was measured at the end of the testing session. After both testing sessions, the 
participant was asked to blow-dry his hair before wearing the EEG cap prior to brain 
activity measurement. The participant was then asked to perform the same three 
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computerized cognitive tasks performed in the beginning again while brain activity was 
recorded, 30 minutes post-intervention to allow for the set-up of the EEG cap.  
 
Although participants and researchers were not blinded to the type of intervention 
that participants were undergoing on the day of testing, researchers were blinded 
during the pre-processing stage of EEG data.  
6.3.3 Measures 
The International Physical Activity Questionnaire (IPAQ) short version was administered 
during visit 1 to measure the participants physical activity status (Craig et al., 2003). 
IPAQ asks participants about physical activities from the last 7 days. Continuous scores 
were created to estimate how much time participants spend on (1) vigorous intensity 
physical activity, (2) moderate intensity physical activity, (3) walking and (4) sitting 
down. A total score of the full amount of time spent on physical activity was also 
calculated. IPAQ has acceptable measurement properties of reliability and criterion 
validity, at least as good as other self-report measures of physical activity (Craig et al., 
2003).  
 
CPT-OX (Doehnert et al., 2008; Valko et al., 2009). This CPT includes rare cued Go and 
NoGo conditions embedded in a vigilance task with frequent distractors to assess 
attentional and inhibitory processes. The test consists of 400 letters presented for 150 
milliseconds with a stimulus onset asynchrony of 1.65 seconds in a pseudo-randomised 
order. The cue letter O occurred with 20% probability (80 Cue stimuli), signaling a 
subsequent Go/NoGo stimulus, and induced response preparation. Participants were 
instructed to press a mouse button as fast as possible every time the cue was followed 
directly by the letter X [(O-X) target sequence, 50% of times after Cue, 40 Go stimuli] 
but had to withhold responses to O-not-X sequences (NoGo trials, also 50% of times 
after Cue, 40 NoGo stimuli). We obtained performance measures of mean reaction 
time (MRT), reaction time variability (RTV; SD of RT), commission errors (CE) and 
omission errors (OE). MRT and RTV were calculated across correctly answered Go 
trials, CE were responses to Cue, NoGo and distractor stimuli or Go stimuli not 
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following a Cue, and OE were non-responses to Go trials. The CPT-OX took 
approximately 11 minutes for participants to complete.  
 
The Eriksen Flanker Task was an adaptation of the original Eriksen Flanker paradigm 
designed to increase cognitive load as used in previous studies (Albrecht et al., 2007; 
McLoughlin et al., 2009). In each trial, a central black fixation mark was replaced by a 
target arrow (a black 18-millimeters equilateral triangle). Participants had to indicate 
whether this arrow pointed toward the left or right by pressing corresponding 
response buttons with their left or right index fingers. Two flanker arrows identical in 
shape and size to the target appeared 22 millimeters above and below the center of 
the target arrow 100 milliseconds prior to each target arrow. Both flankers pointed in 
either the same (congruent) or opposite (incongruent) direction to the target. As such, 
conflict monitoring is maximal during the incongruent condition. When the target 
appeared, both target and flankers remained on the screen for a further 150 
milliseconds, with a new trial being presented every 1650 milliseconds. Two hundred 
congruent and 200 incongruent trials were arranged in 10 blocks of 40 trials. 
Performance measures MRT, RTV and number of errors (left-right errors occurring 
when participants chose the wrong left or right response) were calculated separately 
for congruent and incongruent conditions. The Eriksen Flanker Task took 
approximately 13 minutes to complete. 
 
The Fast Task; Baseline Condition is a slow, unrewarded reaction time task and consists 
of 55 trials (Andreou et al., 2007), which followed a standard warned four-choice RT 
paradigm. Four empty circles (warning signals, arranged horizontally) first appeared for 
8 seconds, after which one of them (the target) was colored in. Participants were 
asked to press the response key that corresponded to the target position. Following a 
response, the stimuli disappeared and a fixed inter-trial interval of 2.5 seconds 
followed. Speed and accuracy were emphasized equally. If participants did not respond 
within 10 seconds, the trial terminated. We obtained performance measures of MRT 
and RTV across correct trials. This version of the Fast Task took approximately 10 
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minutes to complete. 
6.3.4 EEG  
6.3.4.1 Recording and Pre-processing 
EEG was recorded from 62 channels DC-coupled recording system (extended 10–20 
montage), with a 500Hz sampling-rate, impedances kept under 10kΩ and FCz as the 
reference electrode. The electro-oculograms (EOGs) were recorded from electrodes 
above and below the left eye and at the outer canthi. The EEG data was analyzed using 
Brain Vision Analyzer (2.0) (Brain Products, Munich, Germany). After down-sampling 
the data to 256 Hz, the EEG data was re-referenced to the average of all electrodes 
and filtered offline with digitally band-pass (0.1 to 30 Hz, 24 dB/oct) Butterworth 
filters. All trials were also visually inspected for electrical artefacts or obvious 
movement, and sections of data containing artefacts were removed manually. Ocular 
artifacts were corrected using Independent Component Analysis (ICA) (Jung et al., 
2000). The extracted components were manually inspected and components reflecting 
ocular artifacts removed by back-projection of all but those components. Sections with 
other artifacts exceeding ± 100 microvolt (μV) in any channel were automatically 
rejected. Channels that had been removed due to excessive artefacts were replaced 
with topographic spline interpolation after ICA, to estimate virtual EEG activity based 
on artifact-free activity from other channels.  
6.3.4.2 ERP analyses 
ERP analyses involved standard procedures including EEG data segmentation and 
averaging. Average ERPs were computed separately for each participant, were free 
from residual artifacts and contained a minimum of 20 artefact-free segments. 
 
CPT-OX: In the CPT-OX, baseline correction was performed using a 500-milliseconds 
pre-stimulus reference period in line with our previous study using the same task 
(Michelini et al., 2016b). Stimulus-locked epochs (stimulus window from -200 to 1650 
milliseconds) were averaged based on three different response conditions to Cue, Go 
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and NoGo stimuli. Average ERPs only included trials with correct responses or correctly 
rejected trials. ERP components were identified within the selected electrodes and 
latency windows for which effects were expected to be largest, based on previous 
studies (Albrecht et al., 2013; Michelini et al., 2016b; McLoughlin et al., 2010; 2011b), 
and verified against the topographic maps and grand averages (Figures 6.2 and 6.3). In 
Cue trials, the P3 was measured as the highest peak amplitude at Pz between 250-600 
milliseconds and the CNV was measured as the mean amplitude at Cz between 1300-
1650 milliseconds. In NoGo trials, the P3 was measured as the highest peak amplitude 
at Cz between 250-550 milliseconds. In Go trials, the P3 was measured as the highest 
peak amplitude at Pz between 250-500 milliseconds.  
 
Eriksen Flanker Task: In the Flanker task, baseline correction was applied using -300 to 
-100 ms pre-target (-200 to 0 milliseconds pre-flanker) interval. Analyses of ERN and Pe 
components were restricted to incongruent trials, as not enough errors are made 
during congruent trials in this task to allow reliable measurement of ERPs (i.e. at least 
>20 segments).  Data were segmented based on stimulus-locked congruent and 
incongruent trials where a correct response was made (N2) and response-locked 
(error-related) incongruent trials where an incorrect response was made (ERN and Pe). 
The electrodes and latency windows for ERP analyses were selected based on previous 
studies (Albrecht et al., 2007; Michelini et al., 2016a; McLoughlin et al., 2009), 
topographic maps, and the grand averages. The N2 was measured as maximum 
negative peak at the FCz electrode between 250-450 milliseconds after target onset. 
The ERN was measured as a difference from the preceding positivity (PNe, -100 to 50 
milliseconds) and measured at FCz between 0 to 150 milliseconds. This peak-to-peak 
measure was chosen over a maximum peak measure as it has proven to be a robust 
measure of this component (Falkenstein et al., 2001; Geburek, Rist, Gediga, Stroux, & 
Pedersen, 2013; Nieuwenhuis, Ridderinkhof, Blom, Band, & Kok, 2001). The Pe was 
measured as maximum positive peak at the CPz electrode between 150 and 450 




Fast Task: In the Fast Task, baseline correction was performed using 200-milliseconds 
pre-stimulus reference period, in line with other studies using this task (Cheung et al., 
2017; Michelini et al., 2018). P3 amplitude was analysed as the maximum amplitude at 
Pz between 250 and 500 milliseconds following the target. The electrode and latency 
window used were selected based on previous work from our group (Cheung et al., 
2017; Michelini et al., 2018), topographic maps and the grand averages.   
6.3.4.3 EEG frequency analyses 
We estimated absolute EEG power (μV2) in each task by computing spectral power in 
the delta (0.5-3.5 Hertz; Hz), theta (3.5–7.5 Hz), alpha (7.5–12.5 Hz) and beta (12.5–30 
Hz) bands using the Fast Fourier Transform (FFT). In line with previous studies 
(Rommel et al., 2016; Skirrow et al., 2015), absolute EEG power (μV2) within each 
frequency band was averaged across frontal (Fz, F1-F8), central (Cz, C1-C6) and parietal 
(Pz, P3-P8) regions from individual scalp electrodes to reduce the number of statistical 
comparisons.  
6.3.5 Statistical analyses 
We ran 2x2 random-intercept linear models in STATA 14 (StataCorp, College Station, 
TX) to test the effect of acute exercise on cognitive and EEG measures by examining 
main and interaction effects of Condition (Exercise and Resting control) and Time (Pre- 
and Post-intervention). For the EEG frequency analyses, we ran 2x3 random-intercept 
linear models to test the main and interaction effects of Condition, Time and Region 
(Frontal, Central, Parietal areas). If significant Time-by-Condition interaction effects 
emerged, we ran additional contrasts of marginal linear predictions to compare the 
change in outcome measures before and after exercise (Pre- minus Post-intervention 
value) between each Condition. We chose to run mixed models instead of repeated 
measures ANOVAs because they deal with missing data through maximum likelihood 
and have less strict assumptions on normality of the data, both of which are 
advantageous when analysing small samples. The outcome measures CE and OE were 
severely skewed (+/- 2) and were therefore log-transformed (George & Mallery, 2010). 
Cohen’s d effect sizes are presented along with test statistics, to compare group 
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means, where d ≥ 0.20 is a small effect, d ≥ 0.50 is a medium effect and d ≥ 0.80 is a 
large effect (Cohen, 1988).  
 
We further ran Spearman’s rank correlations of each of the fitness level (VO2peak) and 
physical activity (IPAQ) measures with difference-scores (Post- minus Pre-exercise 
intervention) on outcomes that showed significant improvement after exercise. We 
controlled for the change in outcome after the resting control condition.  
6.4 Results 
See Table 6.1 for descriptive data of the participants and measures obtained during 
the initial fitness assessment. Table 6.2 summarises manipulation data obtained during 
the exercise and resting control sessions.  
 
Table 6.1 Participant characteristics  
Measures Mean (SD) 
Body mass index (BMI), kg/cm2 22.54 (2.86) 
    Underweight; BMI<18.5 (n=2) 
   Normal; BMI=18.5-25 (n=23) 
   Overweight; BMI=25-30 (n=4) 
 
PA levels, MET-minutes/week 3,480 (2,657) 
VO2peak, l/min 2.85 (0.69) 
VO2peak, ml*min-1*kg-1 39 (8) 
GET, l/min 1.70 (0.43) 
GET, %VO2max 60 (8) 
Power output, Watt 262 (56) 
HR at end of fitness assessment 183 (13) 
RPE at end of fitness assessment 18 (1) 
PA levels: Physical activity levels from IPAQ, MET: Metabolic equivalent, VO2peak: 
maximal oxygen uptake, GET: gas exchange threshold, HR: Heart rate; beats/min, RPE: 
Borg rating of perceived exertion scale. 
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Table 6.2 Physiological and perceptual outcomes during testing sessions 
Measures Mean (SD) 
Exercise intervention   
% Completion of trials 100 
RPE at end of session 19 (1) 
HR at end of session, beats/min 180 (11) 
Mean VO2, l/min 1.90 (0.40) 
Mean VO2, ml*min-1*kg-1 26 (5) 
%VO2peak 68 (10) 
Peak VO2, l/min 2.74 (0.59) 
Peak VO2, ml*min-1*kg-1 38 (7) 
Power output, Watt 167 (44) 
Mean %∆ 21 (26) 
Resting control   
% Completion of trials 100 
Perceived exertion at end of session 6 (1) 
HR at end of session 75 (13) 
Mean VO2, l/min 0.32 (0.06) 
Mean VO2, ml*min-1*kg-1 5 (1) 
%VO2peak 12 (2) 
RPE: Borg rating of perceived exertion scale, VO2peak: maximal oxygen uptake, GET: gas 
exchange threshold, HR: Heart rate; beats/min, ∆: difference between GET and VO2peak. 
 
6.4.1 CPT-OX 
Means and standard deviations of cognitive performance, ERP and EEG frequency 
measures before and after the exercise and resting control interventions are 





Two participants had missing EEG data at one visit due to excessive artefacts in the 
data; one was heavily sweating and the other experienced a lack of sleep. A further 
participant was excluded from the ERP analysis due to having less than 20 artefact-free 
segments at both visits. One individual had missing cognitive-performance data during 
one visit due to technical issues (see Figure 6.1).  
 
 
Table 6.3 Means and standard deviations of cognitive and brain measures during 
each Time point (Pre- and Post-intervention) and Condition (Exercise and Resting 
control) during the CPT-OX. 
CPT-OX: Cued Continuous Performance Task, MRT: Mean reaction time, RTV: Reaction 
time variability, OE: Omission error, CE: Commission error, CNV: Contingent negative 
variation. Average EEG frequency band measures are reported across all brain regions 
(see Table S1 for each frontal, parietal and central regional measure). 
 
 Exercise intervention Resting control 
 Pre Post Pre Post 
MRT 370.82 (41.08) 370.56 (45.72) 374.55 (60.12) 378.13 (51.91) 
RTV 80.03 (42.54) 105.24 (59.37) 83.73 (51.50) 94.76 (59.12) 
OE 1.04 (1.48) 2.04 (3.36) 1.92 (3.58) 3.27 (5.74) 
CE 1.04 (1.22) 1.84 (1.93) 1.27 (1.99) 2.27 (2.81) 
CNV -2.80 (1.94) -3.06 (2.97) -2.35 (2.23) -2.89 (2.30) 
Cue P3 5.25 (2.64) 5.25 (2.82) 4.99 (2.86) 5.02 (2.92) 
NoGo P3 7.43 (4.01) 8.43 (5.86) 7.31 (5.51) 8.65 (5.74) 
Go P3 8.18 (4.18) 9.34 (5.49) 8.17 (4.51) 8.45 (4.63) 
Delta 3.85 (2.60) 5.44 (4.28) 3.97 (2.22) 4.32 (2.20) 
Theta 0.53 (0.50) 0.68 (0.64) 0.63 (0.67) 0.73 (0.70) 
Alpha 0.83 (1.61) 1.06 (1.71) 0.94 (1.81) 1.11 (1.82) 
Beta 0.11 (0.05) 0.15 (0.09) 0.13 (0.07) 0.14 (0.06) 
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6.4.1.1 Cognitive performance data 
The random-intercept models did not reveal any significant Condition-by-Time 
interaction effects on any of the cognitive measures (all p>0.05): OE, CE, MRT or RTV 
(Table 6.4). We found significant main effects of Time for RTV, CEs and OEs, showing 
that RTV (from M=81.88 milliseconds [SD=37.48] to M=100.88 milliseconds 
[SD=49.05]), CEs (from M=1.15 [SD=1.64] to M=2.06 [SD=2.40]) and OEs (from M=1.48 
[SD=2.24] to M=2.72 [SD=4.08]) increased over time, on average, across the exercise 
and resting control conditions. No other main effects were observed for cognitive 
measures (Table 6.4).  
6.4.1.2 ERP data 
The random-intercept models revealed a significant (p=0.03) Condition-by-Time effect 
on the Go P3. Post-hoc comparisons revealed that the Go P3 amplitude significantly 
increased after exercise (d=0.24, p=0.008) but not after the resting control condition 
(d=0.06, p=0.61) (Table 6.4).  
 
We found no other significant interaction effects on the CNV, Cue P3 or NoGo P3 
amplitudes and only one significant main effect of Time on the NoGo P3, showing that 
the amplitude increased from pre- to post-intervention (from M=7.40 μV [SD=4.38] to 
M=8.63 μV  [SD=5.65]), across the exercise and resting control conditions (Table 6.4).   
6.4.1.3 EEG frequency data 
The random-intercept models revealed no significant Condition-by-Time-by-Region 
effects on any of the EEG frequency bands, but did reveal a significant Condition-by-
Time interaction effect on delta activity, across regions. Post-hoc comparisons showed 
that delta activity significantly increased after exercise (d=0.37, p<0.001), but not after 
the resting control session (d=0.11, p=0.46) (Table 6.4). No other interaction effects 
were significant.  
 
The analyses revealed significant (p<0.05) main effects of Region across the frequency 
bands (Table 6.4). The effect of Time was significant for delta (from M=3.60 μV2 
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[SD=1.56] to M=4.38 μV2 [SD=1.91]), theta (from M=0.57 μV2 [SD=0.59] to M=0.70 μV2 
[SD=0.68]) and beta (from M=0.11 μV2 [SD=0.04] to M=0.14 μV2 [SD=0.06]) activity, 
showing that EEG activity in these bands increased from pre- to post-time points, 
across exercise and resting control conditions (Tables 6.3 & 6.4). No main effect of 
Time was found on alpha activity. The effect of Condition was significant only for the 
theta band, showing that theta activity was higher during the resting control session 
(M=0.66 μV2 [SD=0.69]) compared to the exercise session (M=0.59 μV2 [SD=0.56]), 
across pre- and post-measures.  
 
To investigate the relationship between the significant increases in delta activity and 
Go P3 amplitude after exercise, we ran Spearman rank correlations between the 
change scores (Post- minus Pre-exercise measures). The correlation between change in 



















Table 6.4 Main and interaction effects of Time (Pre- and Post-intervention), 
Condition (Exercise and Resting control) and Region (Frontal, Central and Parietal) on 
cognitive and brain measures, during the CPT-OX 
Presenting significant main and interaction models; p<0.05. Full table in Supplementary 
Table S2. *p<0.05 for post-hoc comparisons. Post-hoc comparisons: aChange after 
exercise intervention, bChange after resting control. cFrontal vs Central, dFrontal vs 
Parietal, eCentral vs Parietal, CPT-OX: Cued Continuous Performance Task, MRT: Mean 
reaction time, RTV: Reaction time variability, OE: Omission error, CE: Commission error, 
CNV: Contingent negative variation, NS: Not significant.  
  Chi2 P-value Effect size 
MRT NS    
RTV Time 5.19 0.02  0.34 
Omission errors Time 4.12 0.04  0.28 
Commission errors Time 11.30 <.001  0.48 
NoGo P3  Time 4.75 0.03 -0.22 
Go P3 ConditionxTime 4.97 0.03 a0.24* b0.06 
CNV NS    
Delta ConditionxTime 5.20 0.02 a0.37* b0.11 
 Time 11.09 <.001  0.26 
 Region 66.18 <.001 c0.77* d0.26* e0.68* 
Theta Condition 4.16 0.04  0.09 
 Time 11.83 0.001  0.18 
 Region 83.04 <.001 c0.64* d0.01 e0.53* 
Alpha Region 52.15 <.001 c0.24* d0.26* e0.45* 
Beta Time 9.16 0.003 0.24 




Figure 6.2 Grand average stimulus-locked event-related potentials of the Cue P3 at 
the Pz electrode (top half) and contingent negative variation (CNV) at the Cz 
electrode (bottom half) following cue trials, with topographic maps (a) after exercise 
intervention and (b) after resting control condition.  
Thin unbroken line for before exercise intervention, bold unbroken line for after exercise 
intervention, thin dotted line for before resting control condition and bold dotted line 




Figure 6.3 Grand average stimulus-locked event-related potentials of the Go P3 at 
the Pz electrode after the Go stimulus (top half) and NoGo P3 at the Cz electrode 
after NoGo trials (bottom half), with topographic maps (a) after exercise intervention 
and (b) after resting control condition. 
Thin unbroken line for before exercise intervention, bold unbroken line for after exercise 
intervention, thin dotted line for before resting control condition and bold dotted line 
for after resting control condition.  
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6.4.1.4 Effect of fitness level and physical activity on improvement from exercise 
The Spearman’s rank correlations did not reveal any significant associations between 
aerobic fitness level and changes in Go P3 amplitude (r=0.23, p=0.32) or delta activity 
(r=0.21, p=0.36) after exercise. Physical activity level was not significantly correlated 
with changes in Go P3 amplitude (r=0.19, p=0.43) or delta activity (r=0.28, p=0.21) 
after exercise.  
6.4.2 Eriksen Flanker Task and Fast Task  
Means and standard deviations of cognitive performance, ERP and EEG frequency 
measures before and after the exercise and resting control interventions are 
summarised in Tables S3 and S4.  
 
We found no significant Condition-by-Time interaction effects on any of the 
performance, ERP or EEG frequency band measures in the ERN or Fast Task (Tables S5 
& S6).  
6.5 Discussion 
In this randomised cross-over study of 29 healthy young men, we examined the effect 
of 20-minutes of high-intensity cycling exercise, compared to resting, on a range of 
performance and brain measures during three consecutive cognitive tasks (CPT-OX; 
Eriksen Flanker Task; Fast Task). In the CPT-OX, we found that exercise improved 
executive attention, indexed by enhanced Go P3 amplitude, but not anticipatory 
attention (Cue P3 and CNV) or inhibitory processing (NoGo P3). Exercise further 
enhanced delta power during the task, which may suggest improved sustained 
attention after exercise (Harmony et al., 1996; Knyazev, 2012; Lakatos, Karmos, Mehta, 
Ulbert, & Schroeder, 2008). Neither aerobic fitness nor physical activity levels were 
significantly correlated with the degree of improvement in the Go P3 amplitude or 
delta activity measures following exercise. We did not find any effects on performance 
measures or any of the outcome measures during the later Flanker and Fast tasks. 
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These findings provide insight into the specific processes that may improve following 
physical aerobic activity. 
 
Our findings suggest that acute high-intensity exercise improves executive attention, 
indexed by Go P3 amplitude in the Go/NoGo paradigm of the CPT-OX, which relates to 
increased attention to the task as you respond to the target stimuli. We did not find 
improvement in ERP components of anticipatory attention or inhibitory processing in 
the task, contrary to two studies in adults that have found improvements in the CNV 
during a visuo-spatial attention task (Tsai et al., 2014) and the NoGo P3 during a 
Go/NoGo task (Kamijo et al., 2004b). The discrepancy in findings may be explained by 
differences in experimental tasks or study design, such as differences in the time 
lapses between exercise and cognitive task performances. Previous studies had time 
lapses of 3 (Kamijo et al., 2004b) and 15-20 (Tsai et al., 2014) minutes, compared to 
the longer lapse of 30 minutes in our study. While most exercise studies have solely 
focused on the P3 component in isolation from other ERPs, our study, looking across 
ERP measures, confirms that the enhanced P3 amplitude following exercise is the most 
robust ERP finding in the exercise literature (Hillman et al., 2003; Chang et al., 2015a), 
and may possibly have the longest-lasting effect after exercise.  
 
We also report for the first time that acute high-intensity exercise enhanced slow delta 
band activity, across parietal, frontal and central brain regions, during cognitive task 
performance in the CPT-OX. Drawing on the cognitive-neuroscientific literature, this 
finding may suggest an improvement in sustained attention after exercise, as increased 
delta activity during task performance has been linked to attentional processes across 
experimental paradigms (Harmony et al., 1996; Knyazev, 2012; Lakatos et al., 2008). 
Yet, the improvements in Go P3 amplitude and delta activity were not significantly 
related, suggesting that these two measures may tap into different aspects of 
attention. While several previous studies have reported that the P3 component is 
largely explained by an increased event-related delta response (Prada, Barcelo, 
Herrmann, & Escera, 2014; Harper, Malone, & Bernat, 2014), less is known about how 
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delta activity throughout a task relates to the event-related P3 components. Previous 
exercise studies have investigated EEG bands only during resting-state and reported 
increases in fast-wave brain activity (reflecting wakeful alertness and cortical 
activation), often immediately after exercise (Moraes et al., 2007; Schneider et al., 
2009b), but not in slow-wave activity (reflecting drowsiness). We now add to the 
literature by showing beneficial effects in slow-wave delta activity during cognitive 
engagement, which instead may reflect attentional processing (Harmony et al., 1996; 
Knyazev, 2012; Lakatos et al., 2008). One implication of our findings is that the 
identified specific neurophysiological processes that improve from exercise may be 
modifiable and suitable targets for exercise intervention programs for psychiatric and 
neurodevelopmental disorders, where these processes are often impaired (Tye et al., 
2014; Ertekin, Ucok, Keskin-Ergen, & Devrim-Ukoc, 2017).   
 
While we find that neither aerobic fitness nor physical activity level was associated 
with how well individuals improved in the Go P3 or delta activity measures, previous 
research on the interacting effect of aerobic fitness on the beneficial effects of exercise 
on brain measures has been scarce and inconclusive (Chang et al., 2015b; Hogan et al., 
2013). Here we add to the literature by showing that aerobic fitness did not influence 
the improvement in brain measures of attention, and extend the research by also 
showing that participants’ average level of physical activity did not influence the effect 
of exercise. One issue to consider, however, is that we may have been under-powered 
to detect significant correlations of aerobic fitness and physical activity levels with 
change in outcome measures after exercise. Based on power calculations (using 
G*Power 3.1) in our sample of 29 participants, we would only be sufficiently powered 
to detect moderate-to-large effects. Thus, further research is needed using larger 
samples to determine the role of aerobic fitness and physical activity level on the 
effects of acute exercise on brain measures.  
 
The beneficial effects of exercise on brain indices of sustained and executive attention 
were not reflected by behavioural task performance. While some previous studies 
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have found parallel improvements in processing speed and performance errors with 
increased Go P3 amplitude (Drollette et al., 2014; Kamijo et al., 2007; 2009), another 
study has solely found improvements in brain measures, similarly to our current study 
(Mierau et al., 2014). Possible explanations for the lack of effects on task performance 
may be that (1) brain measures are more sensitive to the effects of exercise in the CPT-
OX, (2) the CPT-OX task may have been too easy, creating ceiling effects (supported by 
the fact that 52% of the time individuals made no omission errors during task 
performance), and (3) effect sizes of exercise are lower for performance measures 
which might result in too little power to detect these as significant in our relatively 
small sample.  
 
We found no effects of acute high-intensity exercise on any of the measures during the 
subsequent Flanker or Fast Tasks following the CPT-OX. One possible explanation for 
the lack of significant findings in these later tasks is the time lapse between the 
execution of exercise and the performance of the two tasks, leading to wash out of any 
potential effects of exercise. Participants performed the Flanker and Fast tasks 
approximately 41 to 54 minutes and 54 to 64 minutes, respectively, after the exercise. 
This potential interpretation is in line with some previous studies on the effect of acute 
exercise. An EEG study found that activity in the alpha frequency band was inversely 
correlated with the amount of time elapsed since exercise cessation (Crabbe & 
Dishman, 2004) and a meta-analysis reported that the acute effect of exercise on 
cognition, across tasks, was only significant within the first 15 minutes after exercise 
(Chang et al., 2012a). Further, in the present study, the increased Go P3 amplitude 
after exercise in the CPT-OX was not replicated for the target P3 component in the 
subsequent Fast Task, even though both components reflect attention to target stimuli 
requiring a response. Another possible explanation for the lack of findings in the 
Flanker and Fast Tasks may be due to the different nature of the tasks, however, we 





One should interpret our findings in light of the study limitations. As we did not 
counterbalance the order of cognitive tasks, we could not investigate in more detail 
the influence of time lapse or cognitive load on the effects of exercise, as this was not 
our primary focus. Further, while we were interested in studying the effects of a 20-
minute high-intensity exercise session, we could not separate this effect from that of 
the total 30-minute exercise including the warm-up and cool-down elements. While 
this issue is important to note, the warm-up and cool-down elements of the exercise 
session are standard practice in exercise trials for safety precautions (e.g. avoiding 
post-exercise syncope). It is also important to note that only males were included in 
the study, and therefore it would be informative to investigate the generalizability of 
our findings by replicating analyses in females and examining effects of sex in a large, 
well-powered sample. Lastly, our sample size was relatively small, although similar in 
size to the majority of acute exercise studies in the literature (Moraes et al., 2007; 
2011; Schneider et al., 2009b; St-Louise-Deschenes et al., 2015a), thus, larger-scale 
double-blinded experiments are needed to confirm our findings.  
6.6 Conclusion 
In this randomised cross-over study, we found that 20 minutes of acute high-intensity 
exercise improved brain measures of executive and attentional processes during a 
continuous performance task, but not measures of anticipatory attention or inhibitory 
processing. Exercise had no effect on behavioural performance or brain measures in 
subsequent Flanker and Fast Tasks, which could be due to time delay or level of 
cognitive load. Insights on the specific processes that improve from exercise may be 
used to understand the cognitive-electrophysiological targets for intervention 








CHAPTER 7 – Discussion and conclusions 
7.1 Abstract 
In this concluding chapter, I will provide a summary of the key findings from the five 
data-based chapters. I will go on to discuss wider implications of these findings on 
informant source validity and biological correlates of ADHD, relating to both research 
and clinical contexts. Strengths and limitations of the research will then be highlighted 
along with future directions.  
7.2 Summary of aims 
This thesis aimed to investigate informant source validity as well as genetic and 
neurobiological underpinnings of ADHD in adolescents and adults using a multi-
disciplinary approach. In the first part of the thesis, the aim to was to evaluate the 
validity of informant sources for ADHD by examining associations of informants with 
cognitive-neurophysiological correlates and future adverse life outcomes using both 
clinical and epidemiological samples. In the second part of the thesis, the overall aim 
was to further our understanding of different aspects of biological factors associated 
with ADHD using both clinical and population samples. Specifically, the aims were to 
(1) examine the genetic associations between ADHD and commonly co-occurring traits 
and disorders, (2) establish the stability of autonomic arousal profiles in ADHD, 
indexed by electrodermal activity, and (3) study the effects of acute physical exercise 
on cognitive-neurophysiological measures of attention, inhibition and performance-
monitoring.  
7.3 Key findings 
7.3.1 Self-report of ADHD shows limited agreement with objective markers of 
persistence and remittance 
The first study in this thesis (Chapter 2) aimed to investigate how well self-report is 
reflected by objective (cognitive-neurophysiological and actigraph) measures, which 
have previously been shown to discriminate between ADHD persisters, remitters and 
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controls using parent-report (Cheung et al., 2016), in 108 adolescents and young adults 
with childhood ADHD and 167 controls (the SEFOS sample).  
 
The findings showed that the objective data were better at distinguishing between 
persistent and remittent groups when these were based on parent-report, compared 
to self-report. Furthermore, the concordant (meeting ADHD criteria according to both 
informant reports) and discordant (meeting ADHD criteria according to parent report 
only) groups significantly differed from controls on most measures and did not differ 
from each other on any objective measure, suggesting that self-reports of ADHD at 
follow-up added little value over and above parent-report alone in the association of 
ADHD with the objective measures studied. 
 
The analyses on continuous measures of ADHD symptoms revealed that self- and 
parent-reports showed similar patterns of associations with the objective measures, 
suggesting a quantitative difference between self- and parent-reported symptoms, as 
they differed in mean severity. Self-reported impairment correlated significantly with 
fewer objective measures than parent-reported impairment, suggesting a qualitative 
difference between the informants. This suggests that individuals evaluate their level 
of impairment based on other factors than their parents.  
 
This is the first study to suggest that self-report of ADHD outcome in adolescents and 
young adults is not as well reflected by cognitive-neurophysiological and movement 
data as parent-report. These findings demonstrate that there can be considerable 
inconsistencies in research findings based on the informant source used, which is 
important for researchers to acknowledge. For clinicians, the findings also suggest that 
parent-ratings continue to be important in adolescence and young adulthood and that 
during the follow-up of children with ADHD, care should be taken to continue to gather 
reports from multiple informants including parents. 
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7.3.2 Predictive validity of parent- and self-rated ADHD symptoms in adolescence on 
adverse socioeconomic and health outcomes 
The second study in this thesis (Chapter 3) aimed to compare the predictive 
associations of ADHD symptoms rated by parents and their children across 
adolescence on a range of adverse socioeconomic and health outcomes in early 
adulthood in a population-based sample (TCHAD study; N=2,960).  
 
While past research has shown that ADHD symptoms rated by parents in childhood are 
associated with adverse life outcomes, the results from this study now showed that 
both parent- and self-rated symptoms in adolescence were significantly associated 
with adverse outcomes. Parent-ratings of ADHD symptoms rated in early and late 
adolescence were (1) more often significantly associated with and (2) generally more 
strongly associated with the life outcomes compared to self-ratings (ORs=1.12-1.49 
versus 1.07-1.17), although the difference between parent- and self-ratings in their 
predictive strength did not significantly differ for most outcomes. Parent-ratings also 
predicted several outcomes over and above self-ratings, and the discriminative 
accuracy did not significantly improve when self-ratings were added to the models 
compared to when only parent-ratings were used. These findings suggest that despite 
parent- and self-ratings of ADHD symptoms in adolescence only showing modest 
correlations (0.36–0.37), self-ratings do not have added value beyond parent-ratings 
for most life outcomes in young adulthood. While multi-informant approaches (e.g., 
combining informant source ratings) are commonly used based on the belief that each 
informant provides unique and valuable information, these results suggest that self-
ratings do not provide much information once parent-ratings have been taken into 
account in predicting most of the outcomes.  
 
The study findings, taken together with the findings in Chapter 2, suggest that parent-
ratings have higher predictive and construct validity than self-ratings in adolescence. 
Thus, even though our findings suggest that self-ratings provide some prognostic 
information on future life outcomes, the data indicate that obtaining parent-ratings of 
ADHD symptoms should be the priority in child and adolescent clinical and research 
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settings. This may change in older adulthood, where parents generally have less 
frequent contact with their children and therefore have less insight into their 
children’s behaviour and level of functional impairment. 
7.3.3 Associations of polygenic risk of attention-deficit/hyperactivity disorder with 
co-occurring traits and disorders 
The third study (Chapter 4) used a powerful polygenic approach, with PRSs derived 
from the mega-GWAS, to investigate the aetiological overlap between ADHD and 
frequently co-occurring traits and disorders in a large-scale adult population sample 
(UK Biobank; N=135,726).  
 
Findings revealed that polygenic load for ADHD predicted higher BMI, risk-taking and 
neurotic behaviour, depression and anxiety (at a suggestive level), alcohol intake 
frequency, alcohol dependency, tobacco use and lower general cognitive ability in the 
general population. These are the first scientific reports of significant genetic 
associations between ADHD and neuroticism traits, risk-taking, and alcohol use based 
on genome-wide data. The remaining associations are consistent with a relatively 
limited literature of studies demonstrating pleiotropy of the genetic variants 
underlying ADHD (Anttila et al., 2016; Demontis et al., 2018). The overall findings 
suggest that the co-occurrence of these traits and disorders in ADHD is partly 
explained by the same common genetic variants. The same pattern of results was 
found in men and women.  
 
Further research is needed to identify genetic pathways and neurobiological 
mechanisms relating to these genetic overlaps, which could prove vital for improving 
prevention and treatment interventions for individuals with ADHD who are at risk for 
other serious conditions. The common mechanisms underlying ADHD and a co-
occurring trait or disorder could either reflect “biological” (or “horizontal”) pleiotropy, 
where similar mechanisms influence both traits, or “mediated” pleiotropy, where 
certain mechanisms influences one of the traits, which in turn influences the other 




The study findings also lend further support for the continuous nature of ADHD, with 
symptoms representing the high end of traits that occur continuously throughout the 
population. Results showed that common risk alleles that contribute to clinically 
diagnosed ADHD in children and adults also influenced common traits and disorders in 
a general population sample of older adults, suggesting that ADHD symptoms 
represent continuous traits and that similar genetic influences may be present in 
younger and older individuals. This fits well with the current understanding of ADHD as 
a continuum of severity based on evidence from behavioural, neurobiological, and 
genetic studies (Kuntsi et al., 2014; Larsson, Anckarsater, Råstam, Chang, & 
Lichtenstein, 2012; Lubke, Hudziak, Derks, van Bijsterveldt, & Boomsma, 2009).  
7.3.4 Autonomic arousal profiles in young individuals with ADHD as a function of 
recording context 
The fourth study (Chapter 5) aimed to investigate if autonomic arousal in individuals 
with ADHD changes over a long testing session and across time, to clarify if arousal 
profiles are context-dependent or reflect stable impairments, in 71 adolescents and 
young adults with childhood ADHD and 140 controls (SEFOS). 
 
Findings showed that autonomic arousal profiles of individuals with ADHD varied 
across testing conditions. ADHD case-control differences in tonic arousal, indexed by 
SCL, only emerged during a slow and low-demanding cognitive task and differences in 
phasic arousal, indexed by non-specific fluctuations (NSFs), emerged towards the end 
of the assessments. Firstly, these findings suggest that lower arousal levels in 
individuals with ADHD may be especially salient during slow and low-demanding tasks 
compared to faster-paced and more demanding tasks such as the CPT or the fast-
incentive condition of the Fast Task (as demonstrated in James et al., 2016). Our 
findings further suggest that arousal variability in ADHD may become especially salient 
over time, possibly in combination with the low-demanding task. Overall, the finding 
suggests that individuals with ADHD may experience difficulties in regulating their 
arousal levels rather than experience constant hypo-arousal, which implies that 
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arousal is malleable in individuals with ADHD and may therefore be suitable as a 
potential treatment target. The study findings further suggest that inconsistencies in 
the literature (Hermens et al., 2004; Mayer et al., 2016) may be explained by the 
different experimental paradigms used across studies. 
 
Analyses further revealed that lower and more fluctuating arousal was associated with 
a higher level of inattentive and hyperactive-impulsive symptoms, supporting initial 
findings from a study only in girls (Dupuy et al., 2014). These findings were not 
accounted for by ODD/CD symptoms, which is in line with previous limited research 
(Beauchaine et al., 2001; Van Lang et al., 2007). This study using the SEFOS sample is 
the first larger study to investigate the specificity of both tonic and phasic arousal 
profiles in young adults with ADHD by controlling for ODD/CD symptoms in analyses. 
On the other hand, controlling for ODD/CD symptoms enhanced the relationship 
between phasic arousal and ADHD over time, but it is not clear from these results how 
ODD/CD symptoms relate to the other variables, as they did not account for the linear 
associations between NSFs and ADHD symptom domains and were not significantly 
associated with NSFs. While previous research has suggested that individuals with 
antisocial/conduct problems have smaller amplitude of specific SCRs (Delamater & 
Lahey, 1983), less is known of non-specific fluctuations. Further studies are needed to 
clarify the complex relationship between ODD/CD, NSFs and ADHD, to determine the 
specificity of fluctuating arousal profiles in ADHD.  
 
Overall, these findings suggest that individuals with ADHD experience difficulties 
regulating their arousal rather than being constantly under-aroused. Inconsistent 
findings in the literature on autonomic arousal in ADHD might be explained by 
differences in experimental designs and tasks.  
7.3.5 Beneficial effects of acute high-intensity exercise on electrophysiological 
measures of attention processes 
The final study (Chapter 6) used a randomised cross-over design to investigate the 
effects of 20-minute high-intensity exercise, compared to resting, on cognitive-
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performance and brain measures of attention, inhibition and performance-monitoring, 
across three consecutive cognitive tasks (CPT-OX; Eriksen Flanker Task; Fast Task), in 
29 healthy young men (PHAB).  
 
The findings showed that high-intensity exercise improved executive attention, 
indexed by Go P3 amplitude in the Go/NoGo paradigm of the CPT-OX, which relates to 
increased attention to the task as you respond to the target stimuli. Exercise did not 
influence ERP measures of anticipatory attention or inhibitory processing in the task. 
While most exercise studies have solely focused on the P3 component in isolation from 
other ERPs, this study, looking across ERP measures, confirmed that the enhanced P3 
amplitude following exercise is the most robust ERP finding in the exercise literature. 
This study also found, for the first time, that high-intensity exercise enhanced slow 
delta band activity during cognitive task performance in the CPT-OX. Drawing on the 
cognitive-neuroscientific literature, this suggests an improvement in sustained 
attention after exercise. Yet, the improvements in Go P3 amplitude and delta activity 
were not significantly related, suggesting that these two measures may tap into 
different aspects of attention. Acute exercise did not influence any of the measures 
during the subsequent cognitive tasks (Flanker and Fast tasks). It is possible that the 
greater time lapse between the execution of exercise and performance of these tasks 
lead to wash out of any potential effects of exercise.  
 
Overall, these findings suggest that brain indices of executive and sustained attention 
may be modifiable and suitable targets for exercise intervention programs for 
individuals with attentional difficulties, such as in ADHD. The findings also add to the 
literature by showing that aerobic fitness and physical activity level did not influence 
the improvement in brain measures of attention. However, the analyses may have 
been under-powered to detect significant correlations of aerobic fitness and physical 
activity levels with change in outcome measures after exercise, based on power 
calculations (using G*Power 3.1). Thus, further research is needed using larger samples 
to determine the role of aerobic fitness and physical activity level on the effects of 
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acute exercise on brain measures, to establish characteristics of individuals who would 
benefit the most from exercise interventions.  
7.4 Wider implications 
7.4.1 Validity of parent- and self-report of ADHD in adolescents and young adults 
The findings in Chapters 2 and 3 provide convergent evidence that parent-report of 
ADHD in adolescence and young adulthood has higher validity than self-report, in 
terms of construct and predictive value, and that self-report may not add additional 
value over and above parent-report. These conclusions are in line with existing, 
although limited, literature (Barkley, Fischer, Smallish, & Fletcher, 2002; Brikell et al., 
2015) and have direct implications for both research and clinical practice.  
 
Firstly, these findings have important implications for research, in terms of how to 
diagnose and define ADHD accurately, as the use of different informant sources may 
explain inconsistencies in ADHD research across studies of adolescents and young 
adults. For example, recent publications have reported very low ADHD persistence 
rates in adults (Agnew-Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015) using 
self-reports, in contrast to studies using self- and parent-report (Biederman et al., 
2010; Faraone et al., 2006). Results from Chapter 2 confirm the trend for adolescents 
and young adults diagnosed with ADHD to show a tendency to report their ADHD 
symptoms as less severe than their parents (Guelzow et al., 2017; Pierrehumbert et al., 
2006), while the opposite pattern is found in population-based samples, where self-
ratings are higher than parent- or other-ratings (Merwood et al., 2013; Sibley et al., 
2012), as seen in Chapter 3. This may contribute to inflation in reports of adult-onset 
prevalence in population samples (Agnew-Blais et al., 2016; Moffitt et al., 2015). 
Further inconsistent results were found in the first part of this thesis (Chapters 2 and 3) 
where the use of self- and parent-report of ADHD resulted in different findings in 
regards to associations with cognitive-neurophysiological and movement measures 
and future life outcomes. While multi-informant approaches (e.g., combining 
informant source ratings) are commonly used based on the belief that each informant 
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provides unique and useful information, the results from these two studies suggest 
that self-ratings in adolescents and young adults do not necessarily provide added 
valuable insights once parent-ratings have been taken into account. Overall, it should 
be acknowledged that inconsistencies in the ADHD literature may be explained by the 
different informant sources used in research. Based on the findings in this thesis, 
future research studies are encouraged to not rely solely on self-reports of ADHD in 
adolescent and young adult age groups.  
 
For clinical settings, these findings suggest that parent-report of symptoms and 
impairment should especially be prioritized in this age group when establishing an 
ADHD diagnosis, to provide an accurate and valuable diagnosis that captures 
underlying neurobiological impairments and has prognostic value for future outcomes. 
Further research is needed to establish if self-report shows increased validity, relative 
to parent-report or other informant-report (such as spouse/partner), in later ages in 
adulthood and to establish if any specific aspects of self-report may be more valuable 
and have more insight than other informants.   
7.4.2 Genetic overlap between ADHD and co-occurring disorders 
While individuals with ADHD often present with other impairing conditions, little is still 
known of the specific causes for these co-occurrences. Polygenic analyses in Chapter 4 
reported genetic associations between ADHD and several traits and disorders, 
suggesting that the co-occurrences of other conditions in ADHD, such as lower general 
cognitive ability, higher BMI, risk-taking and neurotic behaviour, depression and 
anxiety, alcohol intake frequency, alcohol dependency and smoking may at least in 
part be explained by overlapping genetic bases. These results are consistent with other 
lines of research using other quantitative and statistical genetic methods (e.g. Cole et 
al. 2009; Michelini et al. 2015; Demontis et al. 2018) in suggesting that common 
biological mechanisms are at play between ADHD and co-occurring conditions. The 
findings may guide further research into the specific genetic pathways and 
neurobiological mechanisms that may be useful for clinical applications, by identifying 
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targets for treatment and prevention of the development of impairing conditions in 
ADHD.  
 
The identified genetic associations In Chapter 4 may reflect “horizontal pleiotropy”, 
where the same causal variants contribute to both traits independently, or “mediated 
pleiotropy”, where the genetic variants affect one of the traits directly (e.g. ADHD) and 
that trait subsequently influences the other (e.g. high BMI) (Socrates et al., 2017; 
Solovieff et al., 2013). Future research is needed to establish which type of pleiotropy 
underlies the identified genetic associations between ADHD and co-occurring traits 
and disorders. For example, structural equation modelling and related approaches can 
incorporate genome-wide significant genetic variants or PRS on the traits and 
disorders to provide insights into the causal relationships between them (Pingault et 
al., 2018). 
7.4.3 Malleability of physiological and neurobiological impairments in ADHD 
Findings in Chapters 5 and 6 demonstrate the malleable nature of several physiological 
and neurocognitive impairments often seen in ADHD from different scientific angles. 
Existing, although limited, evidence in the ADHD literature suggests that both 
fluctuations in response speed in cognitive tasks, indexed by high RTV, and low tonic 
physiological arousal, indexed by SCL, are implicated in ADHD and may be modifiable 
(James, Cheung, Rijsdijk, Asherson, & Kuntsi, 2016; Kuntsi et al., 2013). This has been 
evidenced by improvements in these measures during fast-paced, rewarded task 
conditions (James et al., 2016; Kuntsi et al., 2013). Recent findings, using the same task 
paradigm (the Fast Task), have additionally demonstrated that the ERP P3, reflecting 
executive attention, may also be malleable in ADHD, as P3 amplitudes were 
attenuated only in the slow, unrewarded task condition and normalised in the fast-
paced, rewarded condition (Cheung et al., 2017). The results in this thesis now extend 
these findings by showing that tonic (SCL) and phasic (NSFs) autonomic arousal 
dysregulation in individuals with ADHD may be context-dependent rather than reflect 
stable deficits in ADHD. Thus, the autonomic arousal measures may be suitable targets 
in future non-pharmacological interventions for reaching an optimal state of arousal 
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and alertness in individuals with ADHD. Further research in this thesis has also 
reported, using a sample of healthy young adults, that brain indices of executive (P3 
amplitude) and sustained (delta activity during task performance) attention may 
improve from acute exercise. Similarly, these neurocognitive findings suggest that 
brain indices of executive and sustained attention are modifiable and could therefore 
potentially be suitable targets for interventions for individuals with attention 
problems. Taken together, the findings also emphasise the benefits of using fast-paced 
activities and incentives in learning environments for individuals with attention 
difficulties (Cheung et al., 2017) and promoting exercise to enhance the regulation of 
attention and arousal. 
7.5 Strengths and limitations 
7.5.1 Multidisciplinary approach  
This thesis used a multidisciplinary approach to study ADHD in adolescents and adults 
to attempt to answer research questions from different angles, and taking advantage 
of the different strengths and limitations of each method used. For example, while 
clinical samples tend to be smaller in size, due to constraints with participant 
recruitment and diagnostic procedures, these often have rich study measures with 
detailed information on participants. Epidemiological samples, on the other hand, may 
not have as detailed study measures and these are often collected routinely, however, 
they allow for large sample sizes that increase statistical power. Registered-based data 
are specifically advantageous due to the objectiveness of measures rather than relying 
on subjective ratings from participants or their informants. While a multidisciplinary 
approach is useful for combining different techniques that tackle research questions 
slightly differently, the approach may also lead to difficulties in bringing together these 
disparate techniques to form a cohesive conclusion. This thesis has attempted to unify 




Chapter 2 used a clinical sample to investigate the validity of self-report of ADHD, 
allowing for association testing between rigorously collected self-reported ADHD 
measures and detailed cognitive, EEG and movement measures. This methodology 
informed the design of the study in Chapter 3, which used a larger-scaled population 
sample with registry data to examine the validity of self- and parent-reported ADHD 
symptoms. The study in Chapter 3 did not have as detailed ADHD symptom and 
impairment data on participants, but instead was advantageous in its larger sample 
size and use of objectively collected life outcome measures. The findings of self-report 
showing limited validity in comparison to parent-report in Chapters 2 and 3, informed 
the decision to use parent-reported ADHD in the analyses in Chapter 5. ODD/CD 
symptoms in Chapter 5 were obtained through self-report, however, this was due to 
the lack of available parent-reports. The successful use of cognitive-EEG and 
autonomic arousal measures in Chapters 2 and 5 to discriminate between ADHD and 
control groups led to the decision to use these measures in Chapter 6, where the 
effects of exercise were tested on ADHD-related measures in a healthy population 
sample. Unfortunately, autonomic arousal measures could not be used in Chapter 6 
due to technical difficulties with the skin conductance recordings. While I learned that 
it would have been advantageous to counterbalance the order of cognitive tasks in 
Chapter 5 to better answer the research question, this unfortunately did not inform 
the study design in Chapter 6 as the data had already been collected by that time. 
 
Finally, general themes that ran through this thesis were investigations of changes in 
clinical presentations and aetiology across development and modifiability in ADHD. 
Chapters 2 and 3 studied the validity of self- and parent-report of ADHD in the 
transitional stages between childhood and adulthood. While parent- and teacher-
report are used as informant sources for ADHD in childhood, these chapters found that 
parent-report, compared to self-report, showed higher validity also across adolescence 
and young adulthood. Chapter 4 further showed that genetic variants that contributed 
to ADHD in children and adults also increased risk for co-occurring traits and disorders 
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in older adults. The modulation of ADHD-related cognitive-EEG and autonomic arousal 
measures were also examined by testing how measures were related to persistence 
and remittance of ADHD (Chapter 2), were modified across recording contexts and 
time (Chapter 5) and were modified from high-intensity exercise (Chapter 6). 
7.5.2 Sample sizes 
One of the main strengths to highlight in this thesis is the use of large sample sizes in 
Chapters 2, 3, 4 and 5 that provided sufficient power to answer important research 
questions on ADHD. The SEFOS sample used in Chapters 2 and 5 consists of 110 
individuals with childhood ADHD and 169 controls. This represents one of the largest 
follow-up studies of clinical ADHD with available cognitive-electrophysiological 
measures. The TCHAD sample used in Chapter 3 consists of 1,480 twin pairs with both 
ADHD symptom rating data and outcome data derived from Swedish national registers, 
making it a rich and well-powered dataset for the analyses. One exception was for the 
outcome measure suicide attempt where only 35 (3%) individuals were identified as 
having attempted suicide. Despite the low prevalence of suicide attempts in the 
sample, (1) analyses were still able to detect significant associations between ADHD 
symptoms (parent- and self-rated) and the outcome and (2) the overall conclusions on 
the comparison of informant sources would not have been affected as the prevalence 
of the outcome was equally low for analyses using self- and parent-ratings.  
 
The UK Biobank resource used in Chapter 4 is especially large, with a sample of over 
150,000 (which has more recently expanded to >500,000) individuals with detailed 
phenotypic and genotypic data and enabled a large-scale investigation of PRSs, derived 
from the largest GWAS on ADHD, with co-occurring traits and disorders for the first 
time. PRSs, however, explained only a small fraction of the variance in the target 
phenotypes, and to obtain a complete picture of the aetiological overlap between 
ADHD and co-occurring features will require even larger sample sizes. Further, the 
analyses were still likely insufficiently powered to detect effects between PRS for 




The PHAB study used in Chapter 6 consisted of a sample of modest size with its 29 
participants, although participants were assessed twice using a cross-over design to 
increase power in the analyses. PHAB was originally designed as a pilot study to inform 
future larger-scale investigations of acute exercise in clinical groups. Even though the 
PHAB sample was similar in size to a large proportion of studies in the acute exercise 
literature and the sample was large enough to detect significant effects of moderate-
to-large size, the analyses were not powered enough to pick up effects of smaller size. 
Thus, future larger-scale studies are needed to investigate subtler effects of acute 
exercise and possible moderating factors.  
7.5.3 Dimensional and categorical definitions of ADHD 
I employed both dimensional (symptoms and impairment ratings) and categorical 
(diagnostic cut-off) definitions of ADHD in this thesis. A strength in Chapters 2 and 5 
was that both types of definitions could be employed to tackle the research questions. 
Specifically, in Chapter 2, parent- and self-report were compared in their strength of 
association with objective measures by comparing both continuous ADHD symptoms 
and impairments, as well as diagnostic groups of ADHD persisters and remitters. In 
Chapter 5, the relationship between ADHD and electrodermal measures was examined 
with both continuous approaches, using ADHD symptoms, and diagnostic approaches, 
using ADHD case and control groups. Adopting both approaches is valuable to obtain a 
complete and accurate picture of ADHD, as defining ADHD outcome is a complex issue 
that different studies have addressed in different ways. While the categorical approach 
reflects the clinical diagnostic groupings of affected and unaffected individuals, which 
is needed for treatment decisions, the dimensional approach uses ratings of symptoms 
and impairments without relying on arbitrary thresholds, better reflecting the research 
on the continuous nature of ADHD (Kuntsi et al., 2014; Larsson et al., 2012; Lubke et 
al., 2009). A dimensional approach is beneficial also as it allows investigations of (1) 
ADHD symptoms and impairments separately, and (2) ADHD using large available 
population-based samples (such as in Chapters 3, 4 and 6). Findings in this thesis 
further support ADHD as the extreme of a continuum of traits, as similar patterns of 
results were obtained using categorical and dimensional approaches to ADHD 
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(Chapters 2, 3 and 5) and genetic variants underlying clinically diagnosed ADHD were 
also found to contribute to common traits in the population (Chapter 4). 
7.5.4 Generalisability 
It should be acknowledged that, because the studies in Chapters 3, 4 and 6 used 
population-based samples, findings may not generalise to individuals with clinically 
diagnosed ADHD. Although behavioural, clinical and aetiological research converge in 
suggesting that ADHD symptoms are the extreme of a normal continuum of behavior 
in the population (Kuntsi et al., 2014; Larsson et al., 2012; Lubke et al., 2009), it would 
be informative to examine (1) the predictive validity of parent- and self-ratings, (2) 
genetic associations between ADHD and co-occurring conditions and (3) the effects of 
acute high-intensity exercise on cognitive-electrophysiological indices of attention, 
inhibition and performance-monitoring in clinical samples as well to validate findings.  
 
Furthermore, the age groups of the studies included in this thesis were restricted to 
adolescents (Chapters 2, 3 and 5) and adults (Chapters 2, 4, 5 and 6). Results may 
therefore not generalise to other age groups than those studied, especially for 
cognitive-EEG indices in ADHD, where maturational effects have been well-studied 
(Liechti et al., 2013; Valko et al., 2009). In studies where age spanned across 
adolescence and young adulthood (Chapters 2 and 5) and across mid-to-older 
adulthood (Chapter 4), analyses were run controlling for age to account for any effects 
due to age. The remaining studies used relatively narrow age groups.  
 
Most participants were males in the SEFOS sample (used in Chapters 2 and 5) and all 
participants were males in the PHAB sample (used in Chapter 6). The study findings 
using these samples therefore provide limited information regarding females. It would 
be informative to investigate the generalisability of our findings by replicating analyses 
in females and examining sex effects in large, well-powered samples that allow for 
such comparisons. The TCHAD and UK Biobank samples used in Chapters 3 and 6 have 
more equal proportions of females and males and therefore the study findings are 
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more generalisable across sex. Further, the studies using these two samples found that 
the pattern of results were similar across males and females.  
7.5.5 Multiple testing 
For several analyses in this thesis (Chapters 2, 5 and 6), multiple testing corrections 
were not applied because of the exploratory nature of the cognitive, 
electrophysiological and electrodermal investigations and to limit the type-two error 
rates (false negative findings). In the three studies involving the SEFOS and PHAB 
samples, analyses were restricted to measures that were expected to be sensitive to 
impairments in ADHD and related behaviours. For example, ERP analyses were limited 
to amplitude measures and not latency measures, as most previous studies using the 
cognitive tasks have reported alterations mainly in amplitude differences (Cheung et 
al., 2017; McLoughlin et al., 2009, 2010). Further, the PHAB study was primarily set up 
as an exploratory pilot-study to inform cognitive-electrophysiological targets in larger-
scale exercise trials and therefore I aimed to reduce the chance for false negatives by 
not applying multiple testing corrections. Due to the exploratory nature of these 
analyses, future replication of the results is important to validate findings before 
drawing on conclusions and applying implications of findings in practice. In the 
interpretation of the study results in these chapters, the emphasis has been placed on 
both effect sizes and p-values of significance to provide a complete picture of the full 
impact of the results.  
 
In Chapters 2 and 3, the main study aims were to compare the overall pattern of 
associations observed for self- versus parent-report of ADHD with objective measures 
and life outcomes. Multiple testing for the different dependent measures was 
therefore not applied as these were not relevant to the main research questions 
comparing self- and parent-report. In the polygenic analyses in Chapter 4, Bonferroni 
corrections were applied to analyses (Supplementary methods in Appendix B) due to 
the high-resolution analysis approach, which involved a much higher number of 




The study designs in the SEFOS and PHAB studies entailed participants performing a 
series of cognitive tasks in a fixed order. As the presentation order of tasks was not 
counterbalanced, this limited the specific research questions that could be 
investigated. In the study of electrodermal ADHD case-control differences across 
resting-state and performance tasks (Chapter 5), I was unable to examine the separate 
effects of time lapse (i.e. fatigue) and cognitive demand – both which could be 
explanations for the different physiological profiles of ADHD observed during the 
different conditions. This was also an issue in the study on the effects of acute exercise 
on performance across three cognitive tasks (Chapter 6), which limited the conclusions 
that could be drawn about the specific effects of exercise on cognitive-
neurophysiological processes. Future studies that wish to examine measures across 
different recording tasks should counterbalance the order of tasks to optimise the 
research questions to be explored.  
7.6 Future directions 
7.6.1 Replication 
Replication of research findings in independent samples using convergent approaches 
will be required to validate the results in this thesis, as these were for the most part 
novel. The comparison studies in Chapter 2 and 3 were the first to contrast the 
predictive and construct validity of self- and parent-report of ADHD in their 
associations with objective (cognitive, EEG and movement) measures and future 
outcomes. It would therefore be informative to replicate these analyses to see if they 
hold using other research samples and investigating other objective measures of ADHD 
and serious life outcomes. In Chapter 4, several of the reported genetic associations 
between ADHD and co-occurring conditions confirmed previous limited findings in the 
genetic literature, while others represented novel associations. Results should 
therefore be replicated in an independent sample, ideally using an even larger number 
of participants in regards to the non-significant genetic associations reported for ADHD 
with BD and schizophrenia, possibly due to low statistical power. As the findings in 
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Chapter 5 on electrodermal activity in ADHD across recording contexts are completely 
novel, these will also need to be replicated before firm conclusions can be drawn 
based on the findings.  
 
It will be especially important to replicate findings from the exercise study in larger 
samples with sufficient power, as the PHAB study was a relatively small sample 
compared to the other studies in this thesis. Although the sample was of a small-to-
moderate size, the study unravelled informative findings on the beneficial effects of 
acute exercise on brain indices for executive and sustained attention as indexed by 
delta power during task performance. However, these analyses were likely not 
powerful enough to detect small-to-modest sizes, and therefore, future larger studies, 
ideally including both men and women, will be needed to confirm and generalise these 
findings.  
7.6.2 Informant source validity in older adulthood 
The studies described in Chapters 2 and 3 set out to investigate the validity of self- and 
parent-report of ADHD in adolescents and young adults, and future studies should 
attempt to extend these analyses to older adults. The research findings in this thesis 
found relatively low agreement between parent- and self-report of ADHD in 
adolescents and young adults and further suggested that parent-report has higher 
validity than self-report and should be prioritised in studies and diagnostic procedures. 
It would be valuable to extend these findings by exploring the validity of informant 
sources in older individuals, to identify if there is a certain age where self-report 
becomes more valuable than other informants. In older adults, informant sources for 
ADHD in research and diagnosis are often partners/spouses rather than parents, as 
parents are not always available and may lack insight into their adult children’s 
behaviour as they become more independent. There is currently little research that 
has compared self- and other-informant sources in middle or late adulthood. One 
study of individuals aged between 17 and 77 years who were relatives to ADHD 
probands, reported that both self- and other informant-report (spouses, parents or 
siblings) ratings scales could predict clinical diagnosis with high accuracy, although the 
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sample size was small with only ten individuals having an ADHD diagnosis (Magnússon 
et al., 2006). For future research, it would especially be informative to conduct 
longitudinal studies, with ADHD ratings collected at multiple time points, to investigate 
if individuals become more accurate in their own descriptions of experienced ADHD 
symptomology from younger to older adulthood. It would for example be useful to 
examine whether the predictive and construct value of self-ratings of ADHD increases 
at a specific point in development (e.g. middle adulthood). This could be of great value 
for both clinicians and researchers when having to decide at which age self-report 
should be used as the main reporting source of ADHD symptoms. 
7.6.3 The role of electrodermal activity in the pathway to behavioural impairments in 
ADHD 
Findings in Chapter 5 along with numerous studies in the literature have demonstrated 
that abnormal physiological arousal profiles, indexed by electrodermal activity, are 
implicated in ADHD (Barry et al., 2012; Beauchaine et al., 2001; Dupuy et al., 2014). 
Little is, however, known about the mechanisms and pathways involved in the 
associations between physiological arousal and ADHD symptomology. A recent study 
by James et al. (2016) found that attentional lapses during a RT task, indexed by RTV, 
were associated with lower SCL-indexed arousal. The study further showed that 
attentional lapses partially explained the pathway between SCL-indexed arousal and 
ADHD, but there were also direct effects between arousal and ADHD that were not 
explained by attentional lapses (James et al., 2016). It would be informative to further 
explore the pathways between physiological arousal and ADHD symptomology by for 
example (1) replicating analyses by James et al. (2016) using NSF-indexed arousal 
measures, and (2) investigating additional potential cognitive processes that may be 
implicated in the pathways. With a greater understanding of the underlying arousal 
profiles in ADHD and how they are implicated in ADHD symptomology and related 
cognitive processes, we would be at an advantage for finding appropriate targets for 
ADHD treatments and interventions.  
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7.6.4 Large-scale exercise trials  
There is a need for large-scale, methodologically strong studies to establish the 
beneficial effects of physical exercise for individuals with ADHD. Effects of both acute 
and chronic exercise on ADHD should be investigated using adequately powered, blind 
sham-controlled randomized clinical trials, ideally establishing both short-term and 
long-term effects.  
 
Findings in Chapter 6 suggest that acute high-intensity exercise improve brain-indices 
of executive and sustained attention. These analyses should ideally be replicated in a 
sample of young individuals with ADHD diagnoses using the same cognitive-
neurophysiological test battery, to explore if effects are similar in individuals with 
greater cognitive-neurophysiological impairment. Ultimately, to inform and optimize 
exercise interventions in ADHD, studies will need to establish the intensity, frequency 
and duration of physical activity required to yield benefits for individuals with ADHD, 
and further explore whether certain individuals benefit more from exercise than 
others, in terms of factors such as age, fitness levels and levels of function 
impairments, with sufficient statistical power. Drawing on the findings from the 
previous data-based chapters in this thesis, it would further be useful to investigate 
change in ADHD symptoms, based on parent-report, in young individuals with ADHD 
after high-intensity exercise to establish the beneficial effects on core symptoms. In 
addition, it would be useful to examine potential pathways of the effect of exercise on 
ADHD symptoms by examining autonomic arousal and cognitive-EEG recordings 
simultaneously, as well as any genetic variants that moderate the beneficial effects of 
exercise.   
7.7 General conclusions 
Overall, this thesis used a multidisciplinary approach, combining behavioural, 
neurocognitive, electrodermal and genetic methods, to provide insights into (1) the 
validity of source-informants used in research and clinical settings, as well as (2) the 
nature of neurobiological and genetic profiles of adolescents and adult with ADHD and 
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potential benefits of physical exercise. In the first part of the thesis, findings suggested 
that both parent- and self-report of ADHD in adolescence and young adulthood may 
provide some valuable insight into symptoms and impairments, but parent-reports 
may have higher construct and predictive validity in this age range. In the second part 
of the thesis, genetic analyses showed that ADHD risk alleles considered ‘en masse’, 
using polygenic risk scores, predicted several frequently co-occurring traits and 
disorders. These findings suggest that common genetic variation underlying risk for 
ADHD also contributes to higher body mass index, neuroticism, anxiety and depressive 
disorders, substance use, risk-taking and lower general cognitive ability in the general 
population. Further, analyses using electrodermal data suggest that abnormal 
autonomic arousal in ADHD, indexed by electrodermal activity, varies as a function of 
recording context rather than reflecting stable impairments in the disorder. Finally, 
results from a randomised cross-over trial show that electroencephalogram (EEG) 
brain measures of specific and general aspects of attention improved after a single 
session of high-intensity exercise, suggesting that high-intensity exercise interventions 
may be appropriate for improving inattentiveness.  
 
In this final chapter, the study findings and implications were discussed along with the 
strengths and limitations of the research designs, samples and analyses used. 
Employing a combination of different methodological approaches and levels of 
analysis, including genetic factors, physiological and neural mechanisms, cognitive 
processes and behavioural symptoms, is beneficial to provide a complete picture of 
the pathways and implicated mechanisms in ADHD. Future studies will need to 
replicate the research findings in this thesis in independent samples to validate novel 
results.  
7.7.1 Overall clinical and aetiological implications 
Clinical implications of the findings in Chapters 2 and 3 are that parent-report should 
generally be prioritised over self-report in adolescents and young adults with ADHD 
during diagnostic procedures, as parent-report may have higher predictive and 
construct validity. Clinicians may not always have access to other informants, such as 
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parents, in young adults with ADHD, however our findings suggest that it is important 
for clinicians to acknowledge that solely relying on self-reports may have its limitations 
and that corroborating with other sources of information would be ideal. 
 
Chapter 4 found that polygenic load for ADHD predicted higher BMI, risk-taking and 
neurotic behaviour, depression and anxiety, alcohol intake frequency and dependency, 
tobacco use and lower general cognitive ability in the population. These findings reveal 
that co-occurrences of other traits and disorders in ADHD are largely due to 
overlapping common genetic variants and that similar genetic influences underlying 
ADHD are at play across age groups. Aetiological implications of Chapters 5 and 6 are 
that the findings suggest that abnormal autonomic arousal and neurophysiological 
indices of ADHD may be modifiable and may not reflect stable impairments. These 
insights have potential clinical implications in that these neurobiological correlates of 
ADHD may be suitable targets for treatment of ADHD symptoms and impairment and 
should be further studied in randomised controlled clinical trials. 
7.7.2 Overall conclusions 
This thesis found that different methodologies converged in suggesting that parent-
report has higher validity than self-report of ADHD in adolescents and young adults. 
This thesis also provided insights into shared genetic overlaps between ADHD and co-
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Appendix A – Supplementary material for Chapter 3 
 
Table S1.A Predictive value of parent- and self-rated attention-deficit/hyperactivity 
disorder symptoms across adolescence on academic, occupational and adverse health 
outcomes; excluding cases with missing values on either parent- or self-ratings 
 Parent-ratings 
OR (95% CI) 
 Self-ratings 
OR (95% CI) 
 
 Crude  Crude  
13-14 years     
No graduate degree 1.20 (1.11, 1.30)**  1.07 (1.03, 1.12)** 
Unemployment 1.14 (1.06, 1.23)**  1.02 (0.94, 1.11) 
Criminality 1.21 (1.11, 1.32)**  1.10 (0.98, 1.23) 
Injuries 1.12 (1.05,1.20)**  1.07 (1.00, 1.15)* 
Suicide attempts  1.13 (1.00, 1.29)  1.05 (0.91, 1.22) 
Substance use 
disorders  
1.15 (1.04, 1.26)**  1.14 (1.02, 1.26)* 
16-17 years    
No graduate degree 1.49 (1.35, 1.65)**  1.13 (1.08, 1.18)** 
Unemployment 1.15 (1.06, 1.25)**  1.04 (0.96, 1.11)** 
Criminality 1.28 (1.15, 1.42)**  1.17 (1.06, 1.29)** 
Injuries 1.12 (1.03, 1.22)**  1.04 (0.97, 1.12) 
Suicide attempts 1.17 (1.00, 1.36)*  1.14 (1.02, 1.28)* 
Substance use 
disorders 
1.19 (1.06, 1.34)**  1.17 (1.07, 1.29)** 






Table S2.A Predictive value of parent- and self-rated attention-deficit/hyperactivity 
disorder symptoms in females across adolescence on academic, occupational and 
adverse health outcomes (N=1,507, only females) 
 Parent-ratings 
OR (95% CI) 
Self-ratings 
OR (95% CI) 
 Crude Adjusted for 
self-ratings 
Crude Adjusted for  
parent-ratings 
13-14 years     
No graduate 
degree 
1.20(1.07,1.35)** 1.16(1.03,1.30)* 1.08(1.02,1.13)** 1.05(0.99, 1.11) 
Unemployment 1.19(1.07,1.33)** 1.18(1.05,1.33)** 1.08(0.99,1.18) 1.05(0.95,1.15) 
Criminality 1.29(1.13,1.48)** 1.30(1.09,1.55)** 1.11(0.91,1.36) 0.98(0.75,1.29) 
Injuries 1.11(1.00,1.23) 1.10(0.98,1.25) 1.02(0.93,1.12) 1.02(0.92,1.14) 
Suicide 
attempts  
1.15(0.99,1.35) 1.15(0.96,1.39) 1.11(0.93,1.31) 1.01(0.83,1.23) 
Substance use 
disorders  
1.20(1.05,1.36)** 1.16(1.01,1.33)* 1.15(0.99,1.33) 1.06(0.91,1.24) 
16-17 years     
No graduate 
degree 
1.47(1.29,1.67)** 1.39(1.22,1.59)** 1.17(1.11,1.24)** 1.08(1.01,1.15)* 
Unemployment 1.24(1.11,1.38)** 1.18(1.05,1.34)** 1.10(1.01,1.20)* 1.07(0.97,1.18) 
Criminality 1.42(1.21,1.67)** 1.30(1.02,1.67)* 1.25(1.08,1.45)** 1.25(0.99,1.58) 
Injuries 1.12(0.99,1.27) 1.14(1.00,1.29)* 1.03(0.94,1.13) 0.98(0.88,1.09) 
Suicide 
attempts 
1.16(0.96,1.40) 1.13(0.90,1.43) 1.08(0.96,1.22) 1.06(0.90,1.25) 
Substance use 
disorders 
1.13(0.91,1.40) 1.08(0.83,1.40) 1.10(0.98,1.24) 1.10(0.92,1.32) 




Table S3.A Predictive value of parent- and self-rated attention-deficit/hyperactivity 
disorder symptoms in males across adolescence on academic, occupational and 
adverse health outcomes (N=1,436, only males) 
 Parent-ratings 
OR (95% CI) 
Self-ratings 
OR (95% CI) 
 Crude Adjusted for  
self-ratings 
Crude Adjusted for  
parent-ratings 
13-14 years     
No graduate 
degree 
1.20(1.08, 1.33)** 1.18(1.06, 1.31)** 1.07(1.01, 1.14)* 1.03(0.96, 1.10) 
Unemployment 1.08(0.98, 1.20) 1.17(1.06, 1.29)** 0.90(0.79, 1.03) 0.86(0.75, 0.99)* 
Criminality 1.15(1.03, 1.29)* 1.12(0.99, 1.26) 1.12(1.01, 1.26)* 1.06(0.93, 1.20) 
Injuries 1.14(1.04, 1.24)** 1.11(1.01, 1.23)* 1.11(1.01, 1.22)* 1.05(0.94, 1.17) 
Suicide 
attempts  
1.16(0.96, 1.40) 1.21(0.98, 1.51) 1.04(0.81, 1.33) 0.90(0.65, 1.23) 
Substance use 
disorders  
1.11(0.97, 1.28) 1.05(0.87, 1.25) 1.20(1.05, 1.37)** 1.14(0.95, 1.36) 
16-17 years     
No graduate 
degree 
1.50(1.32, 1.71)** 1.48(1.28, 1.70)** 1.17(1.09, 1.25)** 1.09(1.01, 1.17)* 
Unemployment 1.07(0.96, 1.20) 1.16(1.00, 1.34)* 0.90(0.81, 1.01) 0.86(0.75, 0.99)* 
Criminality 1.24(1.10, 1.41)** 1.17(0.98, 1.39) 1.17(1.06, 1.29)** 1.08(0.93, 1.26) 
Injuries 1.13(1.02, 1.26)* 1.09(0.97, 1.24) 1.10(1.01, 1.21)* 1.04(0.93, 1.15) 
Suicide 
attempts 
1.33(1.11, 1.60)** 1.23(0.99, 1.53) 1.14(0.82, 1.56) 1.07(0.81, 1.41) 
Substance use 
disorders 
1.25(1.10, 1.43)** 1.14(0.95, 1.37) 1.20(1.06, 1.36)** 1.17(1.00, 1.36) 





Table S4.A Predictive value of parent-rated attention-deficit/hyperactivity disorder 
symptoms, excluding items not present in the self-rating scale, across adolescence on 
academic, occupational and adverse health outcomes  
 Parent-ratings 
OR (95% CI) 
 
 Crude Adjusted for self-ratings  
13-14 years    
No graduate degree 1.19 (1.10, 1.28)** 1.18 (1.09, 1.28)**  
Unemployment 1.13 (1.05, 1.22)** 1.00 (0.92, 1.08)  
Criminality 1.18 (1.08, 1.29)** 1.18 (1.06, 1.31)**  
Injuries 1.13 (1.06, 1.21)** 1.10 (1.02, 1.20)*  
Suicide attempts  1.15 (1.02, 1.30)* 1.13 (0.96, 1.32)  
Substance use 
disorders  
1.16 (1.06, 1.27)** 1.08 (0.96, 1.21)  
16-17 years    
No graduate degree 1.40 (1.28, 1.52)** 1.38 (1.26, 1.52)**  
Unemployment 1.16 (1.07, 1.25)** 1.03 (0.96, 1.10)  
Criminality 1.27 (1.15, 1.42)** 1.21 (1.04, 1.41)*  
Injuries 1.13 (1.04, 1.23)** 1.11 (1.01, 1.21)*  
Suicide attempts 1.18 (1.01, 1.36)* 1.11 (0.92, 1.33)  
Substance use 
disorders 
1.16 (1.03, 1.32)* 1.12 (0.97, 1.30)  







Table S5.A Odds of experiencing each adverse socioeconomic and health outcome if 
individuals score >95% centile compared to <95th centile on ADHD symptoms rated by 
each informant in early and late adolescence  
 Parent-ratings 
OR (95% CI) 
 Self-ratings 
OR (95% CI) 
 
13-14 years     
No graduate degree 2.60 (1.44, 5.10)  1.23 (0.77, 2.02) 
Unemployment 2.00 (0.90, 4.00)  1.73 (0.75, 3.55) 
Criminality 5.15 (2.12, 10.93)  2.78 (1.03, 6.36) 
Injuries 2.03 (0.95, 3.95)  2.41 (1.23, 4.41) 
Suicide attempts  2.28 (0.43, 7.72)  1.47 (0.17, 6.03) 
Substance use 
disorders  
3.29 (1.30, 7.29)  1.01 (0.20, 3.20) 
16-17 years    
No graduate degree 13.32 (4.40, 65.85)  1.83 (1.11, 3.14) 
Unemployment 1.79 (0.77, 3.69)  1.23 (0.47, 2.70) 
Criminality 3.37 (1.24, 7.87)  1.77 (0.54, 4.51) 
Injuries 1.64 (0.71, 3.37)  1.61 (0.73, 3.18) 
Suicide attempts 1.68 (0.19, 7.01)  1.45 (0.16, 5.96) 
Substance use 
disorders 
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Supplemental methods 
Significance thresholds  
For our primary PRS analyses, we selected a conservative significance threshold to 
control for multiple testing by applying a Bonferroni correction. Euesden et al. (1) 
recommend using a significance threshold of at least P=0.004 in order to control for 
the high-resolution scoring approach of selecting the most predictive PRS. As we 
tested the most predictive PRS across each of the 19 target and control phenotypes, 
we divided the P-value by the number of tests performed (P=0.004/19), which resulted 
in a significance threshold of P=2.1x10-4.    
 
For our secondary analyses, where we tested the main effects of sex and PRS*sex 
interaction effects, we selected a conservative significance threshold of P=0.01 as we 
did not have strong a priori hypotheses of the effects. We applied Bonferroni 
correction in order to control for the 22 secondary analyses we ran (P=0.01/22), which 
resulted in a significance threshold of P=4.5x10-4.     
 
1: Euesden J, Lewis CM, O’Reilly PF. PRSice: Polygenic Risk Score software. 




Table S1.B List of items in the Verbal-Numerical Reasoning test 
Question Possible answers 
Add the following numbers 
together: 1 2 3 4 5 – is the answer? 
13/14/15/16/17/Do not know/Prefer not to 
answer 
Which number is the largest? 642/308/987/714/253/Do not know/Prefer 
not to answer 
Bud is to flower as child is to? Grow/Develop/Improve/Adult/Old/Do not 
know/Prefer not to answer 
11 12 13 14 15 16 17 18 Divide the 
sixth number to the right of twelve 
by three. Is the answer? 
5/6/7/8/Do not know/Prefer not to answer 
If Truda’s mother’s brother is Tim’s 
sister’s father, what relation is Truda 
to Tim? 
Aunt/Sister/Niece/Cousin/No relation/Do 
not know/Prefer not to answer 
If sixty is more than half of seventy-
five, multiply twenty-three by three. 
If not subtract 15 from eighty-five. Is 
the answer? 
68/69/70/71/72/Do not know/Prefer not to 
answer 
Stop means the same as? Pause/Close/Cease/Break/Rest/Do not 
know/Prefer not to answer 
If David is twenty-one and Owen is 
nineteen and Daniel is nine years 
younger than David, what is half 
their combined age? 
25/26/27/28/29/Do not know/Prefer not to 
answer 
Age is to years as height is to? Long/Deep/Top/Metres/Tall/Do not 
know/Prefer not to answer 
150...137...125...114...104... What 
comes next? 
96/95/94/93/92/Do not know/Prefer not to 
answer 
Relaxed means the opposite of? Calm/Anxious/Cool/Worried/Tense/Do not 
know/Prefer not to answer 
100...99...95...86...70...What comes 
next? 
50/49/48/47/46/45/Do not know/Prefer 
not to answer 
If some flinks are plinks and some 
plinks are stinks then some flinks are 
definitely stinks? 
False/True/Neither true nor false/Not 
sure/Do not know/Prefer not to answer 
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Table S2.B List of items in the Eysenck Personality Inventory Neuroticism scale – 
Revised (EPIN-R) 
Note: If individuals responded ‘Do not know’ or ‘Prefer not to answer’, they were 








Question Possible answers 
Does your mood often go up and down? 
Yes/No/Do not know/Prefer not to 
answer 
Do you ever feel ‘just miserable’ for no 
reason? 
 
Are you an irritable person?  
Are your feelings easily hurt?  
Do you often feel ‘fed-up’?  
Would you call yourself a nervous person?  
Are you a worrier?  
Would you call yourself tense or ‘highly 
strung’? 
 
Do you worry too long after an 
embarrassing experience? 
 
Do you suffer from ‘nerves’?  
Do you often feel lonely?  




Table S3.B List of ICD-10 codes for psychiatric diagnoses used as target phenotypes 
Psychiatric diagnoses ICD-10 codes 
Anxiety and stress-related disorders  
Phobic anxiety disorders F40 
Other anxiety disorders F41 
Obsessive-compulsive disorder  F42 
Reaction to severe stress, and adjustment disorders 
(includes post-traumatic stress disorder) 
F43 
Depressive disorders  
Depressive episode F32 
Recurrent depressive disorder F33 
Bipolar affective disorder F31 
Schizophrenia, schizotypal and delusional disorders  
Schizophrenia F20 
Schizotypal disorder F21 
Persistent delusional disorders F22 
Acute and transient psychotic disorders F23 
Induced delusional disorder F24 
Schizoaffective disorders F25 
Other nonorganic psychotic disorders F28 
Unspecified nonorganic psychosis F29 
Mental and behavioural disorders due to use of alcohol  
Acute intoxication F10.0 
Harmful use F10.1 
Dependence syndrome F10.2 
Withdrawal state F10.3 
Withdrawal state with delirium F10.4 
Psychotic disorder F10.5 
Amnesic syndrome F10.6 
Residual and late-onset psychotic disorder F10.7 
Other mental and behavioural disorders F10.8 





Table S4.B List of responses for alcohol intake frequency measure 
Note: Answers were reverse-coded and individuals who responded ‘Do not know’ or 














Question Possible answers 
About how often do you drink alcohol? 1=Daily or almost daily 
2=Three or four times a week 
3=Once or twice a week 
4=One to three times a month 










N Cases (%) 
Height (cm) 
Standing height measured in 
centimeters during initial assessment 
135,495 168.70 (9.21) 
Age (years) 
Age when attended initial assessment, 
derived from date of birth and date of 
attending assessment centre and 
truncated to whole year 
135,726 56.79 (7.96) 
Year of initial 
assessment 








Number of self-reported cancers 
recorded using a touch-screen self-
completed questionnaire followed by 
an interview at initial assessment 
135,146 0.09 (0.31) 
Hand grip 
strength 
Hand grip strength of left hand 
measured using a Jamar J00105 
hydraulic hand dynamometer. This 
measures grip force isometrically in 
kilograms. 
135,163 29.89 (11.35) 
Visual acuity 
Visual acuity of left eye measured as 
smallest size letters that are reliably 
identified at a specified distance. The 
UK Biobank system is based on a 
traditional LogMar chart with data 
captured by Direct Entry to Vox. 




Question: “Are you menstruating 
today?” Possible answers: Yes/No/Do 
not know/Prefer not to answer. 
18,829 2,781 (15%) 
Sex of baby 
Sex of baby refers to the sex of the 
participants’ child as recorded across 
all episodes in hospitals. Possible 
codes: 0=Not 
known/1=Male/2=Female/3= 
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Table S6.B Detailed summary of educational achievement 
 
Note: Participants that replied ‘None of the above’ or ‘Prefer not to answer’ were 










    
Description of education 
variable 
Items 
Education was based on self-
report of highest 
qualification achieved. 
1=College or University degree 
2=A levels/AS levels or equivalent 
3=O levels/GCSEs or equivalent 
4=CSEs or equivalent 
5=NVQ or HND or HNC or equivalent 
6=Other professional qualifications e.g.: nursing, 
teaching 
-7=None of the above 




Table S7.B Predictive accuracy of PRS on the target phenotypes after controlling for 













 P PT R2 (%) 
BMI 2.7*10-99 0.121 0.342 
Verbal-numerical reasoning 2.9*10-9 
0.418 
0.070 
Alcohol intake frequency 2.7*10-5 0.231 0.013 
Risk taking 1.2*10-25 0.291 0.120 
Neuroticism 3.5*10-12 0.139 0.045 
Tobacco use 1.6*10-13 0.488 0.230 
Depressive disorder 1.7*10-8 0.033 0.067 
Alcohol dependency 2.6*10-5 0.175 0.177 
Anxiety disorder 0.005 0.116 0.037 
Bipolar disorder 0.041 0.117 0.022 

































































































































Figure S11.B Plot for tobacco use 
Note: P-value threshold represents the P-value at the cut-off for inclusion of single-
nucleotide polymorphisms in the polygenic risk score. Values on top of the bars 
represent P-values for the regression models.  
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Table S1.C Associations between skin conductance measures and oppositional defiant 
disorder/conduct disorder symptoms within each (ADHD and control) group 
ODD/CD: Oppositional defiant disorder/conduct disorder symptoms. CPT: Continuous 
performance task. SCL: Skin conductance level. NSFs: non-specific fluctuations per 
second.  










 NSFs SCL 
 ADHD  Controls ADHD  Controls 
ODD/CD Beta p Beta p Beta p Beta p 
Rest1 0.01 0.92 0.04 0.50 -0.15 0.41 0.03 0.63 
CPT -0.04 0.79 0.02 0.77 -0.15 0.33 0.05 0.48 
Fast Task 0.05 0.40 -0.02 0.78 0.11 0.44 -0.01 0.98 
Rest 2 -0.04 0.77 0.09 0.13 -0.03 0.85 -0.02 0.84 
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Table S2.C Pair-wise tests between groups (ADHD and control) in each condition on 











CPT: Continuous performance task. SCL: Skin conductance level. NSF: non-specific 









Condition ADHD case-control comparison 
  t p Cohen’s d 
Rest time 1 SCL -0.44 0.66 -.07 
NSF 0.50 0.62 .08 
CPT SCL 0.20 0.84 .03 
NSF 0.40 0.69 .06 
Fast Task SCL -1.17 0.24 -.09 
NSF 2.48 0.01 .38 
Rest time 2 SCL 0.68 0.50 .10 
NSF 2.37 0.02 .36 
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Table S3.C Main and interaction associations between skin conductance and IQ 
CPT: Continuous performance task. SCL: Skin conductance level. NSF: non-specific 














 NSFs SCL 
 Main  Interaction Main  Interaction 
IQ Beta p Beta p Beta p Beta p 
Rest1 0.02 0.80 0.18 0.20 0.14 0.04 0.22 0.21 
CPT 0.05 0.48 0.17 0.27 0.17 0.02 0.30 0.09 
Fast Task 0.02 0.77 -0.07 0.62 0.40 <0.01 0.10 0.49 
Rest 2 -0.01 0.96 0.02 0.89 0.17 0.02 0.04 0.83 
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Table S4.C Pair-wise tests between groups (ADHD and control) in each condition on 
skin conductance measures: Controlling for age and gender 
CPT: Continuous performance task. SCL: Skin conductance level. NSF: non-specific 








Condition ADHD case-control comparison 
  t df p Cohen’s d 
Rest time 1 SCL -1.31 176 0.19 -0.20 
NSF 0.27 175 0.78 0.04 
CPT SCL -0.90 188 0.37 -0.13 
NSF -0.11 188 0.91 0.02 
Fast Task SCL -3.71 171 <.01 -0.57 
NSF 1.98 173 0.05 0.30 
Rest time 2 SCL -0.39 180 0.70 -0.06 
NSF 2.04 177 0.04 0.31 
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Appendix D – Supplementary material for Chapter 6 
 
Table S1.D Means and standard deviations of EEG frequency bands within each region 
during each Time points (Pre- and Post-intervention) and Session (Exercise and Resting 
control) during the CPT-OX 




 Exercise intervention Resting control 
 Pre Post Pre Post 
Delta     
frontal 5.21 (4.63) 7.20 (7.63) 5.35 (3.66) 5.18 (2.21) 
central 2.42 (2.25) 3.31 (2.19) 2.37 (1.16) 3.11 (3.24) 
parietal 3.94 (2.63) 5.81 (4.23) 4.18 (2.38) 4.66 (2.46) 
Theta     
frontal 0.65 (0.63) 0.81 (0.74) 0.73 (0.75) 0.85 (0.80) 
central 0.32 (0.23) 0.42 (0.35) 0.39 (0.32) 0.48 (0.39) 
parietal 0.62 (0.70) 0.79 (0.92) 0.76 (0.96) 0.86 (0.96) 
Alpha     
frontal 0.79 (1.72) 0.94 (1.64) 0.84 (1.70) 0.98 (1.75) 
central 0.48 (0.74) 0.58 (0.70) 0.55 (0.88) 0.68 (0.97) 
parietal 1.21 (2.45) 1.66 (2.87) 1.42 (2.88) 1.67 (2.83) 
Beta     
frontal 0.14 (0.09) 0.19 (0.18) 0.15 (0.11) 0.16 (0.07) 
central 0.08 (0.04) 0.09 (0.05) 0.09 (0.06) 0.10 (0.05) 
parietal 0.12 (0.05) 0.16 (0.08) 0.14 (0.07) 0.15 (0.07) 
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Table S2.D All main and interaction effects of Time (Pre- and Post-intervention), 
Condition (Exercise and Resting control) and Region (Frontal, Central and Parietal) on 
cognitive and brain measures during the Continuous Performance Task 
 Chi2 P-value 
MRT        Condition 1.96 0.16 
                 Time 0.03 0.87 
                 ConditionxTime 0.36 0.55 
RTV          Condition 0.14 0.71 
                 Time 5.19 0.02 
                 ConditionxTime 0.73 0.39 
OE            Condition 3.24 0.07 
                 Time 4.12 0.04 
                 ConditionxTime 0.02 0.89 
CE             Condition 1.08 0.30 
                 Time 11.30 0.001 
                  ConditionxTime 0.14 0.71 
CNV         Condition 0.77 0.38 
                 Time 1.63 0.20 
                 ConditionxTime 0.21 0.65 
Cue P3     Condition 0.41 0.52 
                 Time 0.15 0.70 
                 ConditionxTime 0.01 0.94 
NoGo P3 Condition 0.25 0.61 
                 Time 4.75 0.03 
                 ConditionxTime 0.03 0.87 
Go P3      Condition 0.21 0.65 
                 Time 2.28 0.13 
                 ConditionxTime 4.97 0.03 






















MRT: Mean reaction time, RTV: Reaction time variability, OE: Omission error, CE: 
Commission error, CNV: Contingent negative variation. 
                 Time 11.09 <.001 
                 Region 66.18 <.001 
                 ConditionxTime 5.20 0.02 
                 ConditionxRegion 1.52 0.47 
                 TimexRegion 0.43 0.80 
                 ConditionxTimexRegion 1.98 0.37 
Theta      Condition 0.4.16 0.04 
                 Time 11.83 0.001 
                 Region 83.04 <.001 
                 ConditionxTime 0.44 0.51 
                 ConditionxRegion 0.28 0.87 
                 TimexRegion 0.33 0.85 
                 ConditionxTimexRegion 0.11 0.95 
Alpha      Condition 0.57 0.45 
                 Time 3.59 0.06 
                 Region 52.15 <.001 
                 ConditionxTime 0.07 0.80 
                 ConditionxRegion 0.07 0.96 
                 TimexRegion 0.99 0.61 
                 ConditionxTimexRegion 0.22 0.89 
Beta        Condition 0.01 0.98 
                 Time 9.16 0.003 
                 Region 60.26 <.001 
                 ConditionxTime 1.17 0.28 
                 ConditionxRegion 1.98 0.37 
                 TimexRegion 0.92 0.63 
                 ConditionxTimexRegion 1.59 0.45 
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Table S3.D Means and standard deviations of cognitive and brain measures during 
each Time point (Pre- and Post-intervention) and Condition (Exercise and Resting 
control) during the Eriksen Flanker Task 
Cong: Congruent trial, Incong: Incongruent trial, MRT: Mean reaction time, RTV: 
Reaction time variability. Average EEG frequency band measures are reported across 






 Exercise intervention Resting control 
 Pre Post Pre Post 
Errors (Cong) 2.84 (2.48) 3.88 (3.64) 2.92 (2.45) 4.04 (3.40) 
Errors 
(Incong) 
44.88 (15.66) 41.92 (15.17) 42.35 (14.58) 41.35 (14.27) 
MRT (Cong) 321.67 (35.85) 318.08 (35.11) 328.37 (39.43) 322.41 (36.21) 
MRT (Incong) 402.38 (41.33) 394.97 (41.15) 410.22 (45.69) 402.36 (36.92) 
RTV (Cong) 69.27 (25.11) 76.20 (32.14) 74.84 (29.29) 76.89 (33.20) 
RTV (Incong) 62.60 (24.52) 69.51 (25.62) 68.37 (25.10) 70.43 (25.31) 
N2 (Cong) -2.49 (1.93) -1.80 (2.16) -2.12 (2.21) -1.77 (1.20) 
N2 (Incong) -1.83 (1.87) -1.39 (1.95) -1.97 (2.31) -1.68 (2.06) 
ERN -6.22 (3.56) -5.33 (3.24) -6.31 (3.27) -5.83 (2.69) 
Pe 7.03 (3.52) 8.09 (4.61) 6.45 (4.61) 7.32 (5.03) 
Delta 5.15 (8.12) 4.57 (3.35) 5.94 (11.20) 5.28 (10.94) 
Theta 0.67 (0.65) 0.73 (0.68) 0.75 (0.85) 0.76 (0.70) 
Alpha 0.89 (1.55) 1.03 (1.61) 0.95 (1.81) 0.98 (1.60) 
Beta 0.15 (0.18) 0.15 (0.14) 0.13 (0.12) 0.15 (0.10) 
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Table S4.D Means and standard deviations of cognitive and brain measures during 
each Time point (Pre- and Post-intervention) and Condition (Exercise and Resting 
control) during the Fast Task 
MRT: Mean reaction time, RTV: Reaction time variability. Average EEG frequency band 












 Exercise intervention Resting control 
 Pre Post Pre Post 
MRT 49.84 (10.37) 52.33 (17.16) 54.70 (22.50) 55.78 (22.64) 
RTV 13.62 (16.20) 21.70 (31.60) 24.57 (39.92) 24.20 (37.99) 
P3 6.30 (3.69) 4.90 (5.56) 6.56 (3.90) 5.69 (4.79) 
Delta 3.57 (2.56) 4.12 (3.49) 3.42 (2.71) 4.01 (3.21) 
Theta 0.64 (0.73) 0.66 (0.69) 0.66 (0.77) 0.74 (0.86) 
Alpha 0.90 (1.66) 0.89 (1.33) 0.97 (1.71) 0.98 (1.64) 
Beta 0.13 (0.08) 0.13 (0.09) 0.14 (0.09) 0.15 (0.10) 
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Table S5.D Main and interaction effects of Time (Pre- and Post-intervention), Condition 
(Exercise and Resting control) and Region (Frontal, Central and Parietal) on cognitive 


















MRT: Mean reaction time, RTV: Reaction time variability, NS: Not significant. Only 
significant main and interaction effects are reported.  
 Chi2 P-value 
Errors (Congruent)   
Time 4.87 0.03 
Errors (Incongruent)   
NS   
MRT (Congruent)   
Session 5.93 0.01 
MRT (Incongruent)   
Session 7.16 0.01 
Time 6.45 0.01 
RTV (Congruent)   
NS   
RTV (Incongruent)   
NS   
N2 (Congruent)    
Time 7.91 0.01 
N2 (Incongruent)    
Time 4.35 0.04 
ERN (Incongruent)   
Time 6.10 0.01 
Pe (Incongruent)   
Time 8.71 0.01 
Delta   
Region 22.74 <.001 
Theta   
Region 88.92 <.001 
Alpha   
Region 87.76 <.001 
Beta   
Region 99.90 <.001 
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Table S6.D Main and interaction effects of Time (Pre- and Post-intervention), Condition 
(Exercise and Resting control) and Region (Frontal, Central and Parietal) on cognitive 













MRT: Mean reaction time, RTV: Reaction time variability, NS: Not significant. Only 





 Chi2 P-value 
MRT   
Condition 5.69 0.02 
RTV   
Condition 3.74 0.05 
P3   
NS   
Delta   
Region 103.90 <.001 
Time 5.44 0.02 
Theta   
Region 99.85 <.001 
Alpha   
Region 75.04 <.001 
Beta   
Region 98.04 <.001 
Condition 4.95 0.03 
